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ABSTRACT 
The historical, biological and synthetic aspects 
of -lactam antibiotics are reviewed. 
This is a study of a novel approach to 
bisnorpenicillin, involving an intramolecular Michael 
addition of a thiol onto an acrylate moiety. 	The 
development of novel protecting groups,for the thiol 
functional group, in 4-thioazetidin-2--one, such as 
trimethylsilyl-, trimethyistannyl - and phenylselenenyl-, 
were investigated. 	The application of solid phase 
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CHAPTER ONE - INTRODUCTION 
1.0.0' Introduction 
The family of $-lactam antibiotics haS now been 
available on the market for more than four decades. 
The- low toxicity to mammalian cells (with the exception 
of the small percentage of allergy sufferers) and good 
activity against a broad spectrum of bacterial pathogens, 
make them the antibiotics of choice for the treatment of 
most common infections. 
At an early stage in the use of these antibiotics', 
most treatable bacteria were found to produce enzymes, 
called $-lactamases, which inactivated the antibiotic. 
This prompted a great deal of research in the hope of 
understanding and overcoming this growing problem of 
bacterial resistance. 	The financial rewards in 
obtaining an antibiotic in this class may be very high, 
if a derivative is produced which possesses non 
allergenic properties, the required in vivo stability, 
,B-lactamase resistance or -lactamase inhibition 
properties, and potent activity towards a broad spectrum 
of bacteria. 	Consequently, a great deal of work has 
been undertaken by the major pharmaceutical companies. 
The -lactam area of research is active on many 
fronts, as evident from the growing literature. 	It 
would be a formidable task to attempt a comprehensive 
account on each of the researched areas. 
This review will be divided into three parts. 
The first part will deal with a brief history of these 
antibiotics, and will be confined to the screening 
aspect, as this has been the most successful method of 
producing novel structures with bioactive properties. 
The second part will be concerned with the biological 
aspects of the cell wall, in respect to the lethal effect 
of -lactam antibiotics, and -lactamase inhibition 
2 
properties of some common -1actam derivatives and also 
the biosynthesis of these antibiotics. 	The third part 
will deal with the synthetic aspects of this area. 	The 
synthesis of the p-lactam ring will be given briefly by 
both total synthesis and by penicillin degradation 
methods. 	The major part of this final section will 
concentrate on approaches to the four-five and the four- 
six fused systems. 	The final part of the last section 
will outline the future trends in this area of research. 
1.1.0 Historical Development of Vlactam Antibiotics 
It was the fortunate observation, first reported 
by Fleming1 in 1929, that the presence of a contaminant 
mould (Penicilliuin notatum) facilitated the lysis of 
surrounding bacterial cells which led workers such as 
Florey, Chain and Heately to finally isolate the active 
ingredient and to the production of "penicillin" 
commercially by 1945. 	Penicillin G (1) (Scheme 1) was 
the first commercially available p-lactam antibiotic. 
Soon after the availability of a pure crystalline sample, 
its structure was confirmed by X-ray diffraction by 
Crowfoot. 2 	The early history of penicillin affords 
an interesting account of the early endeavours in 
isolation, purification and chemical modification of 
pen i c ill in. 3 
It was soon discovered that by changing the growth 
medium of the mould, a modified penicillin could be 
formed. 	This differed from penicillin G in its 
acylamino side-chain in the C-6 position, (Scheme 1). 
The alteration gave rise to a change in acid stability 
and a slight change in the spectrum of activity. 	Only a 
limited number of changes could be made in this way, 
(Table I), since the modification of the side chain 
3 
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Scheme 1 Structure of benzy1penicil1nic acid - 
Penicillin G. 
Table I Side chains of natural penicillins 
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depended upon the ability of the mould to take up the 
substrate from the medium and to incorporate it into the 
penicillin molecule. 	This type of modification resulted 
in the acid stable penicillin V (2), which was superior 
to penicillin G (1) in that it could be administered 
orally. 	Initial attempts to modify the side chain 
chemically were restricted due to the shortage of 
penicillin G which was a result of the latter's 
contemporary high demand as a therapeutic agent. 	Work 
began on the enzymatic removal of the side chain. This 
was soon successful, 4 but the important intermediate, 
6-aminopenicillanic acid(6.A.P.A.) (3) (Table II) was 
still in short supply. 	Workers at Beecham 5 found that 
(3) could be isolated, in high yield, from a 
precursor-starved medium. 	Furthermore, improvements in 
fermentation techniques and the use of a high yielding 
penicillin strain from Penicillium chrysogenum, obtained 
by mutation experiments, made it possible to satisfy the 
high demand relatively easily and very cheaply. 	The 
greater supply of this important intermediate (3) gave 
rise to thousands of penicillin derivatives. 	These 
contained a wide variety of C-6 acylamino side chains, 
which had hitherto been unobtainable. 6 	Of these,only a 
few, namely, ampicillin (4) and carbenicillin (5) had any 
improved activity compared to penicillin G (1) and 
penicillin V (2).. 	A few other examples are given in 
Table II. 
It was soon realised by clinicians that Gram-
positive bacteria, such as Staphylococcus aureus, which 
were once very sensitive to penicillins, were becoming 
insensitive. 	These bacteria produced enzymes which 
inactivated the penicillins by hydrolysis to penicilloic 
acids (11) (Scheme 2). 	The problem was quite serious in 
hospitals where penicillin antibiotics were administered 
liberally and where penicillin-resistant strains were 
first detected. 	This discovery gave rise to the imple- 
mentation of controls on the use of these antibiotics. 
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development of some penicillinase resistant derivatives, 
either by total or semi-synthesis. 	Efforts in this 
direction resulted in a few resistant penicillins (10), 
(6) and (7) from semi- synthesis. 	However, totally 
synthetic attempts were unfortunately rewarded with 
derivatives which had considerably lower activity than 
the parent nucleus. 
The screening of moulds from all sources had begun 
soon after the isolation of penicillin. 	A sample of 
mould isolated by Brotzu from a sewerage outlet in 
Sardinia was sent to Abraham at Oxford in 1945. 	This 
was identified as Cephalosporium acremonium. 	Work on 
this sample resulted in the isolation of a substance 
which had poor activity but was stable to the 
penicillanases. 	It was only after a great deal of 
perseverance that the structure of this substance was 
finally identified and reported by Abraham in 1963. 
The novel structure was named cephalosporin C (12) 
(Scheme 3) and was found to be related to penicillin, but 
had a dihydrothiazine ring, rather than a thiazolidine 
ring fused to the /3-lactam ring. 	The experience gained 
with penicillins suggested that the activity of this 
antibiotic may be improved by modification of the 
acylamino side chain in the C-7 position. 	It was not 
possible to remove the side chain, either enzymatically 
or from a precursor-starved medium, in order to obtain 
the corresponding intermediate 7-amino cephalosporanic 
acid (7.A.C.A.) (13) (Scheme 4). 	The acylamino side 
chain removal was finally achieved chemically by the use 
of nitrosyl chloride (NOd), for diazotisation of the 
a-amino group of the U-aminoadipoyl side chain in 
cephalosporin C (12). 	This then underwent an intra- 
molecular cyclisation to result in an imino lactone which 
readily hydrolysed to the amino derivative (13) on 
aqueous work-up. 	Poor yields were initially obtained 
but were improved by workers at Eli Lilly. 8 Availability 
of (13) on a large scale, enabled workers to produce many 
acylamino side clain analogues of higher activity than 
WF 
HHH 




Scheme 2 Structure of penicilloic acid. 
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Scheme 4 Structure of 7-amino cephalosporanic acid. 
the parent-system (Table III). In addition, the 
cephalosporin derivatives were more expensive than 
penicillins due to the-low yielding strains and also due 
to the extra chemical step involved in the manufacture of 
the intermediate (13). 	The first commercially available 
cephalosporin was cephalothin (14) (Scheme 5), 	which 
was shortly followed by cephaloridine (15) (Scheme 6). 
These derivatives were found to be active against 
penicillinase-producing bacteria and also in treating 
patients possessing allergy to penicillins. 	Furthermore, 
the cephalosporins were found to be more acid stable, and 
had a broader spectrum of activity than penicillin, 
however, they were less potent than penicillins against 
non-resistant organisms. 	During the use of 
cephalosporins, it became apparent that some bacteria 
also-produced cephalosporinases. 	This made these 
derivatives useless against the growing number of 
resistant strains of bacteria. 	Work progressed with the 
same urgency, as when the penicillinases were first 
discovered, although now, with controls on the use of the 
these antibiotics, there was less abuse of these drugs 
and consequently, the problem of resistance was not so 
wide-spread. 
The chemical investigations on the s.tereochemical 
requirements, at this stage of development for the 
P-lactam antibiotics, concluded that for a $-lactam 
derivative to possess activity a number of stereo-
chemical aspects and the nature of peripheral 
substituents must be satisfied in the molecule. 
Firstly, the p_lactam bond must be intact and strained. 
The infra-red spectrum was an essential monitor in this 
VA 
respect, since$_lactam carbonyl stretching frequency is 
a characteristic feature of these derivatives. 	The 
exact position of the carbonyl stretching signal varied 
in accordance with the strain involved in the p_lactam 
ring. 	A higher $-lactam carbonyl stretching frequency, 
in the infra-red spectrum (1790cm- 1 ) indicated a more 
reactive nature of the $-lactam bond which suggested a 
Table III Side chains of semi-synthetic cephalosporins 
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Scheme 5 Structure of cephalothin. 
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Scheme 7 penicillin to cephalosporin conversion. 
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highly active antibiotic. 	The relative stereochemistry 
of the two $_lactam ring protons was expected to be cis 
and with R configuration for both penicillins and 
ephalosporins. 	The second chiral postion (c-3) in 
penicillins was also expected to be R. 	The fused ring 
to the -1actam ring could only be five or six atoms in 
size and with a sulphur atom present. 	Larger rings were 
found to be devoid of any activity and replacement of 
sulphur, in penicillins, by oxygen, nitrogen or carbon 
resulted in very unstable derivatives which were also 
devoid of any bioactivity. 	In addition, an acidic 
functional group in the a-position to the -lactam 
nitrogen, was deemed essential in the fused system. 	The 
acylamino side chain was the only type of side chain that 
was found to impart biological activity in both 
penicillins and cephalosporins. 	In the case of 
cephalosporins,it. was found that only the 	3-double bond 
imparted biological activity and the substituent in the 
C-3' position needed to be a good leaving group. 
At this stage, only total synthetic approaches 
were attempted towards modified fused systems. 	Attempts 
to selectively open the thiazolidine ring in penicillins, 
also resulted in opening of the fr-lactam ring. 	An 
important finding was reported by Morin in 1963. This 
involved the first chemical conversion of a penicillin to 
a cephalosporin derivative by refluxing a penicillin 
suiphoxide (16), (Scheme 7), under acidic conditions and 
in an inert solvent [ This transformation will be 
discussed further in the Synthesis section]. This was an 
important discovery for a number of reasons. 	Firstly, 
cheap penicillins could be converted to the more 
expensive cephalosporin derivatives. 	Secondly, it was a 
means of opening the thiazolidine ring withot cleaving 
the -lactam system which then made it possible to 
undertake many semi-synthetic approaches towards novel 
structures. 	The use of these cheap chiral starting 
materials with the correct stereochemistry around the 
A-lactam ring was a distinct advantage over the totally 
12 
synthetic approach. Control of the reaction conditions 
resulted in chiral products reasonably efficiently, and 
these could be used to explore structure-activity 
relationships much more rapidly compared to earlier 
methods. 
Initially, screening 	, of micro-organisms 
for novel -lactam antibiotics were confined to a variety 
of fungi from different sources. 	However, in majority 
of the cases only penicillins or cephalosporins with a 
variety of acylamino side chains were isolated. 	As a 
result, the screening procedures were expanded to various 
strains of bacteria. 
The Actinoinycete species were the only Gram-
positive bacteria which were found to produce Plactam 
containing derivatives. 	The first of these novel 
structures was reported in 1971 by Nagarajan, and 
isolated from a strain of Streptomyces lipmani. 10 	These 
structures, (scheme 8), possessed $-lactamase resistant 
properties. 	This discovery gave rise to the development 
of many methods for functionalisation of the C-6 and C-7 
position of penicillins and cephalosporins respectively. 
In 1976, Japanese workers published a report on 
the isolation of a monocyclic $-lactam derivative from a 
strain of Nocardis uniformis. 11 	This they called 
riocardicin A (18), (scheme 9). Later investigations 
resulted in a number of related structures (B-G) (scheme 
10). 	Only nocardicin A (18) had any significant 
activity, compared to the rest of the derivatives, but 
even this was very weak compared to the penicillins, 
cephalosporins and cephamycins. 	In the same year, 
workers at Beecham reported a novel strcture from a 
strain of Streptomyces clavuligerus (ATCC 27064).12 
This was called clavulanic acid (19) (scheme 11) and -was 
found to have moderate antibacterial activity but 
possessed a very high specificity for -lactamases. 
This important observation started a novel approach to 
the treatment of infections from 13-lactamase producing 
bacteria. 	It was envisaged that by combining a 
13 
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Scheme 8 Structure of cephamycins 
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Scheme 10 Structure of nocardicin isolates. 
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- - -lactamase inhibitor, such as clavulanic acid (19), and 
a highly active penicillin or cephalosporin, depending 
upon the physiological and biochemical compatability, the 
resistance could be overcome and the infection treated 
successfully. 	The intriguing structural aspect of 
clavulanic acid was that it possessed no acylamino side 
chain. 	The ring fused to the $_lactam bond contained an 
oxygen rather than a sulphur atom and the gem-dimethyl 
group of penicillins was replaced by an allyl alcohol 
group. 
Two years later, workers at Merck, Sharp and Dohme 
reported the isolation of a very highly active substance 
from Streptomyces cattleya. 13 	This potent broad 
spectrum antibiotic possessing natural p_lactamase 
resistant properties was called thienamycin (20) (scheme 
12). 	It also had the added property of being highly 
active against normally resistant Gram-negative bacteria 
such as pseudomonas aeruginosa and Serratia marcescens. 
However, the main drawback was its instability in aqueous 
solutions, even under neutral conditions. 	Access to 
(20) is only possible by synthesis, since isolation by 
fermentation methods leads to low yields and a mixture of 
products. 	After investigation of many synthetic 
analogues of (20), Merck have finally managed to obtain 
one which retains the potency and the p-.lactamase 
resistance properties of (20) but also a greater 
stability to aqueous solutions. 	This was called 
formimidothienamycin (21) (scheme 13) and is commonly 
known as "Iinipenem". 14 	The striking features of these 
carbapenem systems were the novel R-1-hydroxyethyl side 
chain at C-6; the trans stereochemistry and 6S and 5R 
configuration of the -lactam protons; the A2 double 
bond in the fused ring and also the methylene group in 
place of a sulphur atom. 	All these features appear to 
contradict the requirements that, only a few years 
earlier, were thought to be essential for any biological 
activity of the penicillin/cephalosporin type system. 








Scheme 11 	Structure of clavulanic acid. 
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Scheme 14 	Structure of olivanic acid. 
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$_lactamase inhibitors, also reported an independent 
discovery of a carbapenem system, from a strain of 
Streptomyces olivaceus. 15 	This was called olivaflic 	acid 
(22) (scheme 14), and was found to be a potent p- 
lactamase inhibitor, similar to clavulanic acid. 
The most significant finding in the 1980 s was 
made simultaneously by two independent research teams at 
Takeda and Squibb. 16 	They reported the isolation of a 
monocyclic p_lactam derivative, from various strains of 
Gram-negative bacteria. 	This monobactam was called 
sulfazecin (23) (scheme 15), and was found to be highly 
resistant to p_lactamase producing bacteria. 	This was 
attributed to the 3-methoxy substituent. 	However, (23) 
was found to have low biological activity against Gram- 
negative bacteria. 	It was hoped that this could be 
improved by modification of the acetamido side chain. 
Work with a variety of 3-acylamirio substituents finally 
resulted in aztreonam (25) (scheme 16), a parenterally 
administered antibiotic with high activity against Gram-
negative bacteria, particularly Pseudomonas species, but 
minimal activity against Gram-positive bacteria. 
Further detailed investigations of the recently 
identified p_lactam producing bacteria have shown that 
these bacteria produce many analogues of the parent 
systems, such as the carbapenem system, which has 
resulted in a number of analogues, namely epithienamycins 
(S. flavogriseus), 17 carpetimycins (Streptomyces 
species), 18 and more recently, asparenomycins (S. 
cattleya) 19 
With the rapid developments in the area of 
microbiology, particularly the field of "genetic 
engineering", work is underway to produce mutant moulds 
or bacteria which would hopefully synthesise novel 
p_lactam derivatives which are as potent as those 
presently used, and which possess novel side-chain 
substituents. 	These side chains might give rise to 
physiological compatibility for other potent. derivatives 
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instability under in vivo conditions. 
In concluding this section, a word of warning must 
be said. 	Unless chemists can develop a potent unnatural 
antibiotic, for which bacteria are unable to find a 
resistance, future bacteria may become super-resistant 
and our present armoury of antibiotics, including 
tetracycline, aminoglycosides, macrocycles, and the- 
lactam family, may all become useless. It is vitally 
important, for future generations, that strict controls 
on the use of these antibiotics be brought into practice 
to prevent wide spread resistant strains from 
developing. 	Furthermore, the adaptable nature of 
bacteria to their environment makes it inevitable for them 
to produce resistance to the antibiotics in use. 
Consequently, understanding the methods of resistance 
employed by bacteria and means of "switching them off" 
selectively, when-: the bacteria have infected a host, may 
allow the control of this serious problem, rather than 
allowing it to escalate to epidemic proportions for 
future generations to solve. 	Finally, screening methods 
have been very successful in producing novel natural 
structures, at the same time giving rise to a higher 
resistance problem; the solution to this paradox, 
-however, lies in the 'hands of the chemist'. 
19 
2.0.0 Biological aspects of $-Lactam Antibiotics 
2.1.0 Mode of Action of p-Lactam Antibiotics 
The bacterial cell differs from that of the 
mammalian cell in that the former possesses a thick cell 
wall. 	It has been found that the cell wall of 
Grain-positive bacteria is largely composed of a 
peptidoglycan layer with which are associated 
polysaccharides and teichoic acids. 	The rigid structure 
of the cell-wall is attributed to cross linkings within 
the peptidoglycan layer. 	The cell wall of the 
Gram-negative bacteria possess 	two distinct layers. 
The outer layer of the wall consists of 
- - 	 proteins, lipopolysaccharides 
and lipoproteins. 	The inner layer of the wall consists 
of a thin rigid layer of peptidoglycan. 	Early 
experiments on bacteria treated with sub-lethal doses of 
penicillin showed that large amounts of cell wall 
constituents were released into the media. 	This type of 
observation led Strominger and Tipper, 20 in 1965, to 
propose the structural analogue theory for penicilins. 
The peptidoglycan layer of the cell wall is 
composed of a complex network of linear heteropolymers. 
These are cross-linked by short pentapeptide strands 
(consisting of glycine in S. aureus), in order to produce 
a rigid overall structure. 	This is essential for a 
growing bacterium. 	The terminal end of the pentapeptide 
strand is found to be connected to a D-alanyl-D-alanine 
unit, the peptide chain being elongated via the 
C-terminus, the terminal D-alanine is removed by a 
carboxypeptidase and the glycan strand joined with an 
amino group from another polymer strand, via a 
transpeptidase. 	This process occurs throughout the 
matrix of the peptidoglycan. 
Strominger and co-workers proposed that D-alanyl-
D-alanjne was the portion of the cell wall to which 
penicillin was an analogue. 	By acylating either the 
carboxypeptidase or the transpeptidase, the cell wall 
structure would weaken and consequently, this would 
20 
rupture the growing bacterium due to the enormous rise in 
the internal osmotic pressure. 
This simple model is a good explanation for the 
observations. 	However, the activity of such diverse 
structures as nocardicins and monobactams, clearly shows 
that the above model is limited. 	Furthermore, ijnproved 
purification and separation techniques in the field of 
microbiology have shown that the exact process of the 
action of -lactam antibiotics is much more complex. 21 
2.2.0 p-Lactamase Inhibitors and their mode of action 
The increasing number of bacteria becoming 
resistant to the p_lactam antibiotics has become a growing 
problem for the clinician. 	The methods of resistance 
employed by bacteria are as follows: (i) production of 
enzymes called -lactamases, which selectively cleave the 
P-lactam bond; (ii) modification of the cell wall in 
order to inhibit the penetration of the antibiotic and 
(iii) a reduction of the growth rate in. the presence of 
the antibiotic. 
This section will only be concerned with the first 
method, since the study of inhibition of $_lactamases is 
probably the easiest for a chemist. 
The -lactamases produced by various resistant 
bacteria have one factor in common; they selectively 
cleave the $_lactam bond in this class of antibiotics. 
The exact nature of these enzymes varies a great deal 
between species and also subspecies. 	This is possibly 
the reason for the absence of an ideal inhibitor to these 
enzymes. 	Excellent reviews are available regarding the 
types of p-lactamases produced by organisms and their 
modes of inactivation. 22 ' 23 
This account will only give the summary of the 
chemical aspects of -lactamase inhibition by the various 
derivatives that are available. 
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Inhibition of j3-lactamases occurs either reversibly 
or irreversibly (scheme 17). 	Normally, /3-lactamase 
sensitive derivatives (such as penicillins) are 
inactivated rapidly, followed by regeneration of the 
/3-lactamase by hydrolysis of the intermediate complex 
(path a). 	The /3_lactamase inhibitor also forms an 
intermediate complex of the type (28). 	This complex may 
involve a covalent bond (30) or simply a strong 
interaction between the enzyme and the inhibitor (28). 
Hydrolysis of complex (28) may be reversible or 
irreversible. 	The reversible hydrolysis may be 
sufficiently slow to allow the concentration of the 
active f3-lactam antibiotic to rise above the tolerance 
level required for the survival of the bacterium thus 
leading to the death of the organism. 
The covalent complex (30) can carry out a number of 
possible pathways (a - c) (scheme 17). 	The most common 
is Path a for most /3-lactamase sensitive antibiotics where 
the enzyme is regenerated and the /3-lactam derivative is 
decomposed; the rate of hydrolysis for the inhibitor is 
usually much lower than for a non-inhibitor. 	Good 
13-lactamase inhibitors normally undergo Paths b or c in 
which the enzyme gets inactivated and the /3-lactam 
derivative undergoes a number of rearrangements and 
remains bonded to the enzyme. 
Clavulanic acid (19) was the first /3-lactamase 
inhibitor discovered by workers at Beecharn. 12 	This was 
found to undergo the rearrangement as in scheme 18. 	The 
enzyme would become irreversibly inactivated by this 
inhibitor. 	However, an excess of the inhibitor was 
usually necessary to inactivate the enzyme irreversibly. 
Synthetic studies of penicillin derivatives which 
were thought to have /3_lactamase inhibiting properties, 
fortuitously, led to the 6-13-bromo-penicillanic acid (34) 
(scheme 19) and later to penicillanic acid suiphone (36) 
(scheme 20). 	Both these derivatives are found to have 
good /3-lactamase inhibiting properties. 	(34) was 
believed to further rearrange to a thiazolidinone-enzyme 
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Scheme 17 General scheme for -1actamase inactivation of 
bicyclic —1actams. 
23 
derivative (35) (scheme 19). 
The carbapenem derivatives have the unique property 
of being highly activp antibiotics with potent /3-lactamase 
inhibition or /3-lactamase resistant properties. 	The 
olivanic acids (22), discovered by workers at Beecham, 15 
were found to be potent J3-lactamase inhibitors; the 
inhibition was observed to be irreversible. 	The detailed 
mechanism has not been reported as yet. 	However, a 
possible mechanism is given in Scheme 21. The 
instability of the pyrroline system may give rise to 
a reaction 	within the active site of the 13-lactamase, 
thus, leading to irreversible inactivation of the enzyme. 
24 
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2.30- 0 BIOSYNTHESI-SOF -LACTAM ANTIBIOTICS 
2.3.1 Introduction 
penicillin biosynthesis has been studied since its 
first isolation from a Penicillium mould. 	The purpose of 
this research was to determine the mechanism of its 
biosynthesis and to find out the use of these metabolites 
by the organism and finally to investigate conditions 
which would maximise the production of penicillin. 
The early work, during the 1940's involved intact 
cells of a Penicillium chrysogenum culture. 
Consequently, progress was slow due to the problems 
involved in the interpretation of the inhibitive or 
activating effects of the substrates to penicillin 
synthesis, and to the poor uptake of isotopically labelled 
amino acids or short peptides (thought to be potential 
precursors) by the intact cells. 
The work by Arnstein and co-workers 24 in the 
1960 s, suggesting that a tripeptide, a-aminoadipoyl-. 
cysteinyl-valine (37) (scheme 22), was a precursor to 
penicillin has since been substantiated. 25 	The 
significant breakthrough in this area came in the 
seventies when cell free extracts and enzymes responsible 
for the transformations on the biosynthetic pathway were 
isolated in a purified form from Penicillium chrysogenum 
and Cephalosporium acremonium. 26 ' 27 ' 28 
The biosynthesis of penicillin (1), cephalosporin C 
(12) and cephamycin (17) is now believed to be involved in 
a single stepwise pathway (scheme 23). 	A great deal of 
work has been done with these purified enzymes as may be 
seen from the number of publications in the literature. 29 
Furthermore, the isolation of novel -lactam structures, 
including nocardicin A (18), clavulanic acid (19) and 
thienamycin (20) from a variety of Gram-positive - bacterial 
species, has stimulated further work on the isolation of 
the enzymes involved in the biosynthesis of the respective 
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Scheme 22 Structure of Arnstein's ACV tripeptide. 
28 
was undertaken in order to determine the biosynthetic 
pathways to these useful natural products. 30 
The presently accepted penicillin and cephalosporin 
biosyrthetic pathway (scheme 23) will be dealt with 
briefly; only the conclusions and some relevant 
experimental data in support of them will be given. 	The 
biosynthetic studies on the novel structures, riocardicins, 
clavulanic acid and thienamycin, are still in their very 
early stages. 
2.3.2 Biosynthesis of penicillin, cephalosporin and 
cephamycin 
The availability of isopenicillin N synthetase, in 
a purified form from both Penicillium chrysogenum and 
Cephalosporium acremonium, has made it possible to uncover 
many of the misunderstandings of the proposed biosyntheses 
of periicillins and cephalosporins. 	It is established 
that L-a-amino adipic acid (38), L-cysteine (39) and 
L-valine (40) are the starting precursors to the (LLD) 
(A.C.V.) tripeptide (37), as first suggested by Arnstein 
in 1957.24 	The interesting aspect is the inversion of 
L-valine to D-valine in the tripeptide. 	Labelling 
experiments with L-[2-3H]-valine resulted in complete loss 
of label in the tripeptide. 3 ' 	Furthermore, double [180] 
labelled L-valine loses one of the oxygen atoms on being 
converted to isopenicillin N. 	This suggested that during 
the incorporation into the tripeptide, the carboxyl group 
of valine was protected as a thioester derivative. 	In 
addition, treatment of (37) with isopenicillin N 
synthetase in [H2 18 0] enriched medium did not incorporate 
any oxygen label in isopenicillin N (43), thus, confirming 
that the loss of 18 	had occurred during the formation of 
the tripeptide (37) rather than during the ring closure 
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The p_lactam ring is formed first. 	The exact 
method is not known but it has been deduced from 
experiments in which the 3H 5 proton of cysteine is lost 
stereospecifically. 	Consequently, the process occurs 
with retention. 32 Propositions have been made which 
suggest hydroxylation at C-3 of the cysteinyl residue 
followed by activation by phosphorylation which would 
result in nucleophilic displacement of the phosphate 
derivative by an amidino nitrogen and lead to ring 
closure. 	Intermediates of the type (50) (scheme 24) have 
been synthesised but cyclisations with the enzyme 
isopenicillin N synthetase have been unsuccessful. 
However, recent reports have indicated the successful 
cyclisation of (50) by use of biomimetic conditions using 
ascorbic acid, ferrous sulphate, oxygen and ethylenedi.a-
minetetraacetic acid (EDTA); these make up the 
Udenfriends reagent. 	These experiments suggest that a 
free intermediate of the type (50.) does not exist and, is 
very likely to be present in an enzyme bound form, bound 
via the sulphur atom as in (41). 	Consequently, 
intermediates of the type (50) would not be able to 
participate in the catalytic cycle. 	Although, it has 
been reported that an intermediate of type (50) has been 
isolated, 34 later reports have shown this finding to be 
unlikely due to the great instability of (50) even under 
neutral conditions. 35 
A great deal of evidence is available which 
suggests that the cyclisation of (41) to form the 
thiazolidine ring in isopenicillin N (43) occurs through a 
radical process. 36 	Labelling experiments suggest that 
this cyclisation occurs with retention, and the methyl 
groups remain in the relative positions they occupied in 
the valine. residue. 	This suggests that the rate of 
cyclisation must be much faster than that of rotation 
about the c-2 - C-3 bond of valine (42). 	On the other 
hand, the enzyme surface may be such that clefts are 
available for the methyl groups to fit into, and the 
steric factors present, would prevent any possible 
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Scheme 25 Kinetic Isotope effect involved in the 
thiazolidine ring cyclisation. 
32 
bond would thus be formed with retention, via a radical 
species. 	Work relating the nature of the intermediate 
involved in the cyclisation of the thiazolidine step (41 - 
43), and the selectivity of isopenicillin N synthetase to 
available substrates, has shown that modified tripeptides 
can be converted to bicyclic fused ring systems with this 
enzyme. 	The distribution of the products confirms the 
intermediacy of a radical species (scheme 26). 	In 
addition, a large kinetic isotope effect is observed 
for intermediates isotopically labelled at the C-3 
position corresponding to C-3 of valine (with deuterium), 
(Scheme 25), both substrates (51) and (52) result in 
(53). 	It must be noted that a 1:1 mixture of a 
tripeptide substrate labelled at C-3 on the valine 
residue, with deuterium, and an unlabelled tripeptide, was 
converted to isopenicillin N (43) without any isotopic 
discrimination between the two available substrates. 
This experiment also indicates that the p-lactam ring 
formation occurs prior to the thiazolidine ring 
formations. 
The conclusions from these experiments suggested 
that during the ring closure with the enzyme, 
isopenicillin N synthetase, the carbon-hydrogen bond that 
would be preferentially broken is determined by the 
strength of the bond being broken, stability of the 
radical generated, and the steric requirement of the group 
adopting the a-face in the penicillin. 	It has been found 
that the more sterically demanding group adopts the 	- 
rnoce Crow dec 	 a-face in the penicillin 
molecule. 	This would suggest that on the enzyme surface, 
the opposing side to the cleft must be sterically 
limiting; the strain generated by this situation may be 
the driving force for closing the thiazolidine ring in 
order to produce the highly rigid penicillin molecule. 
The fusion of the second ring to the p_lactam ring is, 
thus, determined by the subtle interplay between the 
strength of the bond being broken and the steric 
requirements of the appropriate groups. 
33 

























Scheme 26 Modified tripeptide cyclisation with 
isopenicillin N synthetase(IPNS) 
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The biosynthetic conversion of penicillin to 
cephalosporin is found to involve prior inversion of 
configuration of the a-amino adipyl side chain from () in 
isopenicillin N (43) to () as in penicillin N (44). 	An 
unstable epimerase has been detected in protoplast lysates 
of C.acremonium that converts isopenicillin N (43) to 
penicillin N (44), prior to its conversion to 
cephalosporin C (12). 	consequently, in penicillium 
moulds, only penicillin is produced from isopenicillin 
N. 	In Cephalosporium moulds, the epimerase would result 
in penicillin N (44) which would then be converted to 
cephalosporin C (12). 
The exact process of the ring-expahsion step is 
still a little doubtful, but the evidence favours 
hydroxylation. 	It has been found that the -methyl group 
is involved in the ring-expansion step and becomes part of 
the cephalosporin nucleus, whilst the LT-methyl group 
becomes the acetoxyYnethyl group and hence, the c-3' 
position of the cephalosporin nucleus. 	Two enzymes are 
found to be responsible for the ring expansion and the 
hydroxylation steps. These have been identified as being 
dioxygenases 37 which require molecular 
oxygen, iron, ascorbate and 2-oxoglutarate for activity in 
both C.acreinonium and Steptomyces clavuligerus. 	An 
attempt to separate the two enzymes present in 
c.acremonium failed. 	However, recently, the two enzymes 
from S.clavuligerus have been separated. 38 
The acetylation of (47) has been reported to 
involve acetyl Co-enzyme A. 39 
The biosynthesis of cephamycin (17) is reported to 
involve a further hydroxylase, 40 with similar co-factors 
for the ring expansion and successive steps to those of 
cephalosporin C (12). 	The methylation of the C-7 
hydroxy derivative (48) involved methionine (49)•41 
Aspects of the biosynthesis of cephalosporins and 
penicillins have been reviewed in detail. 42 	Further 
excellent reviews have been published recently.43'44 
35 
2.3.3 Biosynthesis of the novel p-lactam derivatives 
Nocardicin A (18) has been reported 45 ' 46 to have 
derived its skeleton from two molecules of tyrosine, with 
a loss of the carboxyl group from each amino acid 
residue. 	Tyrosine is utilised via L-(p-hydroxyphenyl) 
glycine (54). 	The precursor of nocardicin A (18) is 
suggested as (55) (Scheme 27). 
Clavulanic acid (19) has been reported 47 ' 48 to be 
biosynthesised from a C3 and a C5 unit (scheme 28). 	The 
C3 unit is formed from a C3 intermediate of glycolysis, 
0.. 
whilst the C5 unit has its origins in/.C5 amino acid that 
is directly related to 2- oxoglutarate (56). 	Further 
results show that amino acids [ornithine (60), and 
arginine] of the urea cycle, particularly ornithine (60), 
are much better (15-20 times) precursors for Clavulanic 
acid (19) in S.clavuligerus than are glutamic acid (57), 
5-hydroxynorvaline (58) and proline (59)•47 	In an 
interconnected series of experiments, 3H and 14 C labelled 
glycerol, pyruvate, serine, glycerate, and glycine, have 
been examined as precursors for the C3 unit in clavulanic 
acid. 	The results have indicated that glycerate (61) is 
the most direct precursor to the C3 unit of clauvianic 
acid. 48 
The biosynthetic origins of the carbapenem 
knowel 
antibiotics are no 	IlyA and will thus not be dealt with. 
The recent review 44 , however, does indicate some findings 
in this area which are still under investigation. 
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3.0.0 SYNTHESIS OF $-LACTAM ANTIBIOTICS 
Bacterial resistance to p-lactam antibiotics has 
made it necessary for chemists to obtain derivatives 
which overcome this problem. 	Screening of 
micro-organisms has resulted in some novel structures 
which possess superior properties to the penicillins and 
cephalosporins. 
The first modification that is usually undertaken 
on a novel structure involves altering the peripheral 
substituents on the parent ring system. 	This has been 
the most successful method of producing commercially 
acceptable antibiotics. 	The second option is to change 
the atoms within the fused ring system. 	The sensitivity 
of the p-lactam ring to acids and bases and to 
nucleophilic reagents makes the second type of 
modification particularly challenging. 	Furthermore, the 
atoms that can successfully replace sulphur in the penam 
and cephem systems are limited to carbon, oxygen and 
nitrogen, but, even these derivatives usually give rise 
to unstable bicyclic fused systems, particularly under 
physiological conditions. 
A large number of excellent reviews covering the 
many developments in the synthesis of the p-lactam 
antibiotics are available. 49 	It is,therefore, intended 
that all peripheral modifications of the parent systems 
be excluded in this account. 
The two major approaches that have been used for 
the synthesis of -lactam antibiotics are total-, and 
semi-synthesis. 	The total-synthesis approach possessed 
many problems in the early years, particularly with the 
synthesis of the -lactam ring, and of its conservation 
during the subsequent synthetic scheme to the target 
molecule, (either a penicillin or a cephalosporin). 	The 
overall yields were usually low, due to the large number 
of steps involved or due to the inefficiency of some 
approaches. 	A further problem was the lack of 
stereochemjcal control in most routes. 	Recently, this 
problem has diminished since many asymrne-tic syntheses 
of Vlactam derivatives are being developed. 	On the 
other hand, the semi-synthetic approach involved the use 
of penicillin as the starting material and had the 
advantage that the substrate possessed the correct 
sterochemistry around the -lactam ring. 	However, the 
major disadvantage was the necessity for selective 
cleavage of -the thiazolidine ring in the penicillin 
molecule, whilst keeping the -1actam ring intact. 
It is intended that the scope of this account be 
limited to a brief resume of some important traditional 
routes to monocyclic p_lactam intermediates via both 
total synthesis and penicillin degradation methods, and 
then, primarily, this section will be concerned with the 
synthetic strategies which give rise to five or six 
membered rings fused onto the -lactam ring. 	Since many 
novel derivatives have been synthesised, this account is 
restricted to the fused ring systems which commonly have 
biological activity. 
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3.1.0 MONOCYCLIC —LACTAMS 
Interest in monocyclic -1actams has traditionally 
been aroused because of their potential for the synthesis 
of bicyclic fused systems, such as penicillins and 
cephalosporins. 	However, recently interest in their 
synthesis has been stimulated, in their own right, due to 
the isolation of monocyclic 	-lactam derivatives which 
possess some biological activity such as nocardicin A 
(18) and the monobactams (23). 
The synthesis of monocyclic p-lactam derivatives, 
with a variety of functional groups substituted around 
the ring, has been successfully achieved by many routes 
(schemes 29_32).5052 
The most successful and commonly used procedures 
involve [2+2] cycloaddition reactions, such as the ketene 
- imine reaction and the alkene - isocyanate method, and 
an intramolecular amide bond formation utilising the 
activating agent - dicyclohexylcarbodiimide (DCCI), as 
used in peptide synthesis. 	Furthermore, monocylic $- 
lactam derivatives are obtainable by the selective 
degradation of the penicillins, and then transformed into 
the desired derivatives. 	The semi- synthetic route is 
limited by the ability of the chemist to convert the 
available functional groups on the monocyclic $_lactam 
derivative (obtained from penicillin) into the required 
functional groups, under mild conditions which do not 
cleave the $_lactam bond. 
The following section is confined to these two 
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Scheme 33 Ketene-Imine Cycloaddition for $-lactam 
synthesis. 
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3.1.1 TOTAL SYNTHESIS OF MONOCYCLIC -LACTAMS 
a) 	The ketene-imine method for 13-lactam  ring 
formation. 
The earliest synthesis of a f3-lactam derivative 
(3) was reported by Staudinger in 1907. 	This involved 
a ketene (62) addition to a Schiff base (63) (scheme 
33). 	It was only after the p_lactam - thiazolidine 
structure had been established for penicillin that a 
resurgence of interest in this synthetic route occurred. 
This was the most direct route to the formation of the 
p_lactam ring, but it possessed some problems. 	The 
P-lactam ring is very sensitive to acidic and basic 
conditions in the fused ring system. 	It was ,thus, 
necessary to have functional groups present in the 
starting materials (ketene and Schiff base) which could 
readily be converted to the desired ones, in the bicyclic 
fused system, and under mild conditions. 	Furthermore, 
handling of the ketene was made difficult due to the 
possibility of a [2+2] cycloaddition reaction involving 
two ketene molecules. 	Consequently, high dilution 
conditions were necessary. 	Unstable ketenes were much 
more difficult to handle. The imine de.rivative was 
required to be electron rich but with substituents 
present which would stabilise a possible carbocation or a 
radical intermediate. 	The [2+2] cycloaddition may occur 
via a diradical or zwitterion mechanism and suitable 
conditions were necessary for their successful 
stabilisation in order to obtain acceptable yields. 
One of the earliest uses of this route in 
penicillin synthesis was reported by Sheehan and Corey in 
1950 (scheme 34).54 	This method incorporated the amino 
group protected as a succinimide (65). 	The acyl 
chloride (65) readily generated the ketene (67) under 
basic conditions. 	Addition of the ketene (67) to the 
thiazoline (66) generated the bicyclic fused system (68), 
and, by subsequent hydrolytic cleavage of the amino 
43 



















Scheme 34 Use of Ketine-Imine method for penicillin 
synthesis. 
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penicillin. 
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Scheme 37 N-chlorosulphonyl isocyanate addition to an 
alkene for -1actam synthesis. 
protecting group, followed by diazorne6rie5-pheny1 
penicillin (69) was prepared. 	The yields were low due 
to the requirement for hydrolytic conditions for the 
cleavage of the succinimide protecting group and due to 
dimerisation problems of the ketene. 	The yields of the 
monocylic p_lactam derivative could be improved by the 
use of the azido group as the "latent amino function", as 
reported by A.K. Bose in 1968, (scheme 35)•55 	The azido 
group could readily be reduced to the amino group, by 
hydrogenolysis using Adam's catalyst. 	Further 
improvements were made by using the required side chain 
directly, such as p-nitrobenzyloxycarbonylglycyl 
chloride 56 , thus removing two stages in the synthesis. 
However, this modification made the ketene addition more 
difficult due to steric interactions. 
A great deal of variation of the substituents in 
each reagent is possible. 	The acyl chloride, f'o'r 
instance, could be replaced by a mixed anhydride (76) 
(scheme 36) 57  and the ijnine could be acyclic (77) or 
cyclic (66) or (71), and with a variety of substituents. 
The stereochemistry of the addition is determined by the 
steric interactions involved. 	Normally, large groups 
adopt a trans geometry about the p_lactam ring. 	In 
fused systems, the sterically-demanding group adopts the 
a-stereochemistry rather than occupying the crowded 
p-face, as required in the natural penicillin. 	This 
unfortunately makes it necessary to isomerise the C-3 
position, of the azetidinone, to obtain the biologically 
active 	and thermodynamically less stable (C.S) 
derivative. 	However, this isomerisation is not 
necessary for intermediates which are used to synthesise 
thienamycin .(20), which possesses trans ring 
stereochemistry in contrast to penicillins and 
cephalospor ins. 
46 
b) 	The alkene-isocyanate method of p-lactam ring 
formation. 
In the late 1950's, Graf found that 
N-chlorosulphonyl isocyanate (csI) (80) was a powerful 
reagent for the synthesis of p-lactams (scheme 37).58 
Starting with isobutylene, 4,4-dimethylazetidin-2-one 
(82) is formed via the N-chlorosulphonyl addition product 
(81). 	Butadiene gives the corresponding 
4-vinylazetidin-2-one (83) and vinyl acetate affords 
4-acetoxyazetidinone (84). 	4-Acetoxyazetidinone (84) is 
a very useful intermediate, as will be seen later. 	The 
acetoxy group in (84) can readily be displaced by 
nucleophiles such as amines, thiols, alcohols and more 
recently carbanions and is, thus, a means of introducing 
nitrogen, sulphur, oxygen and carbon atoms respectively 
in the-5position of a bicyclic fused system Composec oe° 
_cj:cir r%4 awtck e,ther o, 	 St 	vmberecA 
recpc&vej. 
C) 	Functionalisation of the C-3 position of the 
azetidinone. 
The need to functionalise the C-3 position of the 
azetidin-2-one (85) (scheme 38) to obtain the relevant 
intermediate which would impart biological activity in 
the final compound is made possible by use of strong base 
methodology, 59 such as lithium diisopropylamide in an 
aprotic solvent and at low temperature (-78 0 c), and 
trapping the carbanion at C-3 with an electrophilic 
reagent, for example acetaldehyde or a halogen (which can 
then be further substituted by a nucleophile). 
(d) 	The use of the N,N-dicyclohexylcarbodiimide 
coupling reagent for p-lactam ring formation. 
The first totally synthetic route to penicillin V 
47 
was reported by Sheehan in 1959.60 	The important 
lactam ring formation step was carried out at the end 
of the synthetic scheme and involved a 
dicyclohexylcarbodiimide coupling reaction (scheme 39). 
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Scheme 38 Functionalisation of the C-3 position an 
azetidinone, using strong base methodology. 
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Scheme 40 Selective cleavage of the thiazolidine ring 
in penicillins. 
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3.1.2 Degradation methods of penicillin. 
Penicillins are the cheapest and the most readily 
available p-lactam derivatives obtainable by fermentation 
methods. 	Consequently, all semi-synthetic strategies to 
the variety of novel -lactam antibiotics, have been 
attempted via the penicillins. 
a) 	Selective cleavage of the thiazolidine via a 
penicillin sulphoxide. 
The selective cleavage of the thiazolidine ring in 
penicillins was finally accomplished by R.B. Morin and 
co-workers in 1963 (scheme 40).61 	Refluxing methyl 
phenoxyacetamidopenicillin sulphoxide (92) in xylene in 
the presence of acetic acid resulted in the isolation of 
a cephalosporin derivative (94). 	This novel rearrange- 
ment was investigated in great detail and was concluded 
to involve a suiphenic acid intermediate (93).62 	This 
intermediate (93) has since been found to be very 
versatile. 	It has been trapped by both 
electrophilic 6365 and nucleophilic 6669 reagents. 	The 
sulphenic acid (93) has been reduced with trimethyiphos-
phite to thiazoline (102) 70 and in one instance, it has 
been possible to isolate and characterise a crystalline 
sample (103) (scheme 41).71 	Each of these intermediates 
is a potential source for further modification and 
functionalisation in order to obtain a bicylic fused 
system. 
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b) 	-1rrangement involving selective opening of the 
thiazolidine ring. 
In 1963, Wolfe and co-workers reported 72 a novel 
rearrangement, involving an opening of the thiazolidine 
ring (scheme 42). 	Working with the acid chloride 
derivative (104), it was found that on base treatment, 
(104) would undergo a rearrangement to (105). 	This 
derivative was found to have an identical mass to a 
dehydrated penicillin molecule. 	These derivatives were, 
thus, called anhydropenicillins. They possessed no 
biological activity and were relatively inert to most 
reagents. 	However, the lactone ring could be opened 
with mercuric acetate and acetic acid. 	The product 
distribution was sensitive to temperature. 	Ozonolysis 
of the double bond resulted in only decomposition 
products. As an intermediate (105) was of limited use. 
C) 	Thiazolidine ring cleavage by the Curtius 
rearrangement. 
Selective opening of the thiazolidine ring in 
penicillins was also reported by Sheehan in 1965 (scheme 
43).73 	This involved the Curtius rearrangement of the 
azido derivative (106) to the isocyanate (107) which 
readily afforded the carbinol derivative (108) under 
mildly acidic conditions.(108) existed primarily in the 
ring open form (109). 
d) 	Beecham method of selective cleavage of the 
thiazolidine ring via a p-elimination method. 
Workers at Beecham 74 also developed a very useful 
means of opening the thiazolidine ring, with the 
advantage of having removed the oxidation step of the 
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p-elimination mechanism, by the use of primary alkyl 
halide and a strong base on a protected pencillin 
derivative (110), obtained from 6-APA (3), to afford the 
1,2-secopenicillanate (111) in excellent yields (scheme 
44) 
e) 	Methods developed for the removal of the p_lactam 
N-subs tituent. 
Many methods have been devised to remove the 
N-substituent on the $_lactam nitrogen to obtain the 
monocyclic $_lactam intermediate (115) (scheme 45).- The 
most common method was developed by the Lilly group 75 and 
involved an isomerisation of the -double bond, in 
intermediate (112) with triethylamine, to the conjugated 
system (113), followed by ozonolysis to obtain the 
moderately stable oxonarnide derivative (114) which is 
hydrolysed with aqueous methanol to result in the 
N-unsubstituted drivative (115). 	A one-step removal of 
the butenoate group has also been developed by research 
workers at Beecham. 76 	This involves a permanganate 
oxidation, under basic conditions, of the double bond to a 
1,2 diol- which spontaneously fragments to the monocyclic 
azetidinone (115),under the reaction conditions. 	A 
further method of removing the butenoate substituent on 
the ring nitrogen was reported by Barton and co-workers 
in 1973. 77 	This involved the 1,3-dipolar addition of 
diazomethane to the conjugated double bond to result in 
the pyrazoline (116) followed by either hydrolysis, or 
reduction with zinc and acetic acid, to result in the 
azetidinone (115) (scheme 45). 
f) 	FunctionalisatiOn of the azetidinone derivative. 
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Scheme 45 Methods for the removal of the substituent on 
the -lactam nitrogen. 
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ring nitrogen is now a classical one, and was first 
developed by R.B. Woodward and co-workers and reported in 
1972 (scheme 46).78 	This method involved the 
condensation of the azetidinone (115) with a glyoxylic 
ester (117) in refluxing benzene to afford the hmiaminal 
(118). 	This is readily purified by chromatography and 
converted to the phosphorane (120) via a two step 	- 
procedure involving chioro derivative (119). 	The 
phosphorane (120) is a very important intermediate for 
the synthesis of fused ring systems, as will be seen 
later. 
Functionalisation of the C-3 position in the 
azetidinone (121) (scheme 47), is not normally necessary 
for azetidinones which are obtained from degradation of 
penicillins, and which are used for the synthesis of 
novel penicillins or cephalosporins. 	However, where the 
amino group is not required, the free amino group can be 
replaced by a variety of nucleophiles, via the diazonium 
ion, such as halide, 79 and hydroxide. 80 	The 3-halo 
azetidinone can be reduced to a C-3 unsubstituted 
derivative with zinc and ammonium chloride 81 . 	The 
3-unsubstituted azetidinione can then, using the strong 
base methodology, be substituted electrophilically. 59 
The thiomethyl group in (122) can readily be 
removed by chlorinolysis 82 (scheme 48), and the C-4 
position of the 4-chloroazetidinone (123) is then 
functionalised. 	However, the intermediacy of the 
azetidinonium ion (124) usually results in a mixture of 
4R/4S substituted products (125). 	Replacement of 
sulphur by oxygen or nitrogen atoms is readily possible 
using the appropriate nucleophiles. 	The formation of a 
carbon-carbon bond in the C-4 position of the azetidinone 
(123) is of particular interest, as applied to the 
synthesis of thienamycin (20). 	Use of carbanions, such 
as qrignard or alkyl lithium derivatives, would result 
in -lactam cleavage. 	However, Japanese workers 83 have 
reported an interesting method of carbon-carbon bond 
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Modification of the C-4 position of the 
azetidinone. 
(scheme 49). 	This route involves chiorinolysis of a 
seco-penicillanate derivative (126) tO'kthe 
4-chloroazetidinone (127). 	Treatment of (127) with an 
alkyl cuprate derivative (128) results in a 
diastereomeric mixture of the 4-alkylazetidinoneS(129) 
which is readily transformed through subsequent steps to 
the carbapenem nucleus (20). 
More recently workers at Sankyo in Japan 84 and at 
Merck, Sharp and Dohme 85 have developed a similar 
functionalisation of the C-4 position of the azetidinone 
(127) which they have transformed to thienamycin by 
standard methodology. 
However, due to the poor stereochemical control of 
the C-4 substitution by the above methods, intermediates 
for carbapenem synthesis are normally obtained by totally 
synthetic methods, rather than via semi-synthetic routes. 
The degradation of pencillins to monocyclic 
P-lactam intermediates is a well explored area and 
comprises a great deal of the fascinating chemistry of 
penicillins. 	Many rearrangements of penicillin result 
in non--1actam containing products, but these are 
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3.2.0 SYNTHESIS OF BICYCLIC FUSED SYSTEMS 
Prior to the discovery of antibacterially active 
monocyclic $-lactam antibiotics, such as nocardicifl. A 
and monobactam 5 only fused ring systems such as 
penicillins, cephalosporins and cephamycins were known to 
possess any activity against pathogenic bacteria. 
Consequently, synthesis involving monocyclic p-lactam 
intermediates were normally directed only towards novel 
bicyclic fused systems, which were not obtainable from 
natural sources (scheme 50). 	This situation changed 
during the mid-seventies, with the discovery of the novel 
p-lactam structures from a variety of Gram positive 
bacteria. 	Recently, work has started on suitably 
functionalised derivatives which possess no -1actam 
ring, these being -lactams and 1,2-diazetidin-2-one 
analogues of p-lactam antibiotics. 	These will be 
discussed in the section on future trends. 
Totally synthetic procedures usually involved a 
large number of steps and resulted in low yields of the 
final product. 	Consequently, these routes would not be 
commercially viable. 	However, if the particular 
derivative possessed sufficient activity, attention would 
then be diverted towards determining a viable route. 
Imipenem, a derivative of thienamycin is a case in point. 
Most synthetic routes that will be considered 
start with a monocyclic p-4actam intermediate. 	It is 
assumed that the monocyclic p_lactam intermediate is 
available by either 	- total synthesis, or 
penicillin degradation, procedures described in an 
earlier section of this account. 	The important 
consideration of this section is concerned with the 
methods employed to annelate the second ring system onto 
the -1actam ring. 	This section will be divided 
according to the size of the ring to be formed, and 
further sub-divided according to whether the fused system 
belongs to the penam, oxapenam, carbapenam, azapenam, 
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penern, clavem/oxapenem, carbapenem, azapenem, or cephem, 
oxacephem, carbacephem or azacephem categories. 	The 
modes of cyclisation will also be given according to 
Baldwin's rules. 
3.2.1 FOUR-FIVE FUSED SYSTEMS 
3.2.2 PENAM 
a) 	Synthesis of natural penicillins 
The pencillin nucleus is 	 known as 
the penam system. 	Few attempts have been made to 
synthesise the natural penicillins since they can now be 
readily obtained by fermentation methods. 	However, the 
classic synthesis of pencillin V (2) by Sheehan in 1959 
(Scheme 51),60 was a tremendous step for chemists in the 
art of handling these sensitive compounds. 	Pencillamine 
(130) was condensed with a protected malonaldehyde 
derivative (131) to generate the thiazolidine 
intermediate (132). 	The phthalimide protection was 
removed prior to the formation of the $-lactam ring, by 
treatment with hydrazine and hydrochloric acid to 
generate (133). 	Acylation of the amino group with 
phenoxyacetyl chloride and triethylamine in 
dimethyformamide resulted in (134). 	Acid mediated 
removal of the t-butyl group with formic acid resulted in 
the diacid. 	Generation of a monosodium salt and then 
treatment with N,N-dicyclohexylcarbodiimide (DCCI) in 
dioxane-water finally afforded racemic penicillin V 
(2). 	This was found to have 50% the activity of the 
natural product. 	Furthermore, the confidence generated 
by this route stimulated more chemists to take on the 
challenges provided in this area. 	A route involving 

























Scheme 51 Synthesis of penicillin V by Sheehan's 
method. 
was soon developed by A.K. Bose and co-workers. 5-5 	The 
important step involved the [2+2] cycloaddition reaction, 
utilising the ketene-imin(4 method, for generating the 
P-lactam ring, and isomerisation of the c-6 position of 
the penam nucleus, using the strong base methodology5,9 to 
obtain the$-isomer incorporating the natural 
stereochemistry. 
b) 	Synthesis of bisnorpenicillins 
Synthesis of penam systems lacking the geminal 
methyl groups, present in the penicillin series, has been 
successfully achieved by a number of workers. 	These are 
called bisnorpenicillins (130) (scheme 53). The 
earliest route 86 to (130) involved the condensation of 
cysteine (132) with a masked formyiglycine derivative 
(131). 	This method is similar to that of Sheehan's 
route to pencillin V (scheme 54).60 	The 
bisnorpenicillin V (137) was found to have much reduced 
activity relative to penicillin V (2). 	However, 
recently workers at Beechams described a much shorter 
route to (137) (scheme 55)87 
The azetidinone (138) is readily obtained from 
degradation of penicillin V (2). 	This route, however, 
suffers from the unfortunate problem of the absence of 
any stereochemical control, during the build-up of the 
second ring. 	This gives rise to a mixture of products 
(141) and (142) which have to be separated from the 
desired product (140). 	Further work 88 at Beecham has 
shown that changing the C-6 acetamido side chain from the 
phenoxyacetamido to the protected phenyiglycyl type 
(143), (scheme 56), resulted in increased stability to 
the p_lactamases produced by many bacteria, compared to 
the penicillin counterpart, piperacillin (9). Recently, 
a further synthesis of a penam system lacking the geminal 
methyl groups has been reported (scheme 57).89 
The intermediate (144) was obtained by degradation of a 
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Scheme 58 	Structure of C-..5 epipenicillins. 
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side chain modified penicillin, by sequential treatment 
with mercuric acetate, 90 ozone, 75 and methanol/triethyla-
mine, although it is possible to obtain (144) by a 
totally synthetic strategy. 	Nucleophilic displacement 
of the acetoxy group in (144) with racemic methyl 
2-hydroxy-3- mercaptopropanoate9l, affords (145) as a 
mixture of diastereomers with trans configuration of 
substituents on the -1actam ring. 	The mixture was not 
separated but taken through the synthesis. 	The 
subsequent cyclisation was difficult and occurred only in 
low yield, as had been obtained by many other workers 
previously. 92 	Treatment of (146) with tosyl chloride in 
the presence of dimethylaminopyridine afforded an 
unstable mixture of diastereomeric chlorides (147) and 
tosylates (148). 	Immediate exposure of a mixture of 
(147) and (148) to 2 Molar Sodium hydroxide and 
tetra-n-butylammonium bromide in dichloromethane provided 
a mixture of the bisnorpenicillin esterS(149) in only 
8-10% yield. 	The derivative (150) was not tested for 
biological activity but was further converted to a 
diazoketone derivate (151) for the investigation of 
diazoketone rearrangement. 	This is outside the scope of 
this account. 	It could be anticipated that the 5S 
isomer, being unnatural, is devoid of any activity, as 
has been concluded in previous investigations involving 
epipenicillin derivatives (152) (scheme 58). 	It must 
be noted that the 5-exo-tet mode of intramolecular 
cyclisation involving an intermediate of the type (153) 
has not proved possible with 	cis geometry of the 
P-lactam ring and with a sulphur atom in the c-4 position 
of the azetidinone (153) (scheme 59).94 A possible 
rationale for this conclusion is that the cyclisation, 
with the cis-isomer, would require a highly crowded and 
rigid transition state which may be too unstable to form. 
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C) 	Synthesis of an isopenam derivative by a 5-exo-tet 
cyci isation. 
Moving the sulphur atom to the 2 position of the 
penam nuclus has also been reported. 95 	The isopenam 
(155) (scheme 60), has been synthesised by a versatile 
route involving a very important intermediate (78) 
(scheme 61); which is readily obtained by the ketene-
imine method (scheme 36) 57  and which incorporates a very 
useful -lactam nitrogen protecting group, (2,4-
dimethoxybenzyl), which can be removed oxidatively under 
relatively mild conditions, (K2S208 pH 5-6.6). 	Further 
modification of (78) by standard procedures allows the 
formation of (156). Glyoxylate condensation with the 
azetidinone (156) resulted in a diastereomerjc mixture of 
hemiaminals (157), which,on treatment with thionyl 
chloride and a base,gerierated O mixture of the chloro 
diastereomers (158). 	Reaction of (158) with potassium 
thioacetate in a mixture of dimethylformamide and 
tetrahydrofuran afforded a mixture of thioester 
diasteromers (159). 	Deprotection of the thioester with 
cyclohexylamine in dichloromethane caused the spontaneous 
intramolecular cyclisation via a 5-exo-tet mode, and 
simultaneous deprotection of the benzyl group generated 
the cyclohexylammonjum salt (160). 	It has been possible 
to obtain this derivative by a different strategy, which 
involved the reaction of derivative (158) with hydrogen 
sulphide and a base to afford the ring closed 
product. 96 	The isopenam derivative is reported to 
exhibit good activity against Gram-negative organisms as 
well as S.aureus.97 
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Scheme 59 5-exo-tet cyclisation in the above 




Scheme 60 Structure of an isopenam nucleus. 
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Scheme 62 Structure of intermediate capable to 
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Scheme 64 conversion of the sulphenic acid intermediate 
to penicillin v(v; 	holc€ irrniedoe). 
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d) 	Synthesis of the pencillin system via 
5-endo-trig cyclisation. 
A further method of cyclisation which has been 
reported to afford the penam system involves the Michael 
addition of a thiol onto the butenoate moiety, 
intramolecularly, in derivative (161) (scheme 62). 	This 
5-endo-trig mode of cyclisation is an exception to the 
empirical "Baldwin rules". 98 	The first approach, 
involving a conversion of an anhydropenicillin V (105) to 
penicillin-V (2) under buffered conditions, was described 
by S. Wolfe in 1963 (scheme 63). 99 	It was reported that 
large amounts of anhydropenicillin V were recovered and 
the characterisation of the products (2) was by its 
activity towards penicillin sensitive bacteria. 	This 
work has come under a great deal of criticism due to 
insufficient characterisation data. 	Furthermore, this 
work has not been found to be reproducible and is 
generally considered to be invalid. 	A further method 
was reported more recently (scheme 64)100. 	This 
involved the trapped sulphenic acid intermediate (162) 
which on heating afforded penicillin V (2). 	It was 
suggested that the intermediate involved was of the type 
(161). 	Again,this work has not been reproduced. 
Generally, the above reports are considered to have been 
due to the derivatives (105) or (162) being contaminated 
by the starting material (2). 	Purification of Vlactam 
intermediates is very often a time consuming process,and 
usually requires a great deal of skill to remove trace 
impurities, particularly when dealing with small scale 
preparations. 	A thorough investigation was undertaken 
by Baldwin101 , and this type of 5-endo-trig cyclisation 
was found to be unsuccessful for the intermediates of 
type (161). 	This has been rationalised to be due to 
unfavourable stereoelectronics in (161) by Baldwin.102 
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_'- 	e) 	Synthesis of a modified penicillin molecule via a 
5-exo-trig cyclisation. 
The corresponding allowed route involving a 5-exo-
trig cyclisation has been realised (scheme 65).103 The 
mercapto acid (163) was cyclised to the 2-oxopenarn (164) 
using N,N-diisopropylcarbodiimide. 
Synthesis of a penam nucleus by a 5-exo-tet 
cyclisation involving a thiol at C-4. 
A further route to the penam system that could be 
envisaged, would involve a 5-exo-tet mode of cyclisation 
OF 	
B-t4cm 
the thiol group rd thenitrogen substituent 
by an internal SN2 mechanism (165) (scheme 66). 	This 
strategy consisting of a nucleophilic substitution via an 
SN2 type mechanism to form a penam system, through the 
formation of an S-C2 bond, has not been reported. 
However, in intermediate (166), cyclisation has been 
successfully achieved by a radical method,as described by 
Baldwin and co-workers (scheme 67).104 	This approach 
supported the biosynthetic synthesis of pencillins 
described by the same authors earlier. 
Synthesis of a penam nucleus by a 5-exo-tt 
cyclisation involving a carbanion intermediate. 
Thus far, the cyclisation approaches to afford the 
penam system have involved either a sulphur or a nitrogen 
atom as the nucleophile. 	Workers at Beecham'°5 have 
undertaken considerable research on the chemistry of the 
penicillins and of modified structures particularly with 















Scheme 65 	Use of a thiol 	intermediate for a 







Scheme 66 Structure of intermediate capable of 
undergoing a 5-exo-tet cyclisation via the 
free thiol. 
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Scheme 67 Radical mode of cyclisation of intermediate 
(166). 
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The ring closure involved a carbanion as the nucleophile 
(scheme 68). 	Intermediate (167) is readily obtained via 
a penicillin degradation procedure. 	Activation of the 
methylene substitutent of the alkyl-- thioacyl. 
derivative was accomplished via the use of the sulphoxide 
derivative (168), which made it easier to generate the U- 
carbanion under mild conditions. 	The chioro - 
substituted substituent on the nitrogen was incorporated 
by the well known method devised by Woodward and 
co-workers. 78 	The intramolecular cyclisation involving 
a 5-exo-tet mode was effected by the use of potassium 
tert-butoxide at -20 0 c. 	Derivatives (172) and (173) 
were found to have activity, but to a lesser extent than 
their penicillin V (2) and ampicillin (4) counterparts. 
Attempts to generate the diacid derivative (174) by acid 
treatment of (170) resulted in decomposition. 	However, 
Baldwin and co-workers 106 have recently managed to obtain 
the diacid derivative (175) (scheme 69). 	This suggests 
that the earlier workers may have used too vigorous 
conditions and perhaps a change of the esterS functions 
might have given them success. 	The method employed by 
Baldwin and co-workers involved oxidation of the -methyl 
group in an intact penicillin V molecule to afford the 
P- 	derivative (175). 	(175) was an 
intermediate on route to the synthesis of a novel 
structure, the 2-exomethylene pertain system (177) (scheme 
70) by a decarboxylative Pummerer reaction involving the 
sulphoxide (176). 
A derivative possessing two ester functions in t 
C-2 position of the penam system (184) was also developed 
(scheme 71)107. 	This approach involved the thiazoline 
(178),108 since it was found that the Beecham method of 
ring opening of penicillin by alkylating the sulphur atom 
in the presence of a base, was largely limited to primary 
halides. 74 	Work with thiazolines (178) by Barton and 
co-workers 109 had shown that when an analogue of (179), 
derived from penicillin V (2), was treated with certain 
alkyl halides in aqueous dimethylformamide, containing 
FW 
HH(0)fl 









RCONH 	= S "CO2R 1 
0 00R2 
R = PhOCH2, R1,R2 = tBu 
R = PhOCH2, R 1 = Me, R2 = PNB 
R = PhOCH2, R- 	= Me, R2 = H 
R = PhC}INH2, R 1 = Me, R 2 = H 
R = PhOCH2, R 1 , R2 = H 
Scheme 68 Use of a carbanion intermediate for a 
successful cyclisation. 
H  




















Scheme 70 Synthesis of the 2-exomethylene penam system. 
CH 2 OPh 
O\R 
V U U S-OH (CO 2 Et) 2 











CO2 Et  
CO2 R 
R z CMe3 
R = H 
/ 
Scheme 71 synthesis of a -lactam derivative possessing 
a diester functionality at C-2. 
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urea and an antioxidant, at 50°C, S-alkylation occurred 
with hydrolytic opening of the thiazoline ring. 	This 
procedure was applied using diethyl bromomalonate and the 
thiazoline (179), resulting in (180) which was taken 
through subsequent transformations to afford (182). 	The 
cyclisation step from (182) to (183) avoided the need to 
oxidise the sulphide to the sulphoxide, since the methine 
proton was sufficiently acidic, (due to the electron with-
drawing effect of the two ester groups), to generate the 
carbanion and spontaneously cyclise under the mild 
reaction conditions. 	Attempts to obtain the tn-acid 
derivative failed. 
h) 	Synthesis of a penam nucleus via a 5-exo-tet 
cyclisation involving a substitution by a sulphur 
nucleophile at the C-4 position. 
A synthesis of the penam system has been 
reported, 110 which involves a 5-exo-tet cyclisation onto 
the 4-position of the azetidinone (186) (scheme 72). 
The method affords a mixture of diastereomers and results 
in a number of isomeric products (187). 	Intermediate 
(185) is obtained by total synthesis, via the 
keterie-imirie method. 	Chiorinolysis of the 
sulphj.ir-carbon bonds afforded a diastereomeric mixture of 
(186). 	This was cyclised 11 ' by treatment with one 
equivalent of anhydrous tin (II) chloride in dioxane at 













N3,S Me Me 
CO 2Bz 
Scheme 72 A 5-exo--tet cyclisation involving a 




The oxapenam derivatives are the oxygen analogues 
of pencillins. 	They are usually less stable, and 
possess lower activities than the parent systems. 	The 
different chemical properties of oxygen in relation to 
sulphur has necessitated different methods of cyclisation 
to afford bicyclic fused systems. 
a) 	Synthesis of an oxapenam molecule via a 5-endo-- 
trig cyclisation. 
An early approach 112 (scheme 73) involved the 
transformation of the oxazoline (188), obtained by 
degradation of penicillin G (1) with mercuric acetate at 
room temperature, 113 to oxapenicillin G (189) via 
treatment with a lithium alkyl thiolate in hexamethyl 
phosphoramide, followed by acidification to pH 2.3. 	The 
product (189) was not isolated but possessed similar 
polarity to penicillin G, and had similar biological 
activity to pencillin G which was lost on exposure to a 
pencillinase. 	A further method which was reported by 
Wolfe114 involved the 5-endo-trig cyclisation of (192) to 
(189) (scheme 74). 	This, •however, has proved impossible 
in the sulphur analogue (161). 	In the opinion of the 
author, both of the above reports are questionable on the 
grounds that if the stereoelectronics of the sulphur 
analogue (161) are incorrect, as described by Baldwin, 102 
then the oxygen analogue (192), which would require a 
much tighter angle of "nucleophilic trajectory", would 
not be possible, particularly when considering the 
nucleophilicity and size of oxygen compared to sulphur. 
Secondly, the transition state for the oxygen analogue 
would be expected to be less stable, hence more difficult 
to form, due to the electroriegativity of oxygen which 
would give rise to a more strained bicyclic fused system, 
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compared to the sulphur system. 	Finally, the 
characterisation data available for the products 0-re. not 
sufficient for an unequivocal representation of the 
structure. 
b) 	Synthesis of the oxapenam derivative via a 5-exo-- 
tet cyclisation involving the $-lactam nitrogen. 
The 5-exo-tet mode of cyclisation (scheme 75), 
involving the $-lactam nitrogen in a displacement of a 
halide, has not been possible in the sulphur analogue 
(153), where the cis geometry of the p-lactam 
substituents exists. 	However, in the oxajderivative 
(193), this method of cyclisation has been realised by 
base treatment to generate (194).115 
C) 	Synthesis of the oxapenam derivative involving a 
carbene insertion reaction. 
A novel method of preparing bisnordethiaoxa-
penicillin G (196) has been reported by Cama and 
Christensen, 116 involving a carbene insertion into the 
P-lactam nitrogen-hydrogen bond (scheme 76). 	This 
approach has not been possible for the sulphur analogues, 
owing to complications involving the polarisable lone 
pairs on the sulphur atom and the electrophilic carbene 
intermediate. 
C) 	A 5-exo-trig cyclisation to an oxapenam 
derivative. 
A recent report117 indicated a 5-exo-trig mode of 
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ring nitrogen to generate an oxapenam derivative (200) in 
high yield (scheme 77). 
3.2.4 	CARBAPENAM 
The carbapenam derivatives possess a methylene 
group in place of a sulphur atom. 	These are very 
unstable in comparison to the penam system. 	They do, 
however, possess biological activity. 
Synthesis of a carbapenam nucleus by a ring 
contraction method. 
An important route -to these derivatives involves 
the ring contraction of a 3-diazopyrrolidin-2,4-dione 
derivative (201) (scheme 78), to result in the carbapenam 
(202). 118 
Synthesis of a carbapenain nucleus by a 5-exo-trig 
cyclisation. 
A more recent method 117 involves the azetidinone 
(203),which undergoes a 5-exo-trig mode of cyclisation 
involving the -lactam nitrogen to generate (204) in high 
yield (scheme 79). 
C) 	Synthesis of a carbapenam nucleus by a 5-exo-tet 
cyclisation. 
A further example of a 5-exo-tet mode by 
cyclisation to generate the carbapenam system has been 
reported (scheme 80)119. 	The derivative (205) was 
obtained from (207) (scheme 81)120 by standard 
procedures, for example alkylation of the -lactam 
nitrogen with diethyl bromomalonate, ozonolysis (with a 
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reductive work-up), followed by tosylation. 	The 
cyclisation of (205) was effected by treatment with base 
at 0°C. 
3.2.5 	AZAPENAM 
The azapenain derivatives are the nitrogen 
analogues of penams. 	Their unstable nature has 
attracted only a few synthetic attempts. 	The biological 
activity of these analogues is not very promising. 
However, some weak growth inhibiting properties of 
bacteria are evident. 
A total synthesis of a 2-azapenam system has been 
reported by Huffman and co-workers (scheme 82).121 	The 
versatile intermediate (78), as utilised for the 
synthesis of the isopenam (155), was again used by the 
same authors. 	The interesting step involves the 5-endo- 
trig cyclisation by the p-lactam nitrogen onto the imine 
to result in the bicyclic system (209). 	(210) was 
reported to be unstable, but showed some bacterial growth 
inhibiting properties. 
3.2.6 	PENEM 
The penem system (211) (scheme 83) was the first 
unnatural unsaturated fused -1actam system to be 
obtained synthetically. 	This structure encompasses both 
virtues of the natural products: the ring strain, 
present in the penicillins, and the electron withdrawing 
aspects of the enamide group present in cephalosporins. 
This novel structure was pioneered by R.B. Woodward and 
was delivered in his lecture presented at the first 
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antibiotics. 	The penem derivatives were found to have 
inherent biological activity. 	However, their 
instability to physiological conditions questions their 
use as potential antibiotics for commercial use. 
a) 	Wittig reaction for penem synthesis. 
The synthesis of the penem system has been 
attempted by many workers, but only a few strategies have 
been employed to obtain the bicyclic nucleus. 	The 
earliest attempt was made by Woodward (scheme 84)123, 
which involved an intramolecular Wittig reaction of the 
phosphorane derivative (212) to afford the penem (213). 
The phosphorane (212) was readily obtained by degradation 
of naturally occurring penicillins by well known 
procedures followed by functionalisation of the $-lactam 
nitrogen, as described earlier. 78 	The success of the 
cyclisation was very dependent on the electron 
withdrawing capactity of the carboxylate protecting group 
(0), strongly electron withdrawing groups requiring 
longer reaction times and higher temperatures. 	The 
6p-acetamidopenem derivatives obtained showed some 
biological activity against Gram-positive strains of 
bacteria, but unfortunately, penem (214) was found to be 
labile under acidic conditions, even on silica gel, 
resulting in decomposition to a ketene (215) and a 
thiazole (216) (scheme 85). 
The Wittig method has been a very popular one for 
constructing highly modified bicyclic fused systems and 
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b) 	Nucleophilic substitution at C-4 for a penem 
synthesis via 5-exo-tet cyclisation. 
Another approach to the penem system was devised 
by the Glaxo research group 124 and involved an internal 
nucleophilic displacement at the C-4 position of the 
azetidinone (218) to afford the penem (219) (scheme 
86). 	One major drawback of this method was the 
diastereomeric mixture that resulted due to epirnerisation 
at C-5 of (219). 	Intermediate (218) was obtained from 
the clavulanate (217), by a route involving a novel 
betain intermediate (221) (scheme 87). 	In-vitro 
experiments on (220) suggested that it had very good 
activity. 	However, in in-vivo test results were 
disappointing. 
C) 	Penem synthesis involving a sulphur extrusion 
process. 
A novel method to the penem system (223) has been 
developed by the Farmitalia group, 125 involving a sulphur 
extrusion process from intermediate (222) (scheme 88) 
which can be obtained quite readily from a threonine-
derived 4-benzoyloxyazetidinone derivative (224) (scheme 
89). 	This method has recently been used to obtain a 
1-dethia-l- selenapenein derivative (225) (scheme 
90).126 	The mechanism of this reaction, as proposed 126 
in scheme 91, explains the lack of stereochemical control 
at C-5. 	It has been reported that by appropriate choice 
of solvent,one isomer can be produced in excess, 
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Scheme 90 Structure of a selenopenem derivative. 
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d) 	Synthesis of a penem nucleus via a 5-exo-trig 
cyclisation involving the -lactain nitrogen. 
Wasserman and Hans 127 have recently reported a 
very interesting approach to a penem derivative (236) by 
a route which is sterochemically controlled at C-5 and 
C-6 (scheme 92). 	Derivative (228) is readily obtained 
by a nucleophilic displacement of the acetoxy group in 
derivative (237) by dimethyl thioacetonedicarboxylate and 
base (scheme 93). 	Protection of the N-H group by 
tert-butyldimethylsilyl chloride, followed by ozonolysis 
at low temperature resulted in (230). 	Treatment of 
(230) with N,N-dimethylformamide dimethyl aetal and base 
gave the enamino derivative (231). 	The enamine (231) 
was subjected to photooxidátion and afforded the 
tricarbonyl system (232). 	Desilylation led directly to 
the bicyclic system (234). The hydroxyl group in (234) 
was removed by conversion to the chloride followed by 
treatment with zinc and aqueous acetic acid to form 
The thiolactone (235) was etherified by 
treatment with diazomethane to afford the penem system 
 
e) 	Synthesis of a penem nucleus via a carbene 
insertion reaction. 
It is interesting to note an unsuccessful approach 
to the penem system (scheme 94)128  which involved 
intermediate (238), where it was hoped that a carbene 
insertion would give the bicyclic fused system (239). 
However, all attempts at cyclisation failed. 	This is 
surprising since, as will be seen later, in the 
carbapenem synthesis this ring closure takes place 
successfully. 	However, an efficient chiral synthesis to 
a 2-alkylthiopenem derivative (243) has been reported 
which involves a carbene insertion into a 
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trithiocarbonate protecting group in moderate yields 
(scheme 95).129 	This route is adaptable for a large 
scale synthesis of (243) which is a potent antibiotic 
with broad spectrum activity and -lactamase resistant 
properties. 	This compound is now commercially produced 
by Schering. 130 	Derivative (240) is readily obtained as 
outlined in scheme 96. 
f) 	Structural aspects of the penem system. 
The penem system was found to possess inherent 
biological activity. 123 	However, early attempts at 
utilising the acylamino side chain as in penicillins and 
cephalosporins did not impart the stability in this 
system that was necessary for in-vivo activity. 	The 
6-unsubstituted penem derivative was also synthesised, 1 3 1 
but although this exhibited high activity in in-vitro 
testing, in-vivo results were disappointing. 
Furthermore, it was established 132 that the 5R isomer of 
the penem system was essential for biological activity. 
Consequently, routes affording a racemate would not be 
acceptable for commercial synthesis. 	It was the 
discovery of thienamycin 13 that prompted the introduction 
of the hydroxyethyl group at the C-6 position of the 
penem system 133 and which finally led to the highly 
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Scheme 98 Structures of modified clavulanic acid. 
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3.2.7 	CLAVEM-OXAPENEM 
Clavulanic acid (19) (scheme 97) is the parent 
compound of this class of antibiotics. 	it possesses 
moderate antibacterial activity but shows very high 
specificity for -lactamases. 	It is for this reason 
that it is used as an inhibitor in conjunction with a 
pencillin,such as amoxycillin (8) or ampicillin (4),to 
treat patients infected with $-lactamase producing 
bacteria. 
Beecham workers have undertaken a thorough 
investigation into its modification and its 
chemistry. 134 	It would appear that the isolated 
structure (19) possesses near optimal features for the 
maximisation of its important properties. 	A derivative 
which has five times the activity of (19), is the 
N-benzyl protected amino analogue (244) (scheme 98). 135 
This is believed to be due to increased blood levels and 
half-life, as is found with the free amino derivative 
(245) (scheme 98), relative to clavianic acid (19). 
a) 	Synthesis of clavulanic acid by a 5-exo-tet 
cyclisation. 
The first racemic synthesis of clavulanic acid (19) 
was reported by workers at Beecham, this involved a 
5-exo-tet cyclisation of an enol onto the C-4 position of 
the azetidinone (246) to result in (247) (scheme 
99)•136 No chiral synthesis of clavulanic acid is 
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Scheme 100 Structure of an oxapenem derivative. 
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b) 	Synthesis of an oxapenem by isomerisation of 
clavulanate. 
The oxapenem derivative (249) (scheme 100) could be 
expected to be obtained by base treatment of clavulanic 
acid. 	Attempts to carry out this isomerisation on a 
model compound (250) resulted in a very interesting 
oxazoline ring opening reaction (scheme 101). 138 	The 
Glaxo group found that treatment of (250) with 
triethylamine resulted in the betaine (251) which,on 
heating in ethyl acetate,furnished the endocylic bicyclic 
dervative (252). 	This derivative was reported to be a 
powerful inhibitor of cell free $-lactamases. 	The 
betaine (251) was found to be quite useful in that the 
C-4 position of the azetidinone could be substituted by a 
variety of nucleophiles. 	Furthermore, the ring could be 
easily reformed by heating. 	This procedure was used to 
synthesise penems,as described earlier. 124 
C) 	Stability aspects of oxapenem derivatives. 
Oxapenems were found to be highly unstable to 
normal physiological conditions. 	Their synthesis, for 
antibiotic purposes, is beset with problems, 
particularly their instability to acids and bases, and 
only workers at Beecham and Glaxo have continued to 
concentrate their efforts on these derivatives. 139142  
3.2.8 	CARBAPENEM 
Thienamycin (20) and olivanic acid (22) were the 
first compounds isolated in this class of antibiotics. 
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several similar structures which vary according to the 
C-2 and C-6 substituents, and to the substituent 
stereochemistry of the p-lactam ring, have been 
isolated. 	Examples include carpetamycin (255),143 
asparenomycin (256),144 and PS-5 (257)145 (scheme 102). 
The characteristic properties of high potency, broad 
spectrum activity and -lactamase resistance have made 
the carbapenem derivatives potentially extremely valuable 
antibiotics. 	Unfortunately, these antibiotics suffer 
from physiological instability, particularly to enzymes 
(the dehydropeptidases) present in the mammalian 
kidneys. 	Thienamycin has been found to possess the 
optimal stereochemical requirements for maximum activity 
(namely anR-hydroxyethyl group, trans geometry around 
the -1actam ring and the 62  double bond), in the 
carbapenem series. 146 	Consequently, this section will 
only be concerned with synthetic approaches to 
thienamycin (205). 
a) 	Synthesis of a carbapenem molecule by a 5-exo-tet 
cyclisation involving a carbanion. 
The first synthesis of thienamycin (20) was 
reported by the Merck group in 1978 (scheme 103)147. 
Derivative (258) was obtained from a long synthesis 
starting from chiorosuiphonyl isocyanate and 
1-acetoxybutadiene. 	Cyclisation was accomplished via 
the bromonium ion (259), by treatment with base, to 
furnish (260), which was then dehydrobrominated to 
(261). 	The 8R and 8S isomers could be separated at this 
stage. Decarboxylation of the 8R-isomer gave (262) 
which, after isomerisation to a 4:1 mixture of (263) and 
(262), was separated by chromatography. 	Finally, 
hydrogenolytic removal of protecting groups from (263), 
yielded synthetic racemic thienamycin (20). 
106 
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Carbapenem synthesis involving the Wittig reaction. 
The intramolecular Wittig reaction, as devised by 
Woodword for penem synthesis, 1 23 has been utilised to 
obtain the thienamycin nucleus (265) (scheme 104).148 
An important intermediate (266) (scheme 105) that has 
been developed for carbapenem synthesis has been 
reported. 149 	This requires the use of the Wittig 
methodology for a cyclisation to occur. 	Ozonolysis of 
(266) generates a dialdehyde derivative which 
spontaneously cyclises to the carbapenem nucleus and the 
aldehyde group at the C-6 position is available for 
further modifications. 	Recently, this derivative (266) 
has been employed for the synthesis of a number of 
carbapenem analogues. 150 
Carbapenem synthesis involving a carbene insertion 
reaction. 
Another important route that was developed for the 
synthesis of carbapen-2-em ring system was reported by 
the Merck group (scheme 106).151 	The important aspect 
of this synthesis is the rhodium acetate catalysed ring 
closure of (269) to (270). 	The cyclisation involves a 
carbene insertion into the azetidinone N-H bond. 
Reaction of (270) with phosphonyl chloride/base and also 
a protected cysteamine followed by deprotection of all 
the protecting groups readily generates thienamycin 
(20). 	This approach has been used for the synthesis of 
the aspareriomycins. 152 	This route is generally the 
method of choice for carbapenem derivatives. 153156 
Consequently, much work is at present directed towards 
economic chiral syntheses of intermediates such as 
(267) 1459 and (271) 160-1 6 1 (scheme 107). 	The high 










o 	PPh 3 
CO 2 R 
(266) 

















Me L E13 















( 272 ) 
Scheme 108 Structure of azapenem derivatives. 
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makes it necessary to incorporate the correct 
stereochemistry and substituents at an early stage of the 
synthesis. 
3.2.9 	AZAPENEM 
The 1-azapenem derivative (272) (scheme 108) with 
a nitrogen atom replacing the sulphur atom of the penam 
system has been reported recently. 162 
The 1-azapenem derivative (272) was obtained by 
desulphurisation, with triphenyiphosphine in acetonitrile 
at room temperature, of the azathiacephem derivative 
(274) (scheme 109). 	The ring closure proceeds via the 
azetidinonium intermediate (175) followed by nucleophilic 
subsitution at C-4, by the enamide nitrogen to afford a 
racemic product. 	Attempts to remove the p-nitrobenzyl 
ester to generate the free acid, under a variety of 
conditions gave, after work-up, only decomposition 
products, thus confirming the low stability of this 
system. 
In addition the nitrogen analogue (273) (scheme 
108) of the carbapen-3-em derivative has been 
reported. 163 	This compound was found to be biologically 
inactive. 	The 6-acylamino derivative (279) has been 
synthesised by Pearson. 164 	This route involved an 
interesting intramolecular cyclisation involving a 
reactive nitrene intermediate (277) (scheme 110). 
Intermediate (276) was readily obtained by the 
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3.3.0 FOUR—SIX FUSED SYSTEMS 
3.3.1 SYNTHESIS OF CEPHALOSPORINS 
The cephalosporin nucleus (280) (scheme ill) is 
comprised of a -lactam ring, fused onto a 
dihydrothiazine system. 	Its discovery was prompted by 
its stability to penicillinase producing bacteria which 
had become resistant to penicillins. 	cephalosporin C 
(12) was the first member isolated in this class of 
compounds. 	Its biological activity was quite low. 
However, changing the acylamino side chain (R1 ) to a 
2-thienylacetyl group resulted in a highly active 
derivative with a broader spectrum of activity than 
penicillins G and V. 	This was called cephalothin (14) 
(scheme ill). 	Many modified side-chain derivatives were 
subsequently produced (Table III). 	These had improved 
biological properties, such as acid stability, high blood 
levels, increased potency, a broader spectrum of activity 
and stability topenjcjtljnaseS. 165 	Treatment with 
pyridine produced another derivative which was discovered 
to have very high potency. 	This derivative was found to 
have the pyridine displacing the acetoxy group to result 
in a betaine derivative called cephaloridine (15) (Scheme 
111). 	Consequently, the acetoxy group was substituted 
by many nucleophiles such as alkyl or aryl thiols, amino 
compounds and alcohols to afford modified derivatives 
which improved the biological properties of the cephern 
system l66 
The discovery of cephalosporin derivatives 
containing a 7-methoxy group, the cephamycins (17) 
(scheme 112), imparted a much required property of 
p-lactamase resistance into the system. 	This discovery 
made it necessary to obtain systems with 
7 G-substjtuents. 167 	It is intended that the peripheral 
modifications of this system remain outside the scope of 
this account, since there are already a number of reviews 
115 
available. 168 	However, since the acylamino, 7 a-c and 
C-3 positions impart important biological properties to 
these derivatives, synthetic approaches which allow 
convenient modification of these positions in the 
cephalosporin nucleus will be discussed. 
The cephalosporins are obtained by fermentation 
methods, using a high yielding strain of Cephalosporium 
acremonium. 	The isolated derivative has an 
a-aminoadipyl side chain at C-7 and an acetoxy group at 
c-3. 	Since this derivative has minimal activity, it is 
necessary to carry out chemical modifications, such as 
removal of the 7-acyl group to obtain 7-aminocephalo-
sporanic acid (7-ACA) (13), or removal of both the 7-acyl 
group and the 3' -acetoxy group to obtain 7-amino-
deacetoxycephalosporanic acid (7-ADCA) (281) (scheme 
113). 	Consequently, cephalosporin derivatives are much 
more expensive than penicillins, for which the 
intermediate 6-amino penicillanic acid (6-APA) (3) is 
obtained directly from precursor-starved fermentation 
media. 	It was for these economic reasons that methods 
of converting penicillins to cephalosporins were sought. 
In addition, direct modification of cephalosporins is 
limited due to the problems of isomerisation of the L\ 3-
double bond to the L 2-position (scheme 114), and to the 
problems of lactone formation in /2i 3-isomers under acidic 
conditions (scheme 115). 	The L\ 2-isomer (283) and the 
lactone (284) are devoid of any activity. 	In order to 
undertake a thorough investigation of the structure-
activity relationship of the cephem system, totally 
synthetic approaches were developed. 
a) 	Conversion of natural penicillins to 
cephalospor ins. 
The earliest penicillin to cephalosporin 
conversion was reported by R.B. Morin and co-workers in 
H  




















Scheme 113 Structures of 7-aminocephalosporanic acid 
(7-ACA) and 7-aminodeacetoxycephalosporanic 
acid (7-ADcA). 
Scheme 114 Isomerisation of the double bond 
in the cephem system. 
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1963 (scheme 116), as described in an earlier section. 
This conversion involved refluxing a penicillin V 
sulphoxide ester in xylene in the presence of an acid, 
such as p-toluenesulphonic acid,to result in a mixture of 
products, from which the cephalosporin derivative (287) 
was identified. 	The mechanism of this reaction was 
thoroughly studied by Morin and co-workers 169 and also 
cooper 170 , and was reviewed by Sammes 17 ' (scheme 117). 
The important intermediatethat was generated was the 
sulphenic acid (290). 	This has been trapped by many 
methods as described earlier. 	The intermediate (290) 
undergoes an electrophilic addition to the double bond to 
result in the episuiphonium ion (291). 	Decomposition of 
(291) is dependent on the size of the side chain (R 1 ) and 
the size of the conjugate base (x) of the acid used. 
The different pathways available allow the formation of a 
variety of products. 	Recent developments have allowed 
this conversion from penicillin G sulphoxide derivative 
(286) to deacetoxycephalospranic acid (288) to be 
possible in yields in excess of 80%, with transient 
protection of the carboxylic acid as its trimethylsilyl. 
ester. 172 	The deacetoxycephalosporanic acid derivatives 
are also found to possess good activity and are readily 
absorbed through the intestinal wall and can thus be 
orally administered. 	They are also valuable 
intermediates allowing further modifications to afford 
novel cephalosporins. 
The penicillin sulphoxide to cephalosporin route 
can be modified by involving an intermediate such as a 
disulphide (294), which is obtained by trapping the 
sulphenic acid (290) with 2-mercaptobenzothiazole. 67 
The disulphide (294) can be converted to modified 
penicillins or be transformed to cephalosporins. 
Transformations to the cephem system involving this type 
of intermediate (294) usually involve an episulphonium 
ion (291), which is also capable of affording other by-
products, such as the penam system (298). 	consequently, 
this route has limited usefulness, particularly regarding 
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the functionality available at the C-7 and the C-3 
positions. 
b) 	Synthesis of a cephem nucleus via a 6-exo-tet 
cyci isation. 
A much better route to the cephem system (303) 
involves the use of the thiazoline (301) (scheme 
119).173 	Allylic bromination of the methyl group in 
(301) affords (302),and generation of the free thiol 
results in a 6-exo-tet cyclisation to afford (303). 
This route allows the functiorialisation of the cephem 
nucleus at the c-7 (G and P ) and C-3' positions. 
However, the success of this cyclisation is dependent on 
the presence of an enolisable group (R3) on the double 
bond, particularly if R' is a hydrogen atom. 
C) 	Synthesis of a cephem nucleus via a Wittig 
reaction. 
The Beecham group have also devised an important 
route to the cephem system (306), involving an 
intramolecular Wittig reaction, 174 as used by R.B. 
Woodward for the penem system. 123 	This approach allowed 
a variety of functional groups to be incorporated in the 
C-3' position (scheme 120). 	Intermediate (305) was 
obtained by degradation of pencillin G to the azetidinone 
(304) (scheme 120). 	The p_lactam N-substituent was 
attached by the procedure previously described by 
Woodward and Heusler. 78 	The ketone group was generated 
by a catalytic hydration of the triple bond using 
mercuric chloride and piperidine followed by 
hydrolysis. 	The cyçlisation was successfully completed 
by heating in dioxane or toluene. 
121 
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Scheme 121 Structure of 3-trifluoromethyl cephalosporin. 
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The intramolecular Wittig reaction approach has 
been used by workers at Shionogi, 175 to successfully 
synthesise the 3-trifluoromethyl cephalosporin (307) 
(scheme 121). 	This type of derivative could not be 
synthesised from penicillins prior to this approach. 
d) 	Total synthesis of cephalosporin derivatives via a 
6-exo-trig cyclisation. 
Totally synthetic approaches to the cephem system 
were attempted soon after the identification of 
cephalosporin C. 	The first synthis of cephalosporin C 
was described by R.B. Woodward in 1966 (scheme 58).176 
This elegant synthesis clearly shows the difficulty 
involved in obtaining the intermediates with the correct 
stereochemistry at the chiral positions in the synthesis 
of a natural product. 
L-Cysteine was protected at its three reactive 
sites (308) and functionalised at the unactivated 
methylene position, adjacent to the sulphur atom, with 
complete stereochemical control using dimethyl 
azodicarboxylate to result in a trans substituted 
intermediate (309), oxidation of which with lead 
tetraacetate, followed by hydrolysis of the trans acetoxy 
• derivative (310) to the trans hydroxy derivatives (311) 
and activation of the hydroxyl group with methane 
sulphonyl chloride, and subsequent displacement of the 
mesylate with sodium azide resulted in the cis azido 
derivative (312). 	Reduction of the azido group with 
aluminium amalgam/1M sodium hydroxide resulted in the 
amino derivative (313) which was cyclised to the 
versatile -lactam. intermediate (314) with 
triethylaluminium. 	The $-lactam nitrogen was reacted 
via a Michael addition with a reactive unsaturated 
dialdehyde derivative (315); (obtained from 
malonaldehyde (320) condensed with a trichioroethyl, 
123 
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glyoxylate (321), (scheme 123)), to afford the 
N-substituted diastereomeric mixture (316). 
Deprotection of the acetonide and the t-butyloxycarbonyl 
groups with trifluroacetic acid resulted in the 
2-cephem system (317) via a 6-exo-trig cyclisation. 	The 
amino group at the C-7 position was reacted with a 
trichioroethyl- U - amido-adipylacyl chloride derivative 
to generate (318). Diborane reduction of thea,/3 
-unsaturated aldehyde followed by acylation with acetic 
anhydride resulted in the 	2-acetoxy derivative (319). 
Equilibration of the double bond with pyridine and 
treatment with zinc and acetic acid removed the 
trichioroethyl protecting groups to afford synthetic 
chiral cephalosporin C (12). 
The synthesis of cephalosporin C by Woodward was 
too long to be a means of studying structure-activity 
relationships of cephalosporins. 	However, a very 
important intermediate was obtained; the thiazolidine 
(314). 	The stereochemistry and the functionality around 
the p_lactam bond in (314) is identical to both 
penicillins and cephalosporins and it is thus a very 
important intermediate for both of these systems. 	Work 
commenced on obtaining an intermediate of this type from 
readily available penicillins. 	This transformation was 
accomplished, initially by Woodward and Heusler (scheme 
124)177 and later by the Eli Lilly group (scheme 
125)178. 	The thiazoline (329) could be reduced with 
moist aluminium amalgam in an ethereal solvent, or with 
sodium borohydride, to give the corresponding 
thiazolidine (330). 	The thiazoline (102) could readily 
be obtained by the action of heat and trimethyl phosphite 
on penicillin V sulphoxide followed by ozonolysis and 
methanolysis, as developed by the Ciba group. 70 	Using 
the intramolecular Wittig reaction approach (314) or 
(330) could be functionalised appropriately to obtain 
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Synthesis of the cephem nucleus via a N,N- 
dicyclohexylcarbodiimide coupling reaction. 
The general approach devised by Sheehan for the 
synthesis of penicillins was also successfully adapted 
for the synthesis of cephalosporins by Roussel-Squibb 
(scheme 127).179180 	Intermediate (336) was obtained by 
total synthesis starting from pyruvic acid, formaldehyde 
and dirnethylamine to form the Mannich base (331), which 
was then converted to the thiolacetate (332) by 
displacement of dimethylamine with thioacetic acid. 
Removal of the thiol protecting group under acidic 
conditions and condensation with the amine derivative 
(334) gave both the erythro- and threo-isomers of the 
condensation product (335). 	Treatment with hydrazine to 
remove the phthalimide group, and then acid to remove the 
t-butyl group, gave only the desired threo amino acid 
(336). 	Tritylation of the free primary amino group 
greatly facilitated -1actam formation. 	Cyclisation was 
accomplished via treatment with N,N- dicyc].ohexyl- 
carbodiimide. 	After acid removal of the trityl group 
from (337) the product was resolved with (+)-tartaric 
acid and then the free amino group acylated with 
2-thienylacetyl chloride. 	The lactone (338) was 
converted to the hydroxy-acid (339) by base hydrolysis. 
The yields for the final step were low, generally 
approximately 30%. 
Synthesis of the cephem nucleus via the 
ketene-imine method. 
The Merck group' 83- also devised a versatile route 
to the cephalosporins using the method popularised by 
A.K. Bose, 55 involving a ketene-imine cyclisation and a 
latent amino group (scheme 127). 	The important aspect 
of this synthesis is the manner in which the thiazine 
127 
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derivati.v(340) was obtained in high yield (scheme 
128). However, the drawback to this synthesis (scheme 
127) is the racemic product (14) that is obtained. 
3.3.2 	OXACEPHEMS 
Synthesis of an oxacephem derivative via a 
ketene-imine approach. 
The oxacephems are the oxygen analogues of 
cephalosporins. 	The first synthesis of an oxacephem 
derivative was described by Wolfe in 1974,182 and was 
shortly followed by that of the Merck group (scheme 
129).183 	The racemic synthesis of 1-oxacephalothin 
(350) involved the ketene-imine method to form the 
P-lactam ring, followed by an Emmons condensation using a 
phosphonate and a protected a , t -dihydroxy acetone 
derivative in the C-4 position of the azetidinone (347), 
to form the dihydrooxazine ring system (348). 	(348) was 
then converted through standard procedures to 1-oxa 
cepthalothin (350). 	This was found, after correction 
for the racemic mixture, to have comparable biological 
activity to sodium cephalothin (342). 
Synthesis of an oxacephem derivative via a Wittig 
reaction. 
The Beecham group also utilised their versatile 
pencillin degradation methods to obtain a 1-oxacephem 
derivative (354) (scheme 130).184 	This route used 
penicillin G as the starting material and involved an 
intramolecular Wittig reaction to form the second ring. 
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The ketone (353) was generated by hydration of the alkyne 
substituent using mercuric chloride and piperidine 
followed by aqueous work-up. 	It was found that this 
method of hydration was only successful for terminal 
alkyne substituents, in the oxygen analogues of 
cephems. 	Consequently, in order to obtain the 
appropriately functionalised ketone, a different approach 
was necessary. This modified route involved protecting 
the ketone as an olefin. 	The ketone was readily 
regenerated by ozonolysis at low temperature. 	The final 
oxacephem derivatives were found to be optically active 
and with the cis stereochemistry about the $-lactam 
ring. 	The oxacephem derivatives, thus, prepared were 
found to have only moderate activity compared to their 
cephalosporin analogues. 
The moderate activity of oxacephem derivatives 
stimulated workers at Shionogi, 185 to undertake a 
detailed structure-activity investigation of these 
derivatives, in the hope of finding a highly active 
antibiotic. 	The investigation involved modification of 
substituents at C-7 (a and ) and at C-3 positions of 
the nucleus (scheme 131). 	The systematic investigation 
into the structure-activity relationship of the oxacephem 
system186 resulted in the following findings: the 7(-
ary1malonylamino group (as in carbenicillin (5)), the 
7-methoxy substituent (as in cephamycins) and the C-3-
N-methyltetrazolyl thiomethyl group, (as inthe highly 
active cephalosporins such as cefoperazone, SCE-1365, 
Cefazaflur, cefamandole, cefmetazole and others) caused 
an enhancement of the potency and the pharmo-kinetics of 
the oxacephem system towards a broad spectrum of Gram- 
negative bacteria. 	This work led to the first 
commercially available oxacephem derivative, moxa- 
lactam (355) (scheme 132). 	The synthetic strategy 
employed involved the Beecham method, as discussed 
earlier, but deviated in that the propargyl group was 
converted to an epoxide, which could be opened by acid or 
base to a diol derivative. 	This could subsequently be 
132 
converted to a carbonyl moiety, which would h.avè the 
appropriate substituent in the(7-position and which could 
be used in an intramolecular Wittig cyclisation as 
discussed earlier. 
C) 	Chiral synthesis of an oxacephem nucleus via a 
6-exo-tet cyclisation involving an alkoxy 
nucleophile at the C-4 position. 
An excellent chiral synthesis of the 1-oxacephem 
system from 6-aminopenicillanic acid (6-APA) has been 
reported (scheme 133).187 	The important step in this 
strategy is the enantioselective cyclisatiori of the 
oxazoline intermediate (358) to the 6R fused system 
(359), catalysed by boron trifluoride etherate. 	The 
inversion of the stereochemistry at the C-7 position in 
(360) to (361) was mediated by the tert-butylhypochlo-
rite/lithium methoxide method. 188 This strategy is 
sufficiently flexible to functionalise the important C-7 
( and 	) and the C-3 positions of this fused system. 
The oxacephern derivatives are quite effective 
antibiotics. 	However, relatively few have come onto the 
market. 	The major reason for this is that the oxacephem 
nucleus, being unnatural, requires a great deal of "fine 
tuning" to find the correct combination of peripheral 
functional groups with physiological compatability. 	The 
synthetic approaches described clearly indicate the large 
number of steps that are usually necessary for their 
synthesis. 	These two factors are very time consuming 
aspects of research and are probably the reasons for the 
dearth of oxacephem antibiotics on the market. 	Further 
work towards the oxacephem system is still necessary in 
order to find a much shorter and stereoselective approach 
to them, particularly for large scale synthesis. 	The 
use of penicillins, as raw materials, is probably the 
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Scheme 134 Structure of the carbacephem nucleus. 
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3.3.3 	CARBACEPHEMS 
Synthesis of a carbacephem nucleus via the 
ketene-imine method. 
The carbacephem system (362) (scheme 134) has not 
had the same success as its oxacephem analogue. 	The 
first synthesis of a carbacephem derivative was reported 
by workers at Merck, as part of a study of structural 
analogues of cephalosporins. 189 	This route involved the 
ketene-imine method for the p_lactam ring formation and 
an Emmons intramolecular cyclisation (scheme 135). 	The 
racemic 1-carbacephalothin product (363) was found to 
have comparable activity to the 1-thia congener (14) 
(scheme 5). 	The results obtained had been corrected 
taking into consideration the comparison of a chiral 
sample of cephalothin (14) to the racemic product (363). 
Total synthesis of a carbacephem nucleus 
involving the ketene-imine method and the Emmons 
method. 
A total synthesis of 1-carbacephalothin confirmed 
its high biological activityJ 90 	Introduction of a 
methoxy group in the 7position of the carbacephem 
nucleus (scheme 136) considerably improved its biological 
properties over the 1-thia-congeners. 	The strategy 
employed for their synthesis involved the use of the 
ketene-imine method for the -1actam ring formation and 
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C) 	Synthesis of a c-i substituted carbacephem 
nucleus. 
The carbacephem system has an additional position 
for modification, compared with the cephalosporins. 	The 
c-i position has been substituted by a hydroxy group to 
obtain the 1 a-hydroxy-i-carbacephem derivative (364) 
(scheme 138) by coivin. 192 	The synthetic strategy 
adopted was that of the Merck route. 190 	This derivative 
(364) was found to have little activity compared to the 
1R-suiphoxides of cephalosporins. 	It did not possess 
any p-.lactamase inhibitory activity. 
Synthesis of the carbacephem nucleus via a carbene 
insertion reaction. 
An enantioselective synthesis of the carbacephem 
system (366) has been reported. 193 	The important steps 
involve an asymmetric ketene-imine cycloaddition for the 
$-lactam ring formation 194 and a carbene insertion into 
the azetidinone N-H bond, for fusion of the 
dihydropiperidine ring system to the carbacepfiem 
derivative (scheme 139). 	Intermediate (365) is very 
useful for undertaking a thorough structure-activity 
investigation on the biological effects of varying the 
7(a.p)and the C-3 substituents. 
Structural aspects of a carbacephem nucleus. 
At present, much work is being carried out by 
Japanese workers in order to find the best combination of 
substituents around the carbacephem nucleus. 195 "96 
Carbacephem derivatives containing the 
aminothiazolyl group on the acyl substituent are being 
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investigated. 195 	The biological activity results seem 
to be very good against Gram-negative bacteria but rather 
poor against Gram-positive bacteria. 196 	Further 
successful modifications may soon result in a potent 
carbacephem antibiotic being available on the market. 
3.3.4 	AZACEPHEMS 
The nitrogen analogues of cephalosporins (scheme 
140) are the azacephems. 	The 1-aza cephem derivatives 
have usually resulted in biologically inactive 
derivatives due to their instability. 	However, the 
2_,197 and 3-aza cephems 198 do show some biological 
activity, though very little in comparison to the 
cephalospor ins. 
a) 	Synthesis of a 2-aza cephem derivative via a 
6-exo-trig cyclisation. 
The route employed by Doyle (scheme 141)197 
involved a ketene-imine strategy for the preparation of 
the azetidinone (370). 	The aldehyde function at c-4 of 
the azetidinone (370) was condensed with an amine to 
obtain the schiff base (371). 	This was then reduced 
with sodium borohydride to give the amine (372). 
Attempts to remove the acetal and to induce cyclisation 
resulted only in tars and unidentifiable products. 	The 
approach was modified by protection of the amine (372) as 
an amide (373), using zinc chloride in trifluoroacetic 
anhydride. 	The acetal (373) was converted to the 
fr-ethoxy acrylate (375) under the conditions of the 
reaction, 	previous work by the authors had shown that 
the -hydroxy acrylate (375) could readily be obtained 
via the pyrrolidine derivative (374). 	Hydrolysis of 
139 
X: NH 1 , y:CH 2  Z=CR2 
R- C- N' 
	 X:0H 2  ..Y:NR,Z:C.H 
X:0H 21Y:CH, Z: NR 
COOH 
Scheme 140 Structure of azacephem systems. 
TFA 
•Rl 	OEt 	R 
N 	 R 
oqz;6 
R 0 







ffN 	CF3 /N'J 
R 
Scheme 141 
N t_ ORI 
CC2Bz 
RH 
SO 2 CH 3  
H  
N3 











(374) with acetone/10% hydrochloric acid gave the enol 
(375). 	Removal of the N-trifluoroacetyl group was 
successfully achieved by treatment with sodium 
borohydride in ethanol to result in the bicyclic fused 
system (376). 	However, this approach made it impossible 
to obtain the N-unsubstituted derivative (377). 	A 
further modification was carried out (scheme 142). 	This 
approach allowed the formation of (377). 	(377) was 
found to be quite unstable and had weak activity, 
although this may have been due to low purity. 
b) 	Synthesis of a 3-azaceph-l-em nucleus via a 
6-exo-trig cyclisation. 
An approach to the 3-azacephem system has been 
described by Gleason (scheme 143)198. 	The azetidinone 
(381), readily obtained by a ketene-imine method, 
followed by Woodward's route for the incorporation of 
the p_lactam N-substituent, was smoothly cyclised to the 
bicyclic system (382). 	Selective reduction of the azido 
group followed by acylation resulted in the 
3-aza-1-dethiaceph-l-em (383). Catalytic reduction of 
(382) followed by acylation with 2-thienylacetyl chloride 
afforded the 3-aza-l-dethiacepham (384). 	The 
3-aza-cephem ester (383) possessed very weak activity 
against B. Subtilis, while the saturated ester (384) was 
inactive. 	The use of the methyl esters may have 
invalidated the biological results. 	However, earlier 
reports 197 have shown that the free-acids of the 
aza-cephem derivatives readily decarboxylate. 
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C) 	Synthesis of the 3-azaceph-2-em via a 1,3 dipolar 
addition of an azide to an olefin. 
Recently, workers at Beecham have reported a novel 
route to highly modified azacephem and azapenem 
derivatives. 199 	This involved a 1,3 dipolar addition of 
an azide onto an olefin (scheme 144). 	The final acid 
derivatives (388) were found to be devoid of any 
antibacterial activity. 
d) 	Structural aspects of the azacephem nucleus. 
The instability of the azacephem systems has 
limited their usefulness as antibiotics. 	Furthermore, 
they do not appear to show any inherent strong 
activity. 	It may be necessary to carry out a wider 
structure-activity relationship study, in order to find 
the optimum substituents, to impart stability to this 
system and, perhaps, to improve its activity. 	In terms 
of the economics involved, it would seem that the 
azacephem systems described may not lead to any 
commerical antibiotics. 
3.4.0 	FUTURE TRENDS 
The discovery of the novel p-lactam structures, 
isolated from the screening procedures, has prompted 
chemists to attempt the synthesis of many highly modified 
derivatives in this class of compounds. 	Better 
understanding of the mode of action of both the 
antibacterial activity and the $-lactamase inhibitory 
properties of p_lactam antibiotics, has resulted in more 
rational approaches to drug design. 
- 	 143 
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Throu-h the experience with structure-activity 
investigations, it has been found that a fine balance 
exists between the activity of the antibiotic and its 
stability towards physiological conditions. 	It has also 
been found that sometimes, as with thi.enamycin, that 
in-vitro experiments lead to very promising results, but 
in-vivo testing results are disappointing. 
At present chemists have to synthesise derivatives 
with particular substituents on the periphery of the 
particular fused system using either one, or a 
combination, of the approaches that have been 
described. 	The final pure product is then tested for 
activity against a variety of Gram-negative and 
Gram-positive bacteria. 	The spectrum of bacteria used 
varies from one company to another and also the actual 
method of testing/detecting may vary. 	This type of 
research is very expensive. 	The need for rational drug 
design has been brought about, particuarly by the high 
costs involved in this area of research. 
The large variety of structures which are now 
available and which possess biological activity are very 
different from the simple structural analogue theory of 
D-alanyl - D-alanine that Strominger and co-workers had 
proposed for penicillins, as early as 1965.24 	At 
present, only two important aspects are being considered 
in the p_lactam synthetic strategy. 	The first of these 
is the acylating ability of p-lactam derivatives. 
Making the $-.lactarn bond sufficiently strained, increases 
its reactivity, thus, giving rise to rapid acylation of 
the specific enzymes responsible for cell growth which 
would lead to cell death. 	Attempts to isolate the 
enzymes responsible for cell growth are underway, 
particularly, to obtain structural high resolution x-ray 
diffraction patterns. 	This would allow identification 
of the three-dimensional structure of these enzymes. 
The second factor is to get the antibiotic to its 
target. 	This area has received a great deal of 
attention and requires compatability of the antibiotic 
144 
with the physiological conditions. 	This, unfortunately, 
has to be achieved at the expense of the reactivity of 
the p_lactam ring. 
Work is being carried out in many institutes on 
the y-lactam derivatives (390) (scheme 145). 	These 
derivatives have been found to exhibit weak biological 
activity. 200202 	Furthermore, they have also been 
shown202 to inhibit the cell wall synthesis, as do the 
p_lactam antibiotics. 	It can be envisaged that by 
appropriate functionalisation of these systems, it may be 
possible to improve their potency. 
Over the past few years, Beecham workers have been 
investigating tricyclic fused systems (390) and (391) 
(scheme 146)203 -205. 	Unfortunately, these have been 
found to have very weak activity. 
Recent work on 1,2-diazetidin-3-ones (392) and 
(393) (scheme 147) by Taylor, 206 shows the problems that 
arise when novel systems are sought. 	It was reported 
that simple extensions of standard. p-lactam chemistry to 
its aza analogues were fraught with unexpected 
difficulties. 
The -lactam area of research can be seen to be as 
active now as it was when penicillin was first 
isolated. 	The fascinating chemistry and the important 
selective antibacterial activity and the bacterial 
resistance towards the p-lactam antibiotics has ensured 
active research in this area. 	The greater understanding 
of the mode of action, isolation techniques and better 
synthetic methods may, however, soon make rational drug 
design a reality. 
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CHAPTER TWO - DISCUSSION 
1.0.0 INTRODUCTION 
Work in these laboratories involving dehydroamino 
acids suggested an interesting novel route for the 
synthesis of a bicyclic $-lactam derivative (130) (scheme 
148) 
Richardson 207 has found that thiol addition to the 
dehydroalanine derivative (395) occurred quite readily 
(scheme 149), whereas, addition to the dehydrovaline 
derivative (396) did not occur. 	This finding was 
interesting in relation to the field of -lactam 
antibiotics for the following reasons. 	Firstly, an 
early proposal 208 for the biosynthesis of penicillins 
implicated the cyclisation of the monocyclic p-lactam 
intermediate of t type (394) (scheme 148). 	However, 
this transformation has since been shown, by labelling 
experiments, not to occur in the biosynthesis of 
penicillins. 209 ' 210 	Secondly, careful experimentation 
by Baldwin and co-workers 101 on the monocyclic fl-lactam 
intermediate (399) (scheme 150), under acidic, basic and 
radical conditions, has shown that the 5-endo-trig 
cyclisation does not take place. 	The rationale of the 
conclusion was based upon the poor stereoeletronics of 
this system (scheme 151).102 	These results appeared 
consistent with the work done in our laboratories. 	In 
the acyclic case the steric factor prevented the'ddition 
of the thiol to (396). 	However, Baldwin and co-workers 
did not point out the influence of the steric hindrance 
present in their system. 	We thus questioned their 
conclusion, since our work had suggested that addition of 
a thiol to a dehydroalanine derivative (395) occurred 
readily due to the lack of any steric hindrance. 	This 
prompted us to investigate an intermediate of the type 
(394) (scheme 148), which lacked the steric factor of the 
methyl substituents and depended only on the 
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Scheme 150 	Structure of intermediate used by Baldwin 
and co-workers. 
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stereoelectronics of the process. 	Our experience 
suggested that in the absence of any steric hindrance 
this process m9ht1ead to a successful cyclisation. 	Our 
approach was thus designed to study the stereoelectronics 
in isolation. 	In addition, workers at Beecham 87 have 
devised a route to bisnorpenicillin V (140) (scheme 55) 
which lacks regiospecificity and stereospecificity. 	It 
was envisaged that our approach (scheme 148) would 
possess better stereochemical control at C-3, by 
variation of the side chain (R 1 ) and, possibly, the 
solvent. 	Furthermore, workers at Beecham 88 have shown 
that by appropriate modification of the side-chain (R') , 
the bisnorpenicillin derivative has enhanced biological 
activity over its pencillin counterpart. 	The chemistry 
of the bisnorpenicillin system has not been investigated 
to any great extent. 	Consequently, the facility of this 
route would make it possible to study the chemistry of 
(400) and the bisnorpenicillin sulphoxides (401) (scheme 
152), their stereochemistry and biological activity, the 
effect of base treatment on (400) and (401), typical 
rearrangements of (400) compared with the pencillins, and 
possible transformations to the penem system. 
1.1.0 Background to Early Experimental Work 
Initial studies were carried out by Thackery. 21 ' 
This work, directed towards the synthesis of (414), and 
derivatives thereof (scheme 153), utilised the strategy 
pioneered byR.B. Woodward 212 in the synthesis of 
lactam antibiotics. 
The oxidation of penicillin V potassium salt (402) 
with sodium metaperiodate in an aqueous solution, was 
followed via the starch-iodide test until a negative 
result was obtained, typically 1.5 hrs. 	The reaction 
mixture was then diluted with ice and acidified to pH 2.5 
with 2 Molar hydrochloric acid to afford the precipitated 
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Scheme 151 Stereoelectronics of the intermediate used 
by Baldwin and co-workers. 
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Structure of bisnorpenicillin and its 
sulphoxide. 
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Scheme 153 Synthetic strategy to the target 
molecule (414). 
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S-u1phoxide (403)213 which was then filtered and washed 
with ice water. 	The crude product (403) was 
crystallised from an acetone/water mixture (1:2) and left 
at 5°C overnight. 	The dried product was then dissolved 
in dimethylformamide and treated with 0.5 equivalents of 
anhydrous potassium carbonate. 	To the resulting 
solution excess methyl iodide (2 equivalents) in 
dirnethylformamide was added and the reaction mixture 
stirred for 18hrs. 	The work-up procedure was 
modified. 	Normally, the reaction mixture was 
wkt 	 -ótt proc.uc (Leo 	skt4 
OCitAb..QYt tcLdLOha This method resulted in low yields and 
required a large amount of extracting solvent, because of 
the solubility of methyl penicillin V suiphoxide (404) in 
the water/dimethylformamide system. 	The modified 
procedure involved removal of the dimethylformamide 
in vacuo, maintaining the temperature as low as possible, 
dissolving the residue in ethyl acetate, filtering off 
all insoluble salts followed by washing the filtrate 
twice with water and brine,and finally, drying over sodium 
sulphate. 	The resulting product (404) was obtained by 
crystallisation from methanol in good yield (70-80%) (mpt 
= 116°C) and the reaction could be carried out readily on 
a large scale (bOg batches). 	The product (404) was 
sufficiently pure to be used directly for the following 
step. 	The sulphoxide (404) to the disulphide (405) 
transformation 67 was found to proceed in variable yield 
(0-66%), however, the best conditions were found to be on 
a 0.1 molar scale using 300 ml of toluene, 1 equivalent 
of 2-mercaptobenzothiazole and heating at 95-100°C for 
4hrs under nitrogen. 	The disulphide product (405) 
normally crystallised on cooling, recrystallisation from 
ethyl acetate and petroleum ether (40-60) resulted in 
pure (405) (mpt = 147°C). 	The maximum yield was never 
greater than 66% which may have been due to 
disproportionation of the disulphide (405) into the 
symmetrical disulphides (415) and (416) (scheme 154). 
The isomerisation of the double-bond to the a - 0 
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unsaturated isomer would appear to be a very straight 
forward reaction, however, adding a catalytic amount of 
triethylamine (TEA) to a dichioromethane solution of the 
disulphide (405) did result in the isomerised product 
(406), as indicated by the infra-red analysis, in 
addition to a large amount of precipitate, which was 
found to be the bis-2-mercaptobenzothiazole disulphide 
(416) (mpt = 180 0 C). 	Work-up involved an ice cold wash 
with citric acid (5% (w/v)), drying over magnesium 
sulphate and purification. 	On a small sale, the yield 
of product was 60%, but upon scaling up the reaction, 
from 9mmol to 56 mmol of disulphide (417), the yield 
dropped to 30%. 	Much starting material (405) was still 
present and other by-products were obtained including the 
symmetrical disulphides (416) and (417). 	The resulting 
purification involved a column chromatography using an 
isocratic eluent of (1:1) chloroform and petroleum ether 
(40-60) followed by crystallisation from diethylether and 
cyclohexane, to remove the symmetrical disulphide (417). 
The required product (406) was then obtained as a white 
foam. 	This step was not optimised and it was found that 
the best method was to carry out several small-scale 
reactions, (9mmol of (405)),which were then worked-up, 
combined and purified. 	The pure product (406) was a 
foam and was not capable of crystallisation. 	The 
symmetrical disulphide (417) was, however, readily 
crystallisable from diethylether and was characterised. 
The 1 H n.m.r. spectrum of (417) was similar to that of 
(406) except the allyl methyl signals had a larger 
difference in their chemical shifts, in addition to fewer 
aromatic protons being present in the region 6.9-7.8 ppm. 
The step involving a conversion of disulphide to 
the thioester derivative (407) afforded an excellent 
yield (70%) on a small scale (9mmol). 	However, on a 
large scale (45mmol) the yield diminished to 30-45%. 
The optimised conditions involved dissolving 25mmol of 
the disulphide (406) in a minimum amount of acetic 
anhydride,and then adding 3 equivalents of acetic acid 
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Scheme 154 Disproportionatjon of the disulphide 
derivative (405). 
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whereupon the reaction mixture was stirred and cooled to 
-40°C followed by the addition of triphenyiphosphine (1.1 
equivalents) in small portions until no more solid 
remained (typically 1.5 hrs). 	Pyridine (3 equivalents) 
was then added and the reaction mixture stirred at -40°C 
for 0.75 hr, then allowed to warm to room temperature and 
stirred for 4 hrs. 	The solvents were removed in vacuo 
and the residue chromatographed on silica, the eluent 
being ethyl acetate and petroleum ether (40-60). 	The 
yield was generally greater than 65%. 
Ozonolysis of the thioester derivative (407) was 
carried out as described in the literature, 212 the 
product (408) being filtered out of the reaction mixture 
at 0°C, and recrystallised from ethyl acetate and 
petroleum ether (40-60). 	The yield was moderate 
(50-60%) and could possibly have been optimised by using 
the reaction mixture directly for the subsequent 
methanolysis. 
The methanolysis step was modified in that the 
oxamide derivative (408) was suspended in acetone, excess 
methanol and 4% (v/v) of water. 	The suspension was then 
sonicated at room temperature for 18hrs. 	The product 
(409) sometimes crystallised during concentration of the 
solution and was merely filtered, but more often the 
solvents were removed in vacuo and the residue 
chromatographed on silica using a gradient eluent system 
consisting of ethyl acetate and petroleum ether 
(40-60). 	The yield varied between 60-70%. 
The condensation of the azetidinone (409) and 
p-nitrobenzyl glyoxylate (410) was found to occur with 
variable yields (30-50%). 	Scaling up the reaction 
usually resulted in diminished yields and the reaction 
was found to be difficult to monitor by the usual 
methods, for example, TLC, infra-red or 1 H n.m.r. 	The 
conditions involved azeotroping the hydrate of 
p-nitrobenzyl glyoxylate with benzene for 1 hour, 
followed by addition of the dry azetidinone (409) and 
continued refluxing for 6-8 hours. 	The solution was 
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then cooled and the solvent remove-din vacuo to give a 
residue which was chromatographed on silica using ethyl 
acetate/petroleum ether (40-60) as the eluent. 
The characterisation was difficult since one 
equivalent of each reagent was used and the Rf of both 
the reagents and the product (411) was very similar, due 
to the presence of polar groups. 	The problem was 
overcome by the availability of a spray system, 214 
composed of an oxidant,. (0.5% (w/v) aqueous potassium 
permanganate and a staining agent (0.02% (w/v) ethanolic 
bromophenol blue). 	This spray system could 
differentiate readily the azetidinone (409), the 
p-nitrobenzyl glyoxylate (410) and the product - 
hemiaminal (411) by the difference in their behaviour to 
the oxidant and the staining agent. 	This improvement in 
the monitoring system enabled the yield to be improved 
(65%). 	The infra-red analysis was not very useful 
because identical functional groups existed in the 
reaT mixture and in the product (411). 	Furthermore, 
since a mixture of diastereomers resulted (in the 
product), the 'H n.m.r. spectrum was too complex to be 
useful in monitoring the reaction. 	
neither 
The final diastereomeric mixture was ,< separated 
nor 	fully characterised 215 but used directly 
for the next stage, in accordance with the procedures 
followed previously. 212 
The chloro-derivative (412) was obtained by 
treatment of the hemiaminal (411) in tetrahydrofuran with 
1 equivalent of'thionyl chloride (freshly distilled) and 
1 equivalent of base (2,6-lutidine) at room 
temperature. 	The 2,6-lutidinium hydrochloride was 
filtered and the filtrate evaporated to dryness in 
vacuo. 	Attempts to characterise the chloro-derivative 
(412) were not very successful. 	The crude residue was 
observed to discolour quite rapidly on standing in air at 
room temperature. 	Further synthesis of the 
chloro-derivative (412) involved the following 
modifications. 
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3 equivalents of both thionyl chloride and 
base were used for each equivalent of 
substrate. 
The reaction was carried out at 0°C for 0.5 
hr and at room temperature for a further 0.5 
hr. 
The work-up involved filtration under an 
inert atmosphere. 
The final crude product was used directly 
for the following step, due to its 
instability. 
The phosphorane (413) synthesis was quite straight-
forward. 	This step could readily be monitored by TLC, 
using the developed spray system 214, since the phosphorane 
(413) was quite stable and the reaction proceeded in 
reasonable yield (60%). 	The phosphorane could be 
purified by chromatography on silica. 	Optimal 
conditions were to use 1.5 equivalents of triphenyl-
phosphine and an equimolar amountof base to that of the 
substrate in freshly distilled 1,4-dioxane. 	The 
reaction mixture was heated to 50°C under nitrogen for 
8hrs, the end-point of the reaction being indicated by 
the absence of a yellow spot on the TLC plate (after 
staining) corresponding to the chloro-derivative (412). 
The phosphorane (413) resulted in a purple stain after 
strong heating of the TLC plate. 	The work-up involved 
filtration of the salt, adding dry toluene to the 
filtrate and filtering off any further 2,6-lutidinium 
hydrochloride, evaporating the solvent in vacuo followed 
by chromatography of the residue on silica using a 
gradient eluent system with ethyl acetate/petroleum ether 
(40-60). 	Characterisation of the phosphorane (413) was 
not exhaustive but infra-red analysis and 1 H n.m.r. were 
in agreement with the structure (413). 
The intermolecular Wittig reaction was optimised 
to the following conditions. 	The phosphorane (413) was 
dissolved in dichloromethane and a mixture of gaseous 
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formaldehyde and dry nitrogen was bubbled into the 
solution for short periods (30 seconds to 60 seconds) at 
0.5 hr intervals with constant stirring. 	The procedure 
was repeated until no phosphorane remained in the 
reaction mixture as indicated by TLC. 	The solvent was 
then evaporated in vacuo and the residue chromatographed 
on silica with a gradient eluent consisting of ethyl 
acetate and petroleum ether (40-60) to afford the product 
as a white powder (mpt = 112°C) in good yield (80%). 
The infra-red spectrum in dichioromethane indicated peaks 
at 3410 cnr' (N-H), 1780 cm' (-lactam C=0 str.), 1725 
cm-1 (conjugated ester), 1700 cm -1 (broad, thio-ester and 
amide) and 1520 cnr 1 ,1350 cm -1 (due to asymmetric and 
symmetric stretches of the nitro group). 	The 1H n.m.r. 
spectrum (400 MHz) in CDC13 indicated the represented 
structure (414) and a 'H n.m.r. spectrum (200 MHz) helped 
to assign the vinylic protons by separating the two close 
peaks centered around 5= 6.15 ppm which overlapped with 
the C-4 proton in the 80MHZ spectrum. 216 	1H n.m.r. 
decoupling experiments (360 MHz) confirmed the identities 
of the coupling protons. 	Irradiation at 6.15 ppm 
(vinylic proton, J=08 Hz) resulted in a singlet at 6.11 
ppm. (vinylic proton). 	Irradiation at 5.65 ppm (dd, 
C-3-H, J8.8,5.2Hz)216 resulted in a singlet at 7.25 ppm 
(aromatic region) and the doublet at 6.02 ppm (C-4-H, 
J=5.2Hz) 216 collapsed to a singlet. 	Furthermore, 
evidence was obtained from a 13C n.m.r. DEPT experiment 
which showed three methylene groups to be present, one of 
these being in the vinylic' region. 	The F.A.B. mass 
spectrum showed a protonated molecular ion, [MH+] = 500, 
and elemental analysis was in excellent agreement with 
the required structure (414). 
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1.2.0. Alternative Approaches to Intermediate - (414) 
Before describing the attempts to cyclise the 
target molecule (414), it may be.worthwhile to outline 
alternative approaches to (414), which were examined. 
(Scheme 155) involved following scheme 153 to the oxamide 
(408) step and then carrying out a zinc/acetic acid 
reduction 217 to afford the hemiaminal (411) (R=OMe). The 
crude product was taken through the subsequent three 
steps to the acrylate derivative (414) (R=OMe). 	The 
final product was too impure to characterise and at the 
time it was concluded that the target molecule (414) was 
perhaps unstable to silica chromatography. 	On checking 
the 'H n.m.r., in retrospect, it could be seen that the 
required product (414) (R=OMe) had actually been 
formed. 	This approach was abandoned on the grounds that 
the methyl ester would have been no use in the final 
cyclised product, since the carboxylic acid was required 
for biological assay. 
A further attempted modification was to make use 
of the method used by Hatfield 218 as in (Scheme 156). 
This would have converted the methyl penicillin V 
sulphoxide (404) directly to the thioester derivative 
(407) (after treatment with base), thus omitting the low 
yielding disulphide step and the following step 
(disulphide to thioester conversion). 	Unfortunately, 
this method was not very successful in that, after two 
separate attempts, the required product (407) could not 
be isolated. 	The isolated product appeared to be 
deacetoxycephalosporin V (418) (scheme157). 	This 
suggested that the molecular sieves were not very 
efficient and the water that formed hydrolysed the acetic 
anhydride to acetic acid which would have provided 
suitable conditions, in the refluxing benzene, for the 
classical penicillin suiphoxide to cephalosporin 
rearrangement, first observed by R.B. Morin et al. in 
1963.61 













Scheme 155 Reduction of oxamide with zinc/acetic acid. 
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Scheme 156 conversion of Penicillin V suiphoxide to the 
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Scheme 157 Rearrangement of methyl penicillin V 
suiphoxide under the experimental 
conditions. 
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Further time was not spent on this route and it 
was abandoned for a similar reason as for the zinc/acetic 
acid reduction of the oxamide (408) (scheme 155). 
Furthermore, although the literature yields were quoted 
as 75%, it was believed that on a large scale, the 
reaction would be too sensitive to the conditions and 
result in quite variable yields and a mixture of 
products. 
One kinal alternative approach which was attempted 
was as in scheme 158.219 	It was hoped to condense the 
thiazoline derivative (419) with the p-nitrobenzylglyoxy-
late (410) to generate the hemiaminal (420) and by 
sequential treatment with thionyl chloride, 
triphenylphosphine and gaseous formaldehyde to prepare 
the acrylate derivative (421), which could then be used 
for the cyclisation step. 	When the condensation was 
attempted no reaction resulted. 	Both starting materials 
could be recovered after chromatography. 	If more time 
was available it would have been quite an attractive 
route to the desired target molecule (394). 	Only a 
limited amount of the starting material was available, 
and consequently it was believed that this method would 
not readily give the target molecule in sufficient 
quantity for large scale experimentation. 
One further approach which was considered, but not 
attempted, is shown in scheme 159. 	This involved the 
thioazetidinone (138), readily obtainable from Beecham. 
The sulphur could have been readily protected with the 
desired protecting group. 	The remaining steps to the 
target molecule (394) would have been been identical to 
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1.3.0 Cyclisation attempts to bisnorpenicillin 
When the target molecule (414) was first prepared, 
only 200mg was available. 	The chosen method of 
deprotection of the thioester was that suggested by 
Pearson220 which involved the use of cyclohexylamine. 
This method had been 	 used in the synthesis of 
isopenicillin (426) (scheme 160). 	This involved 
deprotection of the thioester (425) with cyclohexylamine, 
the t'hiol thus formed then underwent an intramolecular 
SN2 reaction on the alkyihalide, at the C-4 position of 
the azetidinone, to generate the isothiazolidine ring 
(426). 	The second equivalent of cyclohexylamirie was 
used to neutralise the hydrogen halide by-product. 
It was decided that deprotection of the thioester 
derivative (414) in our system (scheme 161) would require 
1 equivalent of cyclohexylamine and a second equivalent 
to abstract the proton from the thiol group, in order to 
assist addition to the acrylate. 	Literature reports 22 ' 
indicate that thiols readily add to acrylates in the 
presence of a base. 	The reaction was monitored by 
infra-red spectroscopy and TLC. 	The reaction conditions 
were as described in the experimental section, and the 
work-up involved washing with water and drying over 
magnesium sulphate (anhydrous). 	The aqueous washing was 
re-extracted with ethyl acetate in order to ensure that 
the required product (395) was not discarded. 
The component obtained from the dichioromethane 
layer contained no -lactam, according to infra-red 
analysis, but did contain an ester (17q-0cm 1 ) and a 
strong amide (1670cm -1 ), in addition to the nitro group 
stretches at 1520crir 1 and 1350cm 1 . 	This disappointing 
result suggested that the cyclohexylamine had cleaved 
the p-lactam ring. 	The ethyl acetate extractions 
resulted in a component which contained traces of a 
$-lactam component (1780cm -1 ) which was suggested to be 
the symmetrical disulphide. 	Thus, the cyclisation 
appeared to have failed, since it was expected that the 
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Scheme 160 Deprotection of thioester by use of 
cyclohexylamine for the synthesis of iso-
penicillin (426). 
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Scheme 161 Deprotection of thioester by use of 
cyclohexylanime. 
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infra-red spectrum would indicate an increase in the 
-lactam carbonyl stretching frequency from 1780cm-1 to 
1793cm -1 , as observed in an authentic sample of 
bishorpenicillin supplied by Beecham. 	On TLC,the 
cyclised product (395) was expected to have a higher Rf 
than the monocyclic acrylothioester derivative (414) in 
the eluent system (70% ethyl acetate/petroleum ether 
(40-60)), as observed by comparison of the authentic 
materials. 	The crude residue contained no component 
corresponding to the required product (395) on TLC. 
The above described attempt to cyclise the 
acrylate was repeated when more of the acrylate 
derivative (414) had been obtained. 	The method was 
modified, using only 1 equivalent of cyclohexylamine in 
deuteriodichioromethane and the reaction was monitored by 
n.m.r. 	After 0.5hr a peak at 6= 2.25 ppm was 
observed. This was assigned as being due to the 
acetyl group in the by-product, N-acetylcyclohexylamide 
(428). 	Some starting material (414) still appeared to 
be present but the signals corresponding to the Vlactam 
protons were diminishing with new peaks in the region - 
3.5 ppm being observed which were expected since a 
doublet occurs at 5= 3.5 ppm in the spectrum of 
bisnorpenicillin (395). 	The reaction was continued for 
a further hour after which only a trace amount of 
starting material (414) was present. 	A strong acetyl 
peak due to the by-product was clearly observed but no 
p_lactam proton resonances could be seen in the 'H 
n.m.r. 	The peaks at 6= 3.5 ppm did not increase in 
intensity, as had been expected, but merely remained as a 
complex system of multiplets. 	The reaction mixture 
was then worked-up by an aqueous wash and dried with 
sodium sulphate. 	Infra-red analysis of the cr?u d e 
product indicated the presence of a weak p_lactam 
carbonyl stretch (1780cm -1 ) and the material was purified 
by preparative TLC. 	The first band obtained by 
washing the silica with dichloromethane comprised of 2% 
(w/w) of a component, having infra-red peaks at 1800, 
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17, 169cm 1 , but no nitro stretches were clearly 
observable. 	'H n.in.r. analysis of the dichioromethane 
component indicated signals at the following positions 
5= 7.7-6.9 ppm (m), 5= 6.1 ppm (dd),S21(s) 1 
6= 5.10 (d), 	5= 4.66(s), 6=t./-.3ppm (s). 
However, the sample was too dilute and still 
impure. 	Consequently, the characterisation data were 
ambiguous. 	Structure (430) (scheme 162), was 
tentatively suggested by the available data. 	This is a 
novel structure, but the rearrangement was known 
previously, as described by Wolfe 74 (scheme 163). 	The 
anhydropenicillins (431) possess a -lactam carbonyl 
stretch at 1800cnr 1 in the infra-red spectrum. 	The 
thiolactone carbonyl stretching frequency, however, was 
found to be at 1700cnr 1 and not at 1730cnr' as we found 
in our system. 	Our result seemed confusing when 
comparing the results obtained during previous 
anhydropeni4llin preparations. 	It may be that in the 
anhydropenid,llin (432) (scheme 164) the a , /3-unsaturated 
system may be involved in a mesomeric effect with the 
thiolactone, hence lowering the carbonyl stretching 
frequency to a lower wave number. 	Structure (433) may 
be stabilised by the inductive effect due to the methyl 
groups. 	In our system (scheme 165), the resonance 
involving the nitrogen atom, in the ring, may be more 
involved with the C(, /3 unsaturated moiety. 	Structure 
(434) may be stabilised by the protons much more readily 
than by the methyl groups. 	Attempts to synthesise this 
intermediate by an alternative route, for comparative 
purposes, was decided to be not worthwhile, in the time 
available. Frccw,,l from the preparative TLC was also 
washed with ethyl acetate which afforded 21% (w/w) of the 
component which appeared to be very similar to the 
starting material (414), exhibiting the infra-red 
absorbances 	as follows 1780, 17t9, 10, 1520 and 
1350cm 4 . The 1 H n.m.r. of the sample obtained from the 
ethyl acetate was found not to be that of the starting 
material as expected. 	However, it could be seen that 
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(430) 
Scheme 162 suggested structure of one of the 
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Scheme 164 Possible resonance in the anhydropeniLlin. 
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Scheme 166 Structure of by-product (435). 
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the vinylic protons of the acrylate were absent and that 
the new multiplets in the region 5= 3.5 ppm were too 
complex to be simply due to the thiazolidine methylene 
protons (as in the bisnorpenicllin). 	Resonances due to 
the cyclohexylamino group could also be seen and the 
thioester, phenoxy and p-nitrobenzyl protons were also 
present. 	The -lactam protons were not clearly resolved 
but multiplets in the 6:5.0-5.6 ppm region did exist. 
These results suggested the structure (435) in scheme 
166. 	This is reasonable in that acrylates are 
susceptible to nucleophilic attack, particularly, by 
thiols and primary amines. 222 	The other bands resulted 
in components containing no p_lactam carbonyl stretching 
frequency in the infra-red spectrum but a new strong 
amide carbonyl stretching frequency was present around 
1670cnr 1 . 	This suggested that the cyclohexylamine may 
also have added to the p-lactam(436). 	Scheme 167 
suggests the possible transformations that resulted from 
the treatment of the acrylate derivative (414) with 
cyclohexylamine. 	It was concluded that use of 
cyclohexylamine was inappropriate for our system. 
Furthermore, no evidence for the formation of 
bisnorpenicillin (395) could be detected by infra-red, 1 H 
n.m.r. or TLC analysis. 	It was concluded that the 
cyclisation via a Michael type addition would not take 
place as reported by earlier workers. 223 	This 
conclusion was supported by the above experimental 
evidence. 	It was hoped that the thiol (394) could be 
isolated, since reports by two workers, namely,  
Lattrell, 224 and Baldwin, 225 showed that they had managed 
to obtain the dehydrovaline thiol derivative (399) 
(scheme 150) and had characterised it. 	Similarly, the 
aim was to isolate the pure thiol (394) which,after 
characterisation,would finally complete this area of 
research. 
Scheme 167, using cyclohexylamine as the 
deprotecting reagent for the thioester, shows clearly the 
problems with the use of a strongly nucleophilic 
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reagent. 	From our experience,it was suggested that a 
more sterically hindered base might deprotect the 
thioester and hence give rise to the thiol in a 
reasonably pure form. 	The base chosen was 
diisopropylamine which is both readily available and more 
sterically hindered than cyclohexylamine. 	This was 
found to undergo no reaction at all with the acrylate 
derivative; the starting material being recovered intact 
and in high yield. 	It was decided to add a catalytic 
amount of 4-dimethylaminopyridine but this resulted in 
complete -1actam cleavage. 	A search of the literature 
for mild methods of deprotection of thioesters produced 
an article 226 in which p-chloroaniline was used to 
deprotect a hindered thioester by stirring the reagents 
at room temperature for 24 hrs to afford a 70% yield of 
the thiol. 	This was attempted with the acrylate 
derivative (414) (scheme 168), but again only the 
starting materials were recovered in high yields. 	It 
was at this point that the use of transition metals for 
complexing with the sulphur to labilize the thioester 
group was cons'idered. 227 	An article 228 illustrated the 
use of silver nitrate in aqueous THF or dioxane to 
deprotect a thioester protecting group. 	The yield. of 
the silver thiolate obtained was quoted as greater than 
90%. 
It was concluded at the time that aqueous 
conditions would not be suitable for the acrylate system 
(414). 	Anhydrous conditions could be maintained by use 
of p-chloroaniline (438) as the nucleophile in an organic 
solvent. 	After considerable experimentation 229, the 
following conditions were developed (scheme 169) in which 
the acrylate derivative (414) was dissolved in dry THF, 2 
equivalents of methanol and 2 equivalents of pyridine 
were added, the solution flushed with nitrogen and the 
vessel covered bycLtumifliUmfoil. 	To the reaction mixture 
was added 2 equivalents of silver 	tetrafluoroborate in 
dry tetrahydrofuran and the solution was then warmed to 
3°C for 1-1.5 hrs. 	The solvent was then removed in 
0 
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Scheme 167 possible transformations of (414) on 
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Scheme 168 Use of p-chloroaniline for deprotection of 
the thioester derivative (414). 
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Scheme 169 Deprotection of the thioester derivative by 



















vacuo and the residue chromatographed on silica using a 
(1:1) dichlormethane:ethyl acetate mixture as the 
eluent. The required product was obtained in excellent 
yield (10%) and was of high purity. 	The 
characterisation data confirmed the structure represented 
as (439) (scheme 169). 	Further confirmation was 
obtained when the silver thiolate (439) was reacted with 
acetyl chloride, in dichioromethane and at room 
temperature, in order to regenerate the thioester 
derivative (414). 	This proved to be identical, 
according to infra-red, 'H n.m.r. and TLC analysis, with 
an authentic sample. 
One of the anticipated problems in synthesising 
the silver thiolate (439) was the need to use hydrogen 
sulphi4e, which has been reported 230 to add to acrylate 
scheme noa-) 
systems A,to generate the free thiol (394). 	In the 
literature 23 the usual method employed for removing the 
metal involved bubbling hydrogen sulphide gas through a 
dichloromethane solution of the metal sulphide, the metal 
being mercury or silver, at room temperature. 	The 
yields quoted for the thiol were moderate and the 
p-lactam was not attacked by hydrogen sulphide. 	The 
problems encountered involved the instability of the 
thiol to bases, and to oxygen which could result in 
disulphide formation. 	The thiols were simply filtered 
through celite or kieseighur, to remove the metal 
sulphide by-product, and crystallised from cold benzene. 
Despite the possibility of reaction of hydrogen 
sulphide with the acrylate moiety, we attempted to 
perform the reaction at low temperature (-50°C) in the 
hope that reaction of hydrogen sulphide with the metal 
would be highly specific and that the reaction with the 
acrylate moiety would not take place. 	The hydrogen 
sulphide, generated from ferrous sulphide and 
concentrated hydrochloric acid, was passed through water 
and into a dichloromethane solution of the silver 
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Scheme 170(b) possible rearrangements of the target 
molecule (394). 
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was removed by flushing with nitrogen for 0.5 hr, and 
then the reaction was allowed to warm to room 
temperature. 	The final brown solution was passed 
through kieseighur affording a very pale orange 
filtrate. 	Infra-red analysis of the crude product 
indicated the presence of a strong amide peak (1670cm-1 ) 
and an ester carbonyl stretching frequency (1750cm -1 ) but 
no Vlactam carbonyl stretching frequency 
(1770-1790cm 1 ). 	TLC analysis of the crude reaction 
mixture indicated no mobile species in the eluent used 
(50% dichloromethane/50% ethyl acetate). 	Attempts to 
crystallise the product were unsuccessful, chromatography 
of the sample on silica resulted in complete loss of 
sample. Scheme 170 indicates the possible rearrangements 
that may have taken place. 
One -other attempt to generate the thiol was to use 
excess sodium chloride in aqueous acetonitrile (scheme 
171). 	It was hoped the equilibrium between the sodium 
thiolate (447) and the )silver thiolate (439) may shift 
towards the thiolatJue to precipitation of silver 
chloride. 	The sodium thiolate would have a much more 
ionic sulphur-metal bond and might readily hydrolyse to 
the thiol (394), under the reaction conditions. 	The 
reaction was monitored by TLC analysis (for the 
disappearance of the starting material). 	After 12 hrs, 
the solution was found to have changed from colourless to 
yellow. 	Examination of an aliquot, after work-up showed 
very little p-lactam carbonyl stretch in the infra-red 
spectrum (in the region of 1770cm 1 ). 	However, a strong 
amide carbonyl stretch (165cm 1 ) was seen. 	This result 
suggested the instability of the thiol (394). 
Subsequently, attempts to isolate and characterise it were 
abandoned. 	It was decided to convert the silver 
thiolate into a suitable derivative to characterise the 
product and to confirm the reactivity of the silver 
thiolate. 	It was also decided to confirm the reactivity 
of the acrylate moiety. 	Using the protected acrylate 
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Scheme 171 Exchange of the silver thiolate to sodium 
thiolate. 
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Scheme 172 	Reaction of acrylate derivative (414) with 
other thiol reagents. 
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ethanethiol and hydrogen sulphide under nitrogen, both in 
the absence and presence of pyridine, at room temperature 
and also in refluxing dichioromethane. 	The reaction was 
monitored by TLC analysis (scheme 172). The starting 
material (414) remained unchanged and was recovered in 
high yield (60%) after chromatography. This proved to 
be identical (infra-red, 1 H n.in.r. and TLC analysis) to 
the starting material. The reaction was carried out on 
a 30mg scale. 	The conclusion from these experiments 
suggested that the acrylate moiety is Less feacve 
towotcds thoI, and is not as susceptible to 
nucleophilic addition as typical a-amido acrylates. 232 
In assessing the results of our research, the 
following conclusions were formulated (scheme 173). 	The 
p-elimination is favoured in the thiol intermediate (394) 
rather than the intramolecular cyclisation, via the 
5-endo-trig mode, to bisnorpenicillin V.(395). 
Baldwin' 01 has reported a rearrangement of this type, 
involving a thiol derivative (449) (scheme 174), 
pyrolysis of which at 176 0 c in an inert solvent afforded 
a y-lactam (451). 	Sammes had also proposed this type 
of rearrangement in attempting to rationalise the 
unsuccessful attempts to cyclise derivatives of the type 
(399) (scheme 150), reported by various authors. 171 
In our system, the p_lactam nitrogen is believed to 
be involved in an enamine type of resonance (scheme 
175). 	This is likely to make an intramolecular 
nucleophilic addition to the double bond less likely, due 
to the increased electron density in the 7t-system, and 
simultaneously to encourage the p-elimination process. 
It would seem, the electron withdrawing effect due to the 
p-nitrobenzyl ester plays a smaller role in the electron 
distribution of the 1-sys tern in (p394). 	CePh4IosP0rS 
The bridge-head nitrogen, has a pyramidal structure 
as confirmed by x-ray data. 233 	Furthermore, the 
ultra-violet spectrum , (scheme 176),would suggest that 
the enamine character is quite high,frorn the position 
of Amax,for the acrylate derivative (414) compared to 
178 
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Scheme 174 Rearrangement of the thiol derivative (449) 







Scheme 175 Resonance involved in thiol (394). 
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that of U-amido acryLae derivative (452)232, 
p-nitrobenzylacrylate (453) and the N,N-dialkylamino-
ethene derivative (454). 
Comparison of (414) with the enamine resonance 
form of dehydrovaline derivative (396) (scheme 177), for 
which the thiol has been reported to be moderately 
stable, suggests that the enamine-type of resonance 
results in a less stable canonical form, due to the 
postive inductive effect of the methyl groups, hence 
resisting the a-elimination pathway. 	It was thought 
that the ester would play a dominant role in encouraging 
nulceophilic addition to the double bond of (396). 
However, the steric effect may counter this influence. 
The isopropenyl moiety in secopencillins (396) is 
reported 234 to be relatively unreactive to most 
nucleophiles and electrophiles. 
Consequently, the thiol (394) that was required 
was too unstable to isolate and the molecule underwent a 
a-elimination when the thiol was generated in situ. 
Thus, we have concluded from our experiments that 
of the two factors, namely, steric and stereolectronic, 
for the 5-endo-trig cyclisation of derivative (399) 
(scheme 150), the latter is the important factor during 
cyclisation. 	The inability of derivative (394) (scheme 
148) to undergo cyclisation to a penicillin molecule is 
solely due to the poor steroelectronic alignment of the 
thiol and the double bond. 	Our work has,thus, confirmed 
the findings of earlier workers and is also complementary 
to their work. 	Furthermore, our work suggests that an 
intermediate of the type (394) is not very useful in the 
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Scheme 176 Ultra-violet absorption of model-systems. 
H  








Scheme 177 Enamine resonance of the dehydrovaline 
derivative (396). 
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1.4.0 Modification of intermediate (414) to undergo a 
5-exo-tet cyclisation 
A change in the strategy was considered, (scheme 
178), since the acrylate (414) was not susceptible to 
nucleophilic attack. 	It was hoped that an electrophilic 
addition might be more successful. 	This would allow us 
to carry out a 5-exo-tet cyclisation to a penam system. 
This approach does not contravene Baldwin's rules 98 , as 
did our first approach, (scheme 148), involving a 5-endo- 
trig cyclisation. 235 	The 5-exo-tet cyclisatiori of the 
addition product (456) would be a novel means of ring 
formation, which to our knowledge has not been attempted 
previously in the synthesis of the bisnorpenicillin ring 
system. 	consequently, approaches to the target 
molecules, having structure (457) (scheme 179), were 
investigated. 	Conditions for the synthesis of the 
acrylate derivate (414) had been optimised and it was 
thought that this would be a suitable starting material 
for the synthesis of the target molecule (457) and, 
furthermore, an appropriate sulphur protecting group 
could readily be incorporated via the silver thiolate 
(439). 	It was necessary to add "HX" across the double 
bond of the enamine system.: 	 - 
Ionic addition of hydrogen chloride or 
hydrogen bromide would have been ideal, but 
unfortunately, it was believed that the p-lactam ring 
would not survive the reaction conditions, hence, this 
idea was rejected. 	Addition of bromine (scheme 180), 
would give a 1,2-disubstituted derivative (458) and the 
cyclisation would result in a 3-bromopenam (460), in 
which replacement of the bromine atom by hydrogen could 
readily be carried out by reduction with tributyltin 
hydride 236 . 	The 3-bromopenam (460) derivative could 
also be treated with base in an attempt to give the penem 
derivative (462). 
The silver thiolate (439), (scheme 181), was used 
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Scheme 179 Target molecule for a 5-exo-tet cyclisation. 
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Scheme 180 Uses of the 1,2-dibromo derivative (458). 
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derivative. 
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with bromine to result in silver bromide and the 	- 
sulphur-halide derivative (463) would hydrolyse to the 
thiol (464) and hypobromous acid (HOBr) (which would be 
removed into the aqueous layer and would 
disproportionate). Simultaneously, the bromine would add 
to the acrylate moiety resulting in the 1,2-disubstituted 
derivative (464) and cyclisation might take place to form 
the 3-bromo penam derivative (460). 
On adding bromine water to a dichloromethane 
solution of the silver thiolate (439), a precipitate 
formed after a few minutes. 	The reaction mixture was 
then quenched by addition to saturated aqueous sodium 
bicarbonate and further dichioromethane washes were 
employed to extract the required product. 	The organic 
layer was washed with water and dried over sodium 
sulphate. 	Analysis by infra-red showed that the 
following absorbances were present:- 1 7R0,.fl5g, 17.3 0 
cm-1 , l4icm'. 	Th€sLdata suggested structure (460) 
(scheme 181). 	An attempt to obtain the 'H n.m.r. 
spectrum was, however, unsuccessful since the sample 
appeared to decompose after a short time when kept in 
solution (the-lactam was cleaved on rechecking the 
sample by infra-red spectroscopy). 
Before this experiment was repeated, it was 
decided to carry out an analogous experiment on the 
thioester derivative (414) which afforded a product, 
infra-red analysis of which exhibited a Vlactam carbonyl 
stretching frequency at 1785 cm' (a shift of 5 cm -1 ). 
The ester carbonyl stretch (175 cm -1 ) and the thioester 
and amide carbonyl stretching frequencies remained 
unchanged (1700 dnr'). 	It was decided to purify.the 
crude product by chromatography on silica. 	The only 
component isolated contained no Vlactam carbonyl 
stretching frequency. 	The sample appeared to contain an 
ester carbonyl (1735 cm -1 ) and the nitro group (1520 cm' 
and 1350 cm-1 ). 	These results suggested that the 
product obtained from the reaction was unstable to 
silica. 	Some interesting chemistry appears to have been 
187 
taking place. 	Further work using other electrophiles, 
such as hydroboration and mercuration, to react with the 
acrylate would be desirable to complete this line of 
research. 	It was decided to determine whether the 
sulphur-halide intermediate (463) was unstable to the 
reaction conditiQns, and/or whether it reacted with the 
side-chain. 	A model compound was required to study the 
bromination reaction of the silver thiolate (439) and to 
conserve the supply of the important silver thiolate 
(439) while finding the optimum conditions for the 
reactions. 
The model chosen was structure (465) (scheme 
182). 	It has been reported 237 that the isopropenyl 
moiety is unreactive to bromine, 	consequently, the most 
likely site for any reaction is the silver thiolate. 
The model silver thiolate derivative (465) was obtained 
from intermediate (407), which was prepared during the 
synthesis of the acrylate derivate (414) in scheme 153. 
The cleavage of the thioester was much more easily 
achieved. 	Excess silver nitrate was added to a 
methanolic solution of the thioester derivative(407) 
containinq pyridine, and the solution stirred overnight 
under nitrogen, the flask being covered in aluminium 
foil. 	TLC analysis showed the reaction to have 
proceeded to completion. 	The product (465) was 
filtered, washed with cold methanol and dried under 
vacuum. 	The yield was good (70%) and the 
characterisation data corresponded to the represented 
structure (465) (scheme 182). 
The model silver thiolate (465) was then treated 
with bromine water in a two phase dichioromethane/water 
system, the organic layer being washed with saturated 
sodium bicarbonate. 	Analysis of the residue indicated 
the presence of a $-lactam carbonyl stretching frequency 
(1785 cm -1 ), an ester (1725 cm') and an amide (1700 
cm-1 ) in the infra-red spectrum. 	The -H n.m.r. spectrum 
proved to be complex. 	However, an unusual set of 
signals was clearly seen. 	These were in the region of 
188 
5= 7.9 ppm and were typical of anAABsystem similar to a 
para-disubstituted benzene ring. 	Furthermore, the 
-lactam proton signals were not the typical doublet 
(C-4) 216 and a pair of doublets (C-3) 216 as corresponding 
to the cis-stereochemistry, but appeared more like a 
singlet (5= 5.3 ppm) and a doublet (5= 4.8 ppm) 
assignable to the trans-stereochemistry where the smaller 
coupling constant was not resolved. 	The spectrum also 
indicated that a mixture of products had been formed, but 
no starting material could be detected. 	A tentative 
structure (466) (scheme 183), was suggested. 	The 
following conclusions were derived from this experiment:- 
bromination of the phenoxy side chain was 
taking place under the reaction conditions. 
(only at the para-position). 
A trans-geometry of the p-lactam ring protons 
had resulted. 
bromination of one of the allylic positions 
may also have occurred. 
The crude product was too impure for the above 
conclusions to be definite and purification was not 
possible by chomatography on silica (the sample was 
unstable and streaked on TLC plates). 	A possible 
mechanism for the formation of the represented structure 
(466) is suggested in scheme 184. 	Further investigation 
of this area is desirable. 
1.5.0 Development of novel sulphur-protecting groups in 
-lactam compounds 
Studies have also been continued concerning the 
sulphur protecting group, which could be removed under 
non-nucleophilic conditions. In addition, the group 
should be versatile and its derivatives obtained in high 
189 
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Scheme 184 possible mechanism for the bromination 
reaction. 
190 
yields. 	The protecting groups chosen for examination 
were the trimethylsilyl (SiMe3), trimethyltin (SnMe3), and 
phenylselenide (PhSe) moieties. 	These were chosen on 
the grounds that these groups had not previously been 
used in protecting the sulphur in $-lactam systems. 	In 
addition, the silyl group could be readily removed by 
treatment with flouride ion (scheme 185) and the 
trimethyltin group could be removed via a radical 
method. 	By appropriate functionalisation at the 
position of the acrylate moiety, a biradical species 
(473) could be generated which would potentially ring 
close, (scheme 186). 	This would be the first biomimetic 
synthesis of a bisnorpenam system. 238 	The 
phenylselenide moiety was chosen for a further reason in 
that the selenide could be readily oxidised and by a syn-
elimination of benzeneselenenic acid would afford a 
thione derivative (477) by a novel route (scheme 187). 
It was decided that since only a limited supply of 
the silver thiolate (439) was available, model 
experiments should be carried out using the silver 
thiolate of the isopropenyl derivative (465). 
1.5.1 Synthesis of Sulphur-Seleno derivatives and their 
uses 
Scheme 187 was first attempted, since many 
synthetic reports 237242 were available for the thione 
derivative (477). 
The thione derivative (483) was first reported in 
1976 by Brandt 239 et al. (scheme 18$.). 	This method 
involved a Norrish type II photoelimination reaction of 
the corresponding 4-acylmethylthio-2-azetidinone (482) on 
irradiation with UV light. 	Other reports 240 involved 
thiosulphinate der,vtiVe (488) (scheme 190). 	On heating 
(488) in refluxing benzene, a thione derivative (489) 
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Scheme 187 Use of phenylseleno group as a protecting 
group for sulphur. 
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Scheme 188 Norrish type II photoelimination reaction for 
the generation of a thione. 
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Scheme 189 Base treatment of a thione derivative. 
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method (scheme 191) involving a cycloaddition of 
thioketenes (490) with isocyanates (491) to result in an 
N-unsubstituted 4-thioxo-2-azetidinone (493). 	A recent 
report 242 (scheme 192) which illustrated both total 
synthetic and semi-synthetic approaches to the thione 
derivative (499), and its properties, has been 
published. 	It can be seen that in each of these 
reports, the N-substituent of the p_lactam, is an 
isopropenyl moiety. 	This was partly to confirm the 
report by Brandt et al. 239 (scheme 188) that base 
treatment of the thione derivative (483) resulted in a 
239 bicyclic system (485). 	This report was disputed by the 
authors. 243 	A rearrangement of the thione (483) to an 
oxazolinone derivative (486) (scheme 189) had taken 
place. 	The infrared absorption of the oxazalactone 
carbonyl stretching frequency could easily be 
misinterpreted as an intact p-lactam carbonyl stretching 
frequency. 	From our experience with the acrylate 
derivative (414), it was predicted that the thione 
derivatives (477a) (scheme 187) would not undergo 
cyclisation, as correctly reported by Bachi and 
co-workers. 243 	This failure was attributed to incorrect 
orbital alignment and also to the steric factors, due to 
the methyl groups, as stated earlier. 	We envisaged that 
by appropriate functionalisation of the thione derivative 
(480),it may be possible to cyclise it by a novel route 
and simultaneously to substitute the C-5 position (481), 
as illustrated in scheme 187. 
Reaction of a slight excess of phenylselenyl 
chloride with the model silver thiolate (465) in 
dichioromethane resulted in formation of the phenylseleno 
derivative (474b) within 10 minutes, as indicated by TLC 
analysis. 	The crude product was purified by 
chromatography on silica using two isocratic eluent 
systems, firstly, 100% petroleum ether (40-60) to remove 
diphenyldiselenide (475), and secondly, (1:1) 
dichioromethane/ethyl acetate to isolate the phenyl- 
seleno derivative (474b) in high yield (90%). 	The pure 
195 
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Scheme 190 Generation of a thione from thiosulphinates 
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Scheme 192 Generation of a thione by total synthesis, 
involving a sulphenic acid intermediate. 
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product (474b) had a -lactam carbonyl stretching 
frequency at 1775 cm -1 , the ester at 172$ cm -1 and the 
amide at 1695 cm-1 in the infra-red spectrum. 	The 1 H 
n.m.r. was unchanged compared to (465),except for the 
appearance of the 5-proton phenyl signal in the aromatic 
region. 	The elemental analysis was in agreement with 
the represented structure (474b). 	The reaction was 
repeated using the silver thiolate (439), and after 
purification by chromatography on silica, the product 
(474a) was obtained in 92% yield as a yellow foam. 
Characterisation data were in excellent agreement with 
the represented structure (474a). 
The model phenylseleno derivative (474b) was first 
used for the oxidative - -syn-elimination reaction, 
0 using metach1orperbenzoic acid (MCPBA) in dichlor,jiietnane 
at 0°C under nitrogen. 	After lb hrs, the reaction was 
worked—up by evaporating off the solvent and 
chromatographing the residue on silica. 	Only a small 
amount of the thione derivative (477b) was isolated (14% 
yield). 	However, a high yield (72%) of the starting 
material (474b) was re-isolated, this was treated with 
excess MCPBA overnight but no p_lactam containing product 
was isolated. 	The infra-red spectrum of the thione 
derivative (477b), isolated by chromatography 244 on 
silica, contained an unusually high -lactam carbonyl 
stretching frequency (1830 cm -1 ), as reported in the 
literature. 245 	The sample subjected to 1 H n.m.r. 
analysis was impure, but the doublet J=lOHz at 6= 5.0 
ppm due to C-3 proton of the azetidinone was evident and 
the structure (477b) (scheme 187) was indicated. 	In 
addition, the remaining signals were in agreement with 
the reported characterisation data for the thione 
derivative (477b). 	It was concluded that the strategy 
was viable and the reaction was thus attempted with the 
phenylseleno derivative (474a). 	The low yield of the 
thione derivative (477b) prompted the need to modify the 
work-up procedure. 	This involved a sodium bicarbonate 
wash to remove the m-chlorobenzoic acid and benzene 
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selenenic acid by-products, and carrying out the 
reaction in dichioromethane and monitoring the reaction 
by infra-red analysis, for the appearance of the new peak 
at 1830 cm -1 , resulted in a very weak peak in the region 
of interest. This peak did not increase in intensity 
with addition of a further 1.1 equivalents metachloroper-
benzoic acid, the reaction appearing to have stopped. 
The p_lactam remained intact (broad peak 1770 cm-1,246 
plus a weak peak at 1830 cm -1 ). 	Purification of the 
sample, on preparative TLC, (silica as stationary phase), 
failed to produce the thione derivative (477a). 	The 
starting material (474a) was isolated in 29% yield, and 
exhibited a p_lactam carbonyl stretching frequency (1775 
cm-1 ) in the infra-red spectrum and was obtained in 
sufficient quantity to be identified as (474a). 
Reports 239242 by various workers have indicated 
the unstable nature of thione derivatives, for example 
(483) (scheme 188), to silica and acidic conditions. 	The 
by-products produced in our approach (scheme 187) 
necessitated the need for chromatography on silica for 
purification. 	It was found that the model thione 
derivative (477b) could be isolated after chromatography, 
although low yields were obtained. 	Consequently, it was 
believed that the literature reports had over-emphasised 
the instability of the thiones to silica. 	However, it 
seems that our thione derivative (477a) was much more 
sensitive to silica,and possibly to the reaction 
conditions. 	It is, thus, necessary to use a different 
oxidant in non-acidic conditions, perhaps with the aid of 
a buffer system, and a method that circumvents the 
silica-gel chromatography for purification. 	Work on 
scheme 187 was abandoned. 
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1.5.2 Synthesis of Sulphur-tin derivatives and their 
uses 
A recent report by Baldin 238 illustrated a 
biomimetic synthesis of penicillin-v (scheme 193). 	This 
involved the unstable thiol (501) which was treated with 
Udenfriends reagent 247 [iron(ii) sulphate, asorbic acid 
and ethylenediamine tetra-acetic acid] at pH 4.4 and 
shaken in the presence of oxygen. 	Acidification to pH 3 
resulted in the appearance of a bioactive material in the 
dich1oethane extract. 	This active compound had 
identical characterisation data to penicillin V (2). 
From a detailed analysis, using a dideuteriated species 
(502), the authors had concluded that their biomimetic 
route lacked the stereospecificity and regiospecificity 
of the enzyme catalysed process, and that their work 
supported a free-radical intermediate for the penicillin 
biosynthesis. 
This report then provided confidence for our 
approach (scheme 186) which would have complemented and 
supported the published work. 	It was decided to 
functionalise the acrylate derivative (414) to a 
structure of the type (504) as represented in scheme 
(194). 	This involved a radical addition of 
tributyltinhydride across the double bond. 	Typical 
conditions in the literature 248 involved refluxing the 
unsaturated system and tributyltir4hydride in benzene with 
a radical initiator such as a, a' azabisisobutyro-
nitrile for 1-2 hours and isolating the organotin 
compound by chromatography. 	Carrying out the reaction, 
as reported, resulted in an unexpected product. 
Together with some starting material (414), an additional 
component was isolated, which after a further preparative 
chromatography, was concluded to have structure (505) 
(scheme 195), as indicated by 'H n.m.r. and infra-red 
analysis. 	A diastereomeric mixture had resulted which 
was difficult to separate and this made the ljj n.m.r. 
difficult to assign unambiguously. 	However, the 
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acrylate protons at 6= 6.1 ppm were absent and a new peak 
had developed at 6= 1.6 ppm (this existed as a doublet, j 
= 7.5 HZ, (220 MHz 'H n.m.r.)). 	The acrylate double 
bond had been reduced and no tin-addition product was 
detected. 	This disappointing result indicated that 
radical addition to the acrylate would not be very 
successful. 	Use of a 1,2-dibromo acrylate derivative 
(506) (scheme 196) may be more successful in generating 
the bi-radical intermediate (507) for a successful 
biomimetic synthesis of the bisnorpenam (460). 
The biomimetic approach was still feasible, hence 
the synthesis of the trialkylstannylthio derivative (471) 
was attempted (scheme 186). 	Literature reports 249 
indicated that these types of derivatives are quite 
stable. 	A typical synthesis was as shown in scheme 
197. 	The use of sodium hydroxide would have been too 
vigorous for our purpose, hence, the following method was 
adopted using the model silver thiolate (465) (scheme 
198). 
The reaction was carried out on a 100 mg scale in 
dichioromethane under nitrogen,but no reaction 
resulted. 	Changing the solvent to tetrahydrofuran had 
no effect on the result,and after consideration it was 
concluded that the tributyltin group may have been too 
large, and was too sterically hindered to react with the 
silver thiolate (465). 	Repeating the reaction with 
trimethyltin chloride in dichloromethane under nitrogen, 
resulted in the absence of any starting material 	(TLC), 
within 10 minutes from the start of the 
reaction. 
The p-lactam remained intact as seen in the infra-red 
the 
spectrum (1765 cm -1 ) andAcrude product was 
chromatographed on silica with two isocratic eluent 
systems 
50% dichloromethane/ethyl acetate 
100% ethyl acetate. 
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The expected $-lactam containing component was 
isolated from the 100% ethyl acetate fractions as a white 
solid. 	Infra-red analysis indicated a new peak at 3290 
cm-1 ) (broad), and the amide carbonyl stretch was at a 
higher frequency (1700 cm -1 ) than expected. 	The 
$_lactam carbonyl stretch appeared at 1765 cnr' and the 
conjugated ester carbonyl stretch remained at 1720 cm-
l-one further point was that the carbon-carbon double bond 
appeared to have a stronger absorption band at 1655 
cm-1 . 	The 'H n.m.r. of the white solid in 
deuteriochloroform showed a broad signal at 6= 8.3 ppm 
(N-H), a complex set of multiplets 6= 7.3-6.8 ppm 
(aromatic protons), a set of broad peaks at 5= 5.4-5.1 
ppm (- lactam protons) and the AB system of the 
phenoxymethylene protons at5= 4.6-4.1 ppm. The 
remaining peaks, due to the methyl group ( 6= 3.7 ppm) 
and the isopropenyl group (5= 2.1 ppm and 6= 2.0 ppm) 
were also seen, but the important peak due to the 
trimethyltin protons at 6= 0.7 ppm was too weak to be 
attributable to the structure (511) (scheme 198) and may 
have simply been hexamethyldistannane (512). 	The data 
suggested that the starting material (465) was recovered 
in addition to a small amount of a by-product (513) which 
may have resulted from a rearrangement (scheme 199). 
The TLC (EtOAc) of the -lactam containing 
fraction indicated the presence of 3 spots. A minor high 
running spot (Rf = 0.65) was attributed to the trimethyl-
tin dimer (512) and the major spot (Rf = 0.45) was 
possibly (513). 	Literature data for (513) reported the 
I.R. spectrum as follows:- 1720, 1690, 1655 cm -1 . 	Many 
of these peaks would have overlapped the peaks in the 
silver thiolate infra-red spectrum, except for the peak 
at 1655 cm -1 . 	The base-line spot was the starting 
material (465). The recovery of the starting material 
(465) suggested that incomplete reaction had taken 
place. 	However, a TLC 	(50% EtOAC in DCM) of the 
reaction mixture, after 10 minutes from start of the 
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Scheme 199 Rearrangement of sulphur-tin derivative 
(511). 
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present. 	In retrospect, it would seem that a complex 
involving the silver thiolate and the trimethyltin 
chloride, may have been formed which decomposed either to 
the starting materials, or to the products, when placed 
in contact with silica. 
At the time of the experiment, it was concluded 
that the sulphur-tin bond was cleaved during 
chromatography on silica. 	Consequently, it was decided 
that purification of the trialkyltin derivative (511) 
would not be possible by chromatography, and therefore 
purification of derivatives of this type would have to be 
carried out by crystallisation in future syntheses. 	The 
above reaction was repeated with the reaction time 
increased to 15 hrs, using the acrylo-silver thiolate 
derivative (439). 	The resulting precipitate was 
filtered over anhydrous sodium sulphate and washed with 
dichioromethane. 	Concentration of the filtrate under 
reduced pressure resulted in the recovery of the starting 
material (439) (63mg, 37%), as indicated by TL C , I.R. 
and 'H n.m.r. analysis. 	Further washings of the 
precipitate with acetone resulted, on evaporating the 
solvent, in a white solid (mpt 104 0 C), which contained a 
lactam carbonyl stretch (1765 cm -1 (broad)) 250 . 	The 'H 
n.m.r. in deuterioacetone resulted in extremely broad 
peaks but a peak due to the trimethyltin protons was seen 
at 5= 1.2 ppm. 	However, the integral did appear quite 
low. 	The work was halted at this stage. 	Further work 
is desirable in this area (scheme 180). 
1.5.3 Synthesis of Sulphur-Silicon derivatives and their 
use 
Work had also been carried out-as regards to 
scheme 185. 	Initially, the tert-butyldimethylsilyl 
chloride251 was used to produce the thio-silane 
derivative (515) (scheme 200). 	However, after 
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chromatography, no product was isolated which contained a 
P-lactam intact product. 	The experiment yielded the 
following conclusions: - 
The thio-silane derivative (515) was unstable to 
hydrolytic conditions. 
purification was not possible by chromatography, 
hence, it may be necessary to use the product as a 
crude sample. 
Literature reports 252 have indicated the use of 
thio-silane derivatives (517) (scheme 201), for synthesis 
of thioesters (518) from carboxylic esters (516) in high 
yields and regiospecificy, even in the presence of 
a, 0 unsaturated systems. 	Typical conditions 253 
involved reacting a magnesium thiolate (519) with 
trimethylsilyl chloride (520) in anhydrous ether (scheme 
202). 	Our reaction involved the use of a silver 
thiolate (439) and consequently, by analogy it was 
decided to carry out the reaction described above with a 
few modifications. 	The silver thiolate (439) was 
insoluble in ether, hence, dry dichloromethane was the 
solvent of choice. 	Addition of the reagents was carried 
out at 0°c, excess trimethylsilyl chloride was used and 
the reaction mixture was then allowed to warm-up to room 
temperature and stirred overnight. 	The white 
precipitate was filtered off through celite and the 
filtrate evaporated in vacuo. 	The model silver thiolate 
(465) afforded a white powder on evaporating the 
solvent. 	Infra-red analysis of the crude material 
indicated the presence of a p-lactam carbonyl stretch 
(1765 cm'), in addition to one new peak at 3300 cm -1 and 
the sharp peak at 3410 cm -1 (N-H). 	Furthermore, the 
ester carbonyl stretch remained at 1720 cm-1 and the 
amide carbonyl stretch appeared at 1685 cm' plus a 
further peak at 160 cm -1 . 	The 1 H n.m.r. of the crude 
product was confusing, but no signal due to trimethyl 
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silane derivative (523) (scheme 203) may have been too 
unstable and might have rearranged, similarly to the 
thio-stannane derivative (511) (scheme 199), to (513), 
the hexamethyldisilane (524) being readily lost on 
evaporating the solvent in vacuo. 	Further work with the 
model silver thiolate (465) was abandoned and the above 
reaction was repeated with the acrylo silver thiolate 
(439). 	The resulting crude product was found to be a 
yellow gum. 	1H n.m.r. of the crude material indicated 
broad peaks (possibly due to some paramagnetic material 
being present). 	However, the TMS peak was sharp but the 
integral showed that this was smaller than expected. 	As 
the peaks were not well resolved it was not possible tb 
draw any conclusion. 	The infra-red spectrum indicated 
the presence of the N-H stretch (3400 cm -1 ), the p-lactam 
carbonyl stretch (1775 cm), the ester carbonyl stretch 
(1730 cm-1 ) and the amide carbonyl stretch (1695 cm -1 ). 
Work with this derivative was halted at this stage due to 
insufficient time. 
1.6.0 Penicillin to cephalosporin conversion 
We had also undertaken work as regards to a novel 
conversion of a penicillin to a cephalosporin nucleus as 
outlined in scheme 206. 	Earlier reports make use of the 
classical penicillin suiphoxide to cephalosporin 
rearrangement first reported by Morin in 1963.61 	Other 
reports make use of activated secopenicillins (525) 
(scheme 204) which ring close by a 6-exo-tet type of 
cyclisation. 	More recently, intramolecular Wittig 
reactions (scheme 205)254 have readily been used to make 
highly sensitive cephem nuclei. 	Many other methods have 
been reported and an excellent review has appeared. 255 
Our proposed method (scheme 206) involved reacting 
a very reactive ketone (529), (i.e. readily hydrates if 
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exposed to moisture), with the phosphorane(413) (scheme 
153). 	Activation of the methine position using N-bromo- 
succinimide might result in the bromo derivative (531). 
Cleavage of the thioester (531), using the method 
described earlier, would result in the silver thiolate 
(532), which may be induced to cyclise to the 
cephalosporin (533) with silver bromide precipitation as 
the driving force of the reaction. 
The ketone (529) was obtained by an excellent 
method described by Raphael, 256 who showed that the 
ketone was stable only as the hydrate (534) (scheme 207) 
and required distillation to remove water prior to use. 
The reaction between (413) and (529) was carried out in 
dichloromethane, under nitrogen. 	However, it was found 
that no reaction took place at room temperature or in 
refluxing dichloromethane. 	Both starting materials were 
recovered by chromatography in very good yields and were 
identical to the authentic samples by infra-red and 1 H 
n.m.r. analysis. 	Changing the solvent to toluene 
resulted in no reaction at room temperature. Gradual 
increase in temperature to 90°C over 4 hrs resulted in 
some reaction taking place as indicated by the 
development of a new spot in the TLC plate. 	The 
reaction was continued for 16 hrs , worked up and 
chromatographed on silica. 	Some starting material was 
(.Ihth was 
isolated, in addition to a further component,Aattributed 
structure (535), which was probably formed by an 
intramolecular Wittig reaction followed by fragmentation 
of the penem system (536) (scheme 209) under acidic 
conditions. 257 	No trace of any intermolecular Wittig 
product was isolated, hence showing that no reaction had 
taken place between the phosphorane(413) and the 
5-oxo-2-phenyl-1,3-dioxane (529). 	Thus, the 
intramolecular Wittig reaction was favoured compared to 
the intermolecular Wittig reaction. 	Consideration of 
the problems 258 led to the conclusion that this approach 
(scheme 206) should be abandoned. 	Changing the thiol 





















































Scheme 206 Novel penicillin to cephalosporin 
conversion. 
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have allowed more forcing conditions to be used and, 
thus, possibly lead to a successful conclusion. 
1.6.1 A modified penicillin to cephalosporin conversion 
involving a carbanion in a 6-endo-trig cyclisation 
A recent report was found which used 	a-bromo- 
nitromethane for the 	synthesis of thio-ethers. 	This 
reagent suggested an alternative approach to the 
synthesis of a cephem nucleus (scheme 210). 	Alkylation 
of silver thiolates of the type (465) with alkyl halides 
are well known. 259 	It was hoped that the nitro group 
would promote a nucleophilic displacement of the bromide 
and precipitation of silver bromide would drive the 
reaction to completion. 	The methylene protons 
ato the nitro group would be sufficiently acidic in the 
sulphoxide derivative (541) to be removed using a mild 
base, such as triethylamine, and the carbanion (542) 
generated rr9tundergo an intramolecular Michael addition 
to result in the cepham derivative (543). 	Reduction of 
the suiphoxide (543) to the sulphide (544) could readily 
be accomplished using a trihalophosphine in dimethylform- 
amide. 	Substitution of the nitro group by a 
phenylseleno group affords the derivative (546) which 
could give rise to a double bond in the ,\2  position 
(547) via oxidative elimination. 	This would readily be 
converted to the A3  structure (548). 	The reaction 
between (439) and (539) was carried out in dichiormethane 
at 0°C, room temperature and refluxing dichloromethane. 
No reaction occurred and only the starting material (439) 
was isolated after chromatography. 	A survey of the 
on the 
literature 260 react1ons of a-bromo nitromethane indicated 
that this reagent promoted radical reactions, thiolates 
normally affording disulphides. 	This approach was 
abandoned. 
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1.7.0. Novel strategy for protection and deprotection of 
esters of p_lactam derivatives 
Work was commenced on new strategies for 
deprotection of the ester group of -lactam compounds. 
This involved the use of solid-phase methodology. 261 	In 
the course of recent work carried out in these 
laboratories, a novel "handle" (549) was developed which 
could be used to remove the peptide from the solid 
support by use of fluoride ions (scheme 211). 
In the p_lactam field, the common protecting ester 
groups for the carboxylate are as follows:- 
2,2,2-trichioroethyl (555) (TcE) (scheme 212). 
This is readily removed by zinc and acetic acid. 
Yields are moderate (60%), and the group can only 
be used for acid stable derivatives. 
p-nitrobenzyl (556) (PNB) (scheme 212). 	This is 
readily removed by hydrogenation over palladium on 
charcoal in a variety of solvents. 
Poisoning of the catalyst due to the presence of 
sulphur in the p-lactam derivative makes the 
process expensive. 
C) 	benzhydryl (557) Bzh) (scheme 212). 	This is 
commonly used for cephalosporin derivatives due to 
their greater acid stability. 	Deprotection 
involves the use of trifluoro acetic acid (TFA) 
which results in serious losses due to 
P-lactam cleavage and, hence, low yields. 
It was envisaged that our strategy, (scheme 213), 
would readily afford the ester (560) on the solid support 
by use of a suitable method (acyl halide, mixed anhydride 
or DCCI coupling) and after the transformation of the 
A-lactam derivative (R 1 ) had been completed the ester 
would be deprotected using anhydrous tetrabutylammonium 
fluoride. 	The tetrabutylammonium salt (562) could 
readily be washed off the support and the solution passed 
through an ion-exchange column (pH 3, carboxylic 
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acid-type) which should afford the required acid (563) in 
high yield. 	The advantages for the use of solid phase 
are as follows:- 
The method of deprotection of the ester is very 
mild, due to the use of fluoride ion. 
No expensive catalysts are required. 
yields are expected to be near quantitative. 
Very pure samples can be obtained, which can be 
used directly for biological testing. 
However, there are disadvantages, as follows:- 
Only small quantities of sample can be obtained 
(depending on weight of support used, size of 
reaction vessel and efficiency of 
protecting/deprotecting steps). 	In peptide 
synthesis, the small amount of material obtained 
from solid-phase synthesis, usually has high 
activity and the effect is identified quite 
readily. 	However, for -lactam antibiotics, 
reasonable quantities are needed in order to check 
the activity against the many gram-negative and 
gram-positive bacteria. 
Esterification must be quantitative. 	Prior to 
carrying out the. reactions on the support,it was 
necessary to determine whether the strategy worked 
in solution (scheme 214). 
The synthesis of the handle (565) is shown in 
scheme 215,262 and the crude material was chromatographed 
on silica to afford the desired product in yields of 
50-60% (unoptimised). 	Characterisation data were in 
excellent agreement with the assigned structure (565) 
(scheme 215). 	Small scale reaction of the potassium 
salt of penicillin-V (564a) with the handle (565) in 
dimethylformamide (DMF) at room temperature was 
unsuccessful after 19 hrs. 	The reaction conditions were 
then modified by addition of one equivalent of silver 
nitrate. 	After stirring the reaction mixture for a 
further hour,the TLC indicated that no reaction had taken 
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that the silver nitrate had not dissolved. 	However, 
addition of a little water resulted in a homogeneous 
solution. 	After stirring for 0.5 hr, the TLC indicated 
some reaction was taking place. 	The reaction was 
continued for a further hour and then worked-up. 
Chromatography on silica of the crude sample resulted in 
the isolation of some starting material (the handle 
(565)) and also a further -lactam containing component, 
which required a further chromatography for 
purification. 	The 1 H n.m.r. of the sample confirmed 
that the required product (566a) had been obtained. 	A 
new peak was observed at 6= 5.2 ppm which was a singlet 
and had an integral corresponding to two protons. 	In 
addition, the signal due to the chioromethyl group ( 6= 
4.7 ppm) had disappeared. 	Furthermore,the signal due to 
the trimethylsilyl (TMS) group was in the correct ratio 
to that of the phenoxymethylene protons ( 6= 4.5 ppm) of 
the penicillin-V. 	The yield, however, was only 8%. 	It 
was concluded at the time that insufficient silver 
nitrate was added, 263 and the reaction time should be 
increased. 
Repeating the aqueous reaction conditions on a 
larger scale and with longer reaction times, for both 
potassium penicillin V (564a) and sodium cephalothin 
(564b), resulted in either very low yieldsor no product, 
respectively. 
The reaction was then modified toemploy the 
following conditions (scheme 216):- potassium iodide was 
added to the dimethylformamide solution of the reagents 
and the reaction mixture stirred and monitored by TLC 
analysis until no starting materials remained. 	This 
method improved the yields and made the strategy 
feasible. 	It was found that potassium penicillin V 
(564a) required longer reaction times (22 hrs - 24 hrs) 
compared to the sodium cephalothin (564b) (8 hrs). 	In 
general, higher yields were obtained with the 
cephalosporin derivative (60%) compared to the penicillin 
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Having obtained the required esters in a pure form,small 
scale attempts were made to cleave the -lactam moiety 
from the handle by use of anhydrous tetrabutylammonium 
fluoride (TBAF). 	'he reaction was carried out in 
acetonitrile using 1 equivalent of ester and 1 equivalent 
of TBAF, whereupon the reaction mixture changed colour 
(yellow-orange) within 5 minutes. 	The reported 264 
procedure involved treating the resin with TBAF for 5-10 
min followed by working-up the product. 	In our case, it 
was found that longer reaction times were needed for the 
reaction to complete. 	The penicillin V derivative 
(566a) was found to deprotect faster (5 mm) than the 
cephalothin derivative (566b) (20 mm). 	The reaction 
was also modified by the use of triethylamine (TEA), 
which would have neutralised any traces of HF generated 
in the reaction mixture. 	The work-up .nvolved 
evaporation of the reaction solvent in vacuo 0 To the 
crude residue 	diethyl ether was added, the solvent was 
decanted (this removed the soluble cinnamide derivative 
(567)), and to the remaining residue was added water and 
ethyl acetate. 	The two-phase system was stirred, cooled 
to 0°C, and acidified with 2N hydrochloric acid to pH 
2.5. 	The organic layer was separated, washed with brine 
and dried with sodium sulphate. 	Furthermore, it was 
found that the cephalosporin derivative (568b) required a 
basification (5% sodium bicarbonate solution) followed by 
an acidification (2N hydrochloric acid) and extraction 
into an organic solvent. 	The results were ambiguous in 
that the p_lactam containing products were not readily 
characterised due to the problems in purification. 	It 
was concluded that the problems had arisen due to the 
tetrabutylammonium salt of the penicillin V (568a) and 
cephalothin (568b). 	This salt would give rise to 
solubility of the products (568a) and (568b) in both the 
aqueous and the organic phases. 	Consequently, the 
organic phase would contain the tetrabutylammonium salt 
of the -lactam component (568), the penicillin V acid 
(569a) or the cephalothin acid (569b), and the by-product 
225 
(567). 	It was not possible to chromatograph either 
penicillin V acid (569a) or cephalothin acid (569b) on 
silica, as this would result in -lactam cleavage. 	Ion 
exchange 265 columns also resulted in $-lactam cleaved 
products. 	It was decided to use a different means of 
providing the fluoride ion, for deprotecting the handle 
and simultaneously providing a suitable salt of 
penicillin V or cephalothin. 	The modified method 
involved the use of potassium fluoride in methanol at 
0°C. 	The required products would have been readily 
obtained in the organic phase on acidification of the 
aqueous/organic two phase system. 	The deprotection 
reaction was carried out at 0°C for 0.5 hr and the 
reaction worked-up. 	This resulted in isolation of only 
the starting material (566). 	The reaction was repeated 
at room temperature, with the reaction time increased to 
24 hrs, again only the starting material (566) was 
isolated. 	It was concluded that the fluoride ion was 
strongly solvated and thus, unavailable for reaction with 
the silyl group. 	The work was stopped at this stage. 
It was concluded that the strategy worked, but 
difficulties in purification of the product made it 
impossible to determine the efficiency of the process. 
The purification problem would be minimised when using 
the solid support, since the cinnamide by-product (567) 
would remain on the resin. 	Further work is, thus, 
desirable in this area. 
1.8.0. Summary of work completed 
Achievements 
This work has confirmed and supported previous 
failures in the attempts to form the thiazolidirie ring of 
the penicillin, by an intramolecular Michael addition, as 
represented in scheme 148. 	Furthermore, a novel route 
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to the thione derivative (477a) was developed. 	The 
novel solid phase strategy for carboxylate protection and 
deprotection in the p-lactam area has been shown to have 
some success. 
1.9.0. Future work in this area of research 
It is hoped that future work would involve an 
electrophilic addition to the acrylate moiety in (570) 
(scheme 217). 	This would allow an intramolecular 
nucleophilic substitution, via a 5-exo-tet mode of 
cyclisation - to afford a bisnorpenicillin type system 
(395). 	Furthermore, by appropriate functionalisation of 
the addition product (571), it may be possible to obtain 
the penem deriatives (574). 	Work involving the sulphur 
protecting groups such as silyl, stannyl or seleno, still 
requires further investigation in order to develop 
conditions which would readily generate a thiolate, a 
thyl or a thione species respectively and which may 
undergo annelation to form a bicyclic ring system. 
Finally, work on the novel solid-phase strategy (scheme 
213) could give rise to the synthesis of some very 
sensitive -lactam systems. 	Furthermore, manipulation 
of the resin bound -1actam derivative may give rise to 
high yields of the required products with little or no 
P-lactam cleavage, due to steric inhibition around the 
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Scheme 217 Future investigations involving acrylate 
derivative (570). 
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CHAPTER THREE -EXPERIMENTAL 
1.0.0 EXPERIMENTAL SECTION 
1.1.0 Purification of Solvents 
Dimethylformamide (DMF) was distilled over calcium 
hydride under reduced pressure. 
Acetonitrile, dichioromethane (DCM) and 1,4-dioxane were 
refluxed over, and distilled from, calcium hydride. 
Tetrahydrofuran (THF) was distilled from sodium 
benzophenone ketyl under nitrogen. 
Benzene and toluene were washed with cold concentrated 
sulphuric acid, aqueous sodium bicarbonate and water, 
dried over magnesium sulphate, decanted and distilled 
from sodium under nitrogen. 
Ethyl acetate and petroleum ether (bpt 40-60°C) were 
redistilled. 
Acetic Anhydride was dried over phosphorus pentoxide 
followed by reflux and distillation over magnesium 
turnings. 
Diethyl ether was dried over sodium wire. 
Chloroform was passed through an alumina column. 
1.1.1 Analytical procedures 
Thin-layer chromatography (TLC) was performed on 
Merck silica gel 60 F254 plates. 	The major eluent 
systems employed were as follows:- 
A = 75% ethyl acetate/25% petroleum ether (40-60) 
B = 50% ethyl acetate/50% petroleum ether (40-60) 
C = 50% ethyl acetate/50% dichloromethane. 
Some minor eluent systems were also used. 	These 
are indicated when utilised. 
The spots were identified by three methods: 
ultra-violet irradiation at A = 254 nm. 
potassium permanganate spray:- 0.5% w/v aqueous 
solution. 
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C) 	bromophenol blue:- 0.02% w/v ethanolic solut-in. 
Preparative column chromatography was performed as 
follows: - 
Dry flash chromatography 266 using TLC grade Merck 
Silica - Kieselgel 60H. 
Flash chromatography using Merck silica, mesh size 
230-400. 
The sample was either pre-adsorbed on the silica 
or applied as a concentrated solution to a prepared 
chromatography column depending on the stability of the 
sample. 	The eluent employed was variable and will be 
indicated in the appropriate section. 
Melting points were determined using a Buchi SlO 
apparatus and are uncorrected. 
Infra-red (I.R.) spectra were recorded on a Perkin 
Elmer-781 spectrophotometer, using dichioromethane as the 
solvent, unless stated otherwise. 
1 H nuclear magnetic resonance spectra were 
determined on varian EM-360 (60 MHz), Bruker FT WP 80 MHz 
and FT WP 200 MHz instruments. 	Chemical shifts measured 
in ppm using tetramethylsilane 5= 0) as an external 
standard, with deuteriochloroform as the solvent unless 
otherwise stated. 	Ultraviolet spectra were recorded on 
Varian/Cary 210 spectrophotometer. 	Mass spectroscopy 
was performed on a KRATOS Ms 50 TC machine. 	Fast atom 
bombardment (FAB) spectra were obtained using 
thioglycerol as the matrix. 	Microanalyses were 
performed by Mrs. E. McDougall of the Edinburgh 
University analytical service. 
All reactions were performed under dry nitrogen 
unless stated otherwise. 
1.1.2 Characterisation data of derivatives from scheme 
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Potassium penicillin V (402) 270 
Vmax/cml (n'ujol): .. 	3370, 1775, 1726, 1660. 
230 . -,_,Penicillin V suiphoxide (403) 62 
mpt = 162 0 c (dec.) (acetone/water); 
Vmax/ cm_l(nujol) : _ 3370, 1788, 1725, 1660, 1020. 
Methyl penicillin V suiphoxide (404)62 
rnpt = 116°C (methanol) 
Rf = 0.21 (A) Vmax/cm_l:... 3390, 1805, 1750, 1685, 1160; 
'H n.m.r./ppm:- 1.19 (s, 3H), 1.70 (s, 3H), 3.81 (s,3H), 
4.54 (S, 2H), 4.68 (S, 1H), 5.06 (d, J=6Hz, 1H), 6.09 
(dd, j = 6, 12Hz, 1H), 6.92-7.38 (m, 5H), 8.25 (d, J=12 
Hz, 1H). 	Found C, 53.4; H, 5.0; N, 7.4: C17H20N206S 
requires C, 53.7; H, 5.3; N, 7.4%. 
Methyl 3-methyl 2(S)-[3(4)-Penoxyacetamido-4(R)-S-(2-mer-
captobenzothiazolyl()thioazetidin-2-on-1-yl]but-3-enoate 
(405) 57  
mpt = 147°C (ethyl acetate/petroleum ether (40-60); 
Rf = 0.48 (A); 
Vmax/cm_l : _ 3405. 1780, 1745, 1695; 
'H n.m.r./ppm:- 1.96 (s, 3H), 3.72 (s, 3H), 4.56 (m. 
2H), 4.96 (s, 1H), 5.20 (s, 1H), 5.21 (s, 1H), 5.49 (dd, 
J = 6, 12 Hz, 1H), 5.61 (d, J = 6Hz, 1H), 6.9-7.9 (m, 
6H); Found C, 53.7; H, 4.3; N, 7.5; C24H23N304S3 
requires C, 54.4; H, 4.3; N, 7.5%. 
Methyl 3-methyl-2-( 3 (R)-phenoxyacetamido-4(R)-(S-(2-
mercaptobenzothiazolyl) )thio azetidin-2-on-1-yl] 
but-2-enoate (406)67 
Rf = 0.48 (A); 
Vmax/cm_1 : _ 3425, 1780, 1728, 1695, 1633; 
'H n.m.r./ppm:- 2.15 (S, 3H), 2.17 (s, 3H), 3.58 (s, 
3H), 4.58 (m, 2H), 5.25 (dd, J = 5,10 Hz, 1H), 5.60 (d, j 
= 5Hz, 1H), 6.91-7.85 (m, 10H); 	Found C, 54.6; H, 4.3; 
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N, 7.8; C24H23N305S3 requires C, 54.4; H, 4.4; N, 7.5%. 
Methyl 3-methyl-2-(3(R)-phenoxyacetamido-4(R)-acetylthio-
azetidin-2-on-1-yl) but-2-enoate (407)123 
Rf = 0.48 (A); 
Vmax/cml : _ 3400, 1780, 1725, 1700, 1690, 1635; 
'H n.m.r./ppm:- 2.06 (S, 3H), 2.22 (s, 3H), 2.25 (s, 
3H), 3.79 (5, 3H), 4.55 (S, 2H), 5.37 (dd, J = 5, 8Hz, 
1H), 6.02 (d, J = 5Hz, 1H); 	6.7-7.4 (m, 5H), 7.92 (d, J 
= 8Hz, 1H). 
1-(methyloxalyl)-(3R)-phenoxyacetamido-(4R)-acetylthio- 
a7tidin-2-on (4n)j23 
mpt = 145°C (ethyl acetate/petroleum ether (40-60); 
Vmax/cm_l : _ 3415, 1823, 1754, 1705; 'H n.m.r./ppm:-
2.33 (s, 3H), 3.99 (S, 3H), 4.49 (s, 2H), 5.54 (dd, J = 
5, 10Hz, 1H), 6.02 (d, J = 5Hz, 1H); 	6.95-7.4 (m, 5H), 
8.76 (d, J = 10Hz, 1H). 	Found C, 50.5; H, 4.3; N, 7.4; 
C16H16N207S requir as C, 50.5; H, 4.2; N, 7.4%. 
(3R)-Phenoxyacetamido-(4R)-acetylthioazetidin-2-one 
(409). 123 
mpt = 138°C (ethyl acetate/petroleum ether (40-60); 
Rf = 0.30 (A); Vmax/cm_l:.. 3410, 1790, 1697; 
'H n.m.r./ppm:- 2.24 (S, 3H), 4.52 (5, 2H), 5.45 - 5.57 
(m, 21!, ABX system), 6.92-7.14 (m, 3H), 7.25 - 7.37 (m, 
2H, 7.46 (d, J = 10Hz, 1H); Found C, 52.8 ; H, 4.9 ; N, 




Rf = 0.27 (B); 	'max/dm-1 :- 3400, 1770, 1725, 1690, 
1625, 1520, 1350; 'H n.m.r./ppm:- 2.25 (s, 31!), 4.53 (s, 
21!), 5.25 (s, 2H), 5.45-5.57 (m, 2H), 6.92-8.34 (m, 24H. 
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di[1-(1-methoxy-3-methyl-1-oxobut-2-en-2-yl )-3(R)-Phen-
oxyacetamido azetidin-2-on-4(R)-yl]disulphide (417).67 
mpt = 123°C (diethyl ether); Rf = 0.48 (A); Vmax/cml:-
3400, 1780, 1725, 1698, 1635; 	'-H n.m.r./ppm:- 2.0 (s, 
3H), 2.3 (s, 3H), 3.54 (s, 3H), 4.56 (rn, 211), 5.25 (dd, J 
= 5, 10Hz, 111); 	5.61 (d, J = 5 Hz, 1H), 6.91-7.85 (m, 
6H). FAB MS [MH]+ = 704. 
1.2.0 Synthesis and Chemistry of 4-Nitrobenzyl 2-((3R)-
Phenoxyacetamido- ( 4R )-acetylthio--2-azetidinon 
-1-yl) propenoate (414)212 
The phosphorane 212 (4.0g, 5.35 mmol) was dissolved 
in dichioromethane (200m1). 	Dry formaldehyde 266 was 
bubbled into the reaction mixture for short periods 
(2 mm) every fifteen to twenty minutes until no more 
starting material (413) remained ( 1.5h) by TLC (A). 
The solution was filtered through celite and the filtrate 
concentrated under reduced pressure 268 whereupon the 
residue was purified by flash chromatography, using 
gradient elution with ethyl acetate and petroleum ether 
(40-60), affording (414) (1.3g, 49%). 	This solidified 
on trituration with diethylether. 	Mpt = 112°C, Rf = 0.7 
(system C); Vmax/cml:- 3410, 1782, 1735, 1700, 1525, 
1350; lH n.m.r./ppm:- 2.3 (s, 311), 4.6 (s, 2H), 5.35 (5, 
211), 5.65 (dd, J = 5.2 Hz, 8.8 Hz, 1H), 6.05 (d, J = 5.2 
Hz, 1H), 6.15 (d, J = 0.8 Hz, 111), 6.19 (d, J = 0.8 Hz, 
111), 6.9 (d, J = 7.9 Hz, 2H), 7.05 (m, 111), 2.28-7.4 (m, 
311), 7.58 (d, J = 8.7 Hz, 211), 8.25 (d, J = 8.7 Hz, 2H); 
n.m.r., 6/ppm269 30.5 (a), 59.9 (b), 64.5 (c), 65.5 
(d), 66.9 (e), 114.5 (f), 118.1 (g), 121.9 (h), 123.4 
(i), 128.2 (j), 129.4 (k), 130.0 (1), 142.0 (m), 147.5 
(n), 156.9 (o), 161.2 (p). 163.5 (q), 168.6 
(r); 13C n.m.r., DEPT P0 = 3 	, ö/ppm 30.8 (+ve), 
4 
60.1 (+ve) 64.6 (+ve), 65.8 (-ye), 67.0 (-ye), 114.6 
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(+ve), 118.4 (-ve),122.1 (+ve), 123.3 (+ve), 123.6 
(+ve), 128.5 (+ve), 129.6 (-i-ye); UV(MeCN)Amax  218,261nm; 
Found C, 55.1; H, 4.2; N, 8.0; C23H21N308S 
requires C, 55.3; H, 4.2; N,8.4%; M.S (FAB, Thioglycerol) 
m/e 500 (MH). 
1.2.1 Attempted cyclisation of (414) 
Using 2 equivalents of cyclohexylamine 
The acrylate derivative (414) (200 mg, 0.4 inmol) 
was dissolved in dichioromethane (Sml). 	The solution 
was flushed with nitrogen and freshly dried 
cyclohexylamine (0.8 mmol) in dichioromethane (Sml) was 
added. 	The reaction was monitored by infra-red analysis 
and it was found that the $-lactam carbonyl stretching 
frequency (1780 cm -1 ) diminished with time and became 
negligible after 1.5 h. 	The solvent was removed in 
vacuo. Thin layer chromatographic analysis indicated a 
complex mixture and the infra-red spectrum of the crude 
product contained no carbonyl stretching frequency above 
1740 cm-. - 
Using 1 equivalent of cyclohexylamine 
The acrylate derivative (414) (60.5 mg, 0.12 mmol) 
was dissolved in CD2C.L2 (0.5 ml). To the solution,dry 
cyclohexylamine (0.014 ml, 0.12 mmol) was added and the 
reaction was then monitored by 'H n.m.r. spectroscopy (80 
MHz) at 15 minute intervals for 45 minutes. 	The 
olefinic protons had disappeared after 15 mm, as had 
the -1actam protons. 	After 30 min,a new peak at 6= 
2.4 ppm had developed (N-acetyl cyclohexylamide). 	The 
reaction mixture was then diluted with dichloromethane 
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(lOmi) and washed with distilled water. 	The 
dichloromethane layer was dried (sodium sulphate) and the 
solvent evaporated in vacuo. 	The aqueous washing was 
re-extracted with ethyl acetate and then discarded. 	The 
ethyl acetate was dried (sodium sulphate) and evaporated 
in vacuo. 	Thin layer chromatographic analysis of the 
dichioromethane fraction indicated only components with 
lower Rf values than the starting material, together with 
a trace amount of starting material. 	TLC analysis of 
the ethyl acetate fraction indicated a component with a 
similar Rf value to the starting material. 	Infra-red 
analysis of the ethyl acetate fraction indicated the 
presence of a -lactam carbonyl stretch (1780 cm -1 ) but 
only a trace amount was available. 	The crude product 
from the dichloromethane traction was purified by 
preparative thin layer chromatography, the eluent being 
ethyl acetate. 	Three fractions were observed, each was 
extracted from the silica with ethyl acetate and 
dichioromethane. 	Fraction 1 (dichioromethane), 1 mg, 
(430), 'max/cm 1 1800, 1730, 1695; 6/ppm 4.33 (S, 2H), 
4.65 (s, 1H), 5.10 (d, J = 5Hz, 1H), 5.22 (s, 1H), 6.1 
(dd, j = 5 Hz, 12Hz, 1H), 7.4 (M, ); Fraction 1 (ethyl 
acetate), (435), 10.8 mg, Vmax/cml 3410, 1780, 1748, 
1690, 1520, 1350; 	'H n.m.r./ppm 1.5 
(m, 11H), 2.3 (S, 3H), 3.5 (m, H) 4.6 (S, 2H), 5.4 (S, 
2H), 5.6 (m, 2H), 6.9-8.3 (m, 10H); 	Fraction 2 
(dichloromethane) (430), 0.7 mg, 	max/cm-1 1800, 1755, 
1695; Fraction 2 (ethyl acetate) (436), 1.5 mg, 
Vmax/cm_1 1730, 160, 1520, 1350; Fraction 3 
(dichloromethane + ethyl acetate) (436), 1.7 mg, 
Vmax/cm_1 1730, 1610, 1520, 1350. 
c) 	Using 1 equivalent of diisopropylamine 
The acrylate derivative (414) (31.2 mg, 6.3 x 10-5 
mol) was dissolved in dichioromethane (5 ml) under 
nitrogen. 	The solution was cooled to -20°C. 	To the 
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reaction mixture was added a solution of diisopropylamine 
(6.3 x 10 	mol, 6.4 mg) in dichioromethane (0.5 ml) and 
the reaction was monitored by infra-red and TLC 
analysis. 	The reaction mixture was allowed to warm to 
room temperature over 0.5 h and then stirred overnight. 
After 20 h, no reaction had taken place as indicated by 
infra-red and TLC analysis. Vmax/cm_i 3410, 1780, 1730, 
1700, 1420, 1350. 	A catalytic amount (2.5% w/w (414)) 
of N,N-dimethylaminopyridine was added. 	The 
P-lactam cleaved within two minutes as indicated by infra 
red analysis. 	Vmax/cml 3400, 1730, 1700 (br), 1520, 
1350. 
Using 1 equivalent of 4-chioroaniline 
4-chioroaniline (4.4 mg, 3.5 x 10 	mci) was added 
to a solution of the acrylate derivative (414) (17.7 mg 
3.5 x 105 mol) in sodium dried benzene (5 ml). 	The 
reaction mixture was stirred for 25h at room temperature 
under nitrogen. 	The solvent was then evaporated in 
vacuo and the residue dissolved in dichloromethane. 	An 
infra-red spectrum was obtained which indicated peaks 
identical to the starting materials. 	This was confirmed 
by TLC analysis. 	The residue was re-dissolved in 
benzene (5m1) and heated to 35°C for lh and to 40 0 c for 
2h. 	In,both cases,no reaction occurred and infra-red 
and TLC analysis confirmed the presence of only the 
starting materials. 
Using 1 equivalent of mercuric acetate 
The acrylate derivative (414) (24 mg, 4.7 x 10-5 
mol) was dissolved in dimethylformamide (DMF) (5ml) under 
nitrogen. 	The reaction mixture was cooled to -20°C. 
To the stirred solution, a solution of mercuric acetate 
(16 mg, 5.08 x 10 	mol) in DMF (5 ml) was added 
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dropwise. 	The reaction mixture was allowed to warm to 
room temperature and stirred for a further 50 mm. 	No 
precipitate formed, as was expected. 	TLC analysis 
indicated the presence of the starting material (414) (Rf 
= 0.7, A). 	The reaction mixture was warmed to 35°C. 
After lh,TLC analysis indicated presence of mainly 
starting material in addition to a few minor spots close 
to the base line. 	DMF was removed in vacuo and the 
residue was taken up in dichloromethane11t precipitate 
remaining. 	Infra.-red analysis of the dichloromethane 
layer indicated that the starting material was the main 
component. 	Vmax/cm_1 3410, 1780, 1730, 1700, 1520, 
1350. 	Infra-red analysis (nujol mull) of the 
precipitate indicated no -lactam containing component, 
to be present. 
Using 1 equivalent of Lithium Hydride 
The acrylate derivative (414) (18.6 mg, 3.73 x 
10-5 mol) was dissolved in dry benzene (10 ml) to which 
lithium hydride (0.3 mg, 3.73 x 	mol) was added. 
The suspension was heated to 65°C and stirred for 2 h. 
TLC analysis (A) indicated ory 	the presence of 
the 	starting 	-rnäteria-L--(-4i4)-. 	- - 	- 
Removal of the lithium hydride and evaporating the 
filtrate to dryness in vacuo afforded a clear gum. 	'H 
n.m.r. analysis indicated only the starting material to 
be present. 	1H n.m.r, (200 M Hz) ö/ppm 2.2 (5, 3H), 
4.55 (s, 2H), 5.35 (s, 2H), 5.65 (dd, J = 5.2, 8.8 Hz, 
1H), 6.03 (d, J = 5.2 Hz,. 1H), 6.09 (s, lH), 6.14 (S, 
lH), 6.8-8.2 (m, 10H). 
Using 1 equivalent of lithium hydroxide 
Treatment of the acrylate derivative (414) (20mg, 
4 x iü 	mol) in 50% aqueous tert-butanol (5 ml) with an 
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aqueous solution of lithium hydroxide (0.05M) by a 
titrimetric method resulted in complete decomposition of 
the starting material (414) as indicated by TLC analysis, 
by a U.V. active spot on the base-line. 	Infra-red 
analysis of the dried residue indicated no carbonyl peak 
above 1730 cm -1 . 
1.2.2 Synthesis of 4-Nitrobenzyl 2-((3R)-phenoxyacet- 
amido-(4R)-Silver thiolato-2-azetidinon-1-yl) 
propenoate (439) 
The acrylate derivative (414) (470 mg, 9.4 x.10-4  
mol) was dissolved in freshly dried and distilled 
tetrahydrofuran (10 ml) under nitrogen and the reaction 
vessel was covered by aluminium foil. 	To the stirred 
reaction mixture was added,dropwise,a solution of silver 
tetrafluoroborate (367 mg, 18.8 x 	mol) in 
tetrahydrofuran (5 ml), containing methanol (1 ml) at 
room temperature. 	Excess dry pyridine (0.05 ml) was 
added, and the reaction mixture was then heated at 30°C 
for 1.5 h. 	The end point of the reaction was determined 
by TLC analysis (C). 	The reaction mixture was allowed 
to cool to room temperature and the solvent was 
evaporated in vacuo. 	The residue was taken up in 
dichioromethane and washed twice with distilled water (10 
ml) and once with brine (10 ml). 	The organic layer was 
dried with anhydrous sodium sulphate, filtered, and the 
solvent evaporated in vacuo. 	The crude product was 
chromatographed by flash chromatography. 
Two isocratic eluent systems were used 
70% ethyl acetate/30% petroleum ether (40-60) 
50% ethyl acetate/50% dichioromethane 
The silver thiolate (439) (379 mg, 70%) was isolated from 
the fractions of (b). 	The product (439) solidified on 
trituration with diethyl ether and was stored at 0°C and 
in the dark. 	Mpt 113-115 0 c. Rf = 0.64 (C), Vmax/cm_l 
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3405, 1770, 1710, 1675, 1525, 1350, 1 H n.m.r. (CD2C12, 80 
MHz) b/ppm 4.61 (m, 2H), 5.35 (m, 3H), 6.13 (S, 1H), 6.19 
(S, 2H) 1 ., 	6.97 - 8.18 (rn, 10H); 	Found C, 44.1; 	H, 
3.1; N, 7.5; AgC21H18N307S (1/2 HzO) requires C, 44.0; 
H, 3.3; N, 7.3%; M.S. (FAB, Thioglycerol) m/e 565 (MH), 
587 (MNa), 458 (MH - Ag). 
1.2.3. Reaction of the Silver thiolate (439) with acetyl 
,,1il rr 
The silver thiolate (439) (45.2 mg, 8.0 x 10-5 
mol) was dissovied in acetonitrile (5 ml) under 
nitrogen. 	The reaction vessel was covered with 
aluminium foil and cooled to 0°C. 	To the stirred 
solution was slowly added acetyl chloride (0.14M in MeCN, 
0.6 ml). 	After five minutes,the white precipitate was 
removed by filtration through celite. 	The filtrate was 
concentrated in vacuo and the residue was purified by 
flash chromatography on silica using a gradient eluent 
system of ethyl acetate and petroleum ether (40-60), 
affording the acrylate derivative (414) (11mg, 30%)as a 
colourless gum. 	Rf = 0.7 (C); Vmax/cml 3410, 1780, 
1732, 1700, 1525, 1350; 'H n.m.r. (80 MHz) b/ppm 2.2 (s, 
3H), 4.6 (s, 2H), 5.3 (5, 2H), 5.6 (dd, J = 5, 9Hz, 1H), 
6.0 - 6.1 (d, J = 5Hz, 3H), 6.8-8.3 (m, lOH); 	Found C, 
55.1; H, 4.5; N, 8.0; C23H21N308S requires C, 55.3; 
H, 4.2; N, 8.4%; M.S. (FAB, Thioglycerol) m/e 500 (MH). 
1.2.4. Attempted generation of the thiol (394) from (439) 
a) 	Reaction with hydrogen sulphide 
The silver thiolate (439) (35 mg, 6.2 x 10 -5 .mol) 
was dissolved in dichioromethane (10 ml) under nitrogen 
239 
and the reaction vessel covered with aluminium foil. 
The reaction mixture was then cooled to -50°C. 	A 
mixture of hydrogen sulphide and nitrogen was bubbled 
slowly through the reaction mixture for 30 seconds. 	The 
solution was kept at -50°C, flushed with nitrogen for 
0.5h and then allowed to warm to room temperature. 	The 
black precipitate was removed by filtration through 
kieselguhr and washed with dichioromethane. 	The 
filtrate was concentrated in vacuo. 	TLC analysis of the 
crude product in systems A and C indicated no mobile 
components, the spot remaining on the baseline. 	Infra 
red analysis indicated that the -lactam had cleaved; 
Vmax 3390 (br), 1750, 1690-1670 (br), 1525, 1350 cm -1 . 
Attempts to purify sample by crystallisation or 
chromatography resulted in complete loss of material. 
b) 	Reaction with sodium chloride 
The silver thiolate (439) (10mg, 1.75 x iü 	mol) 
was dissolved in (1:10) water/acetonitrile mixture, (5 
ml), to which was added excess sodium chloride (500 
mg). 	The reaction mixture was then stirred for 12J 
TLC analysis (C) indicated a new spot (Rf = 
0.71) and a spot on the base line. 	No spot 
corresponding to the starting material (439) (Rf = 0.64) 
was present. 	Infra-red analysis of the crude product 
indicated that the -lactam had cleaved. 	Preparative 
thin layer chromatography resulted in a solid (1 mg); 
Vmax/cm1 3375, 1723, 1685, 1590, 1522, 1350. 
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1.2.5 Reactions of silver thiolate (439) 
With bromine water 
The silver thiolate (439) (51 mg, 9.10 x 10 - mol) 
was dissolved in dichioromethane (15 ml) and to this 
solution was added distilled water (15 ml) and a 1% (w/v) 
solution of aqueous bromine (0.5 ml). 	The reaction 
mixture was stirred for 5 minutes and then diluted with 
saturated aqueous sodium bicarbonate solution (10 ml). 
The organic layer was removed, washed with distilled 
water and dried over anhydrous sodium sulphate. 	The 
dried solution was filtered and concentrated in vacuo to 
afford a clear gum (58 mg). 	Vmax/cm_l 3405, 1790, 
1755, 1730, 1695; Attempts to obtain a 1 H n.m.r. 
spectrum resulted in the formation of a precipitate in 
CDC13 and no -lactam containing component. 	Work was 
stopped at this stage with this sample. 
With phenylselenenyl chloride 
The silver thiolate (439) (97 mg (1.71 x 	mol) 
was dissolved in dichioromethane (10 ml),the solution was 
flushed with nitrogen and the reaction vessel was covered 
with aluminium foil. To the stirred solution 
phenylselenenyl chloride (33.7 mg, 1.76 x 	mol) in 
dichioromethane (lOmi) was added dropwise. The 
reaction mixture was stirred for 2h. 	The reaction 
mixture was filtered through celite and the filtrate 
concentrated in vacuo. 	The residue was purified by 
flash chromatography on silica using two isocratic eluent 
systems: 	(i) petroleum ether (40-60), (ii) 50% ethyl 
acetate/50% dichloromethane. This afforded 96 mg (92%) 
of a pale yellow foam. 	Rf 0.75 (C); 'H n.m.r. (60 
MHz) 	i/ppm 4.54 (S, 2H), 5.27 (S, 2H), 5.6-6.2 (in, 4H), 
6.95-8.6 (m, 15H); Vmax/cnr 1 3410, 1775, 1730, 1695, 
1525, 1350; M.S. (FAB, Thioglycerol) m/e 613 (MH); 
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Found C, 52.3; H, 3.7; N, 6.7 C27H23N301S Se requires C, 
52.9; H, 3.8; N, 6.9%. 	These data suggested that the 
product had the structure (474a).. 
Oxidation of the sulphur-seleno derivative (474a) with 
meta-chloroperbenzoic acid (mCPBA) 
The thio-seleno derivative (474a) (90.7 mg, 1.48 x 
10-4 mol) was dissolved in dichloromethane (5 ml) and the 
solution flushed with nitrogen. The stirred reaction 
mixture was cooled to 0°C and a solution of mCPBA (26 mg, 
1.5 x iü 	mol) in dich1otnethane (1 ml) was added 
dropwise. The reaction mixture was stirred, allowed to 
warm to room temperature and the reaction was monitored 
by TLC analysis (B). 	After 55h,the reaction appeared to 
have stopped although some starting material (474a) was 
still present (TLC). 	An aliquot (1 ml) of the reaction 
mixture was removed and worked-up via a saturated sodium 
bicarbonate wash and dried with anhydrous sodium 
sulphate. 	Infra-red analysis indicated the following: 
Vmax/cm1 3360, 1825 (w), 1772, 1730, 1685, 1520, 1348. 
The major component appeared to be the starting material 
(474a) (TLC and IR) but some required product (477a) 
seemed to be present. 	The crude mixture was treated 
with further mCPBA (4 mg, 2.3 x 10 	mol) in 
dichloromethane (2 ml) and the solution was stirred for 
10 minutes. 	Usual work-up resulted in a gum, infra-red 
analysis of which indicated the following: Vmax/cml 
3405 (br), 1790, 1760, 1735, 1700, 1590, 1525, 1350, 
which was not compatible with the required product (477a) 
and, hence, was not pursued further. 	The remaining 
mixture was worked up in the usual way. 	Infra-red 
analysis of the crude sample indicated the following: 
Vmax/cm1 3410, 1825 (w), 1775, 1730, 1695, 1522,1350. 
Attempt to purify the sample by preparative TLC (B) 
resulted in the isolation of a solid which was identified 
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as (474a) (19 mg, 3W - (TLC and IR analysis). 	No thione 
derivative (477a) could be isolated. 	Work was stopped 
at this stage with this sample. 
C) 	With trimethyltin chloride 
The silver thiolate (439) (99 mg, 1.76 x 10 	mol) 
was dissolved in dichioromethane (2 ml) with stirring 
under nitrogen. The reaction vessel was covered with 
aluminium foil and a solution of trimethyltin chloride 
(40.6 mg, 2 x 10- 4 mol) in dichloromethane (1 ml) was 
added at 0°C. The reaction mixture was stirred for 
15h. 	The white precipitate was removed by filtration 
through anhydrous sodium sulphate and washed with 
djchloromethane (3 x 10 ml) and the filtrate concentrated 
in vacuo. 	37.4 mg of a yellow gum resulted. 	This was 
identified as the starting material (439) (37% 
recovery); Rf = 0.64 (C); 	 3405, 1770, 1710, 
1675, 1525, 1350. 	The residue was further washed with 
acetone (5 x 10 ml) and the filtrate resulted in . a white 
solid (57 mg) on concentrating in vacuo. 	Mpt 104°C; 
Vmax (Nujol)/cnr' 1765, 1715, 1675, 1522, 1350; 'H n.m.r. 
(80 MHz) (d6- acetone) s/ppm 1.2 (S, 311), 4.7 (s, 211), 
5.5 (s, 211), 6.0-8.3 (m, 411), 6.9-8.2 (m, 1011): (peaks 
were generally broad). 	Work was stopped at this stage 
with this sample. 
d) 	With chiorotrimethylsilane 
The silver thiolate (439) (158 mg, 2.8 x 10 	mol) 
was dissolved in dichloromethane (3 ml) and the reaction 
vessel covered with aluminium foil and flushed with 
nitrogen. 	The stirred reaction mixture was cooled to 
0°C and chiorotrimethylsilane (0.3 ml, 3.2 mmol)was 
added. 	The reaction mixture was stirred for 18 hours 
resulting in a white precipitate. 	The reaction mixture 
was' filtered 
filtrate was 






evaporated in vacu 
Vmax/cml 3400 
A satisfactory 'H 
Work was stopped 
under nitrogen and the 
D resulting in a yellow 
(br), 1774, 1725, 1688, 
n.m.r. spectrum could not 
at this stage with this 
e) 	With bromonitromethane 
The silver thiolate (439) (96 mg, 1.7 x 10 	mol) 
was dissolved in dichioromethane (5 ml). 	The reaction 
vessel was covered with aluminium foil, flushed with 
nitrogen and cooled to 0°C. 	To the stirred solution was 
added a solution of bromonitromethane (26 mg, 1.71 x 10-4 
mol) in dichloromethane (2 ml). 	The reaction was 
monitored by TLC analysis (C). After 6h at 0°C,no 
reaction had occurred. 	The reaction was allowed to warm 
to room temperature and stirred for lh. 	No reaction was 
detectable. 	The reaction mixture was heated to 36°C for 
1 h. No reaction was detected. 	The solvent was removed 
in vacuo and replaced by dimethylformamide (5 ml). 	The 
reaction was continued at room temperature for 6h. No 
reaction was detectable by TLC analysis, only the 
starting materials being present. 	Work was abandoned on 
this line of research. 
1.2.6. Attempted synthesis of 4-Nitrobenzyl 2-((3R)-
pheno-xyacetamido-(4R)-thioacetyl--azetidin-2-one-1-
yl )-3-tributy1stanny1 propanoate (504) 
The acrylate derivative (414) (180 mg, 0.36 mmol) 
was dissolved in benzene (10 ml) under nitrogen. 
Azobisisobutyronitrile (5mg, 3% w/w) was added to the 
reaction mixture followed by tri-n--butylstannane (215 mg, 
0.74 mmol). 	The reaction mixture was heated to 80°C for 
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2h . 	The cooled solution was concentrated in vacuo and 
the residue subjected to flash chromatography on silica 
using an isocratic eluent system (70% ethyl acetate/30% 
petroleum ether (40-60)). 	The -lactam containing 
fractions were combined and preparative TLC using an 
eluent system of 30% ethyl acetate/70% petroleum ether 
(40-60) was carried out. 	Three components were 
isolated. 	Fraction 1 (20mg); Rf = 0.8 (A), Vmax/cm_l 
1733, 1610, 1520, 1349, 'H n.m.r. (80 MHz) 6/ppm .0.9-2.0 
(m, 5H), 4.81 - 4.84 (m, 2H), 7.46-8.25 (AB, J = , 4H); 
sample not identified: Fraction 2 (80 mg) Rf = 0.67 (A) 
identical to acrylate derivative (416) in system A; 
Vmax/cm ...l 3410, 1783, 1733, 1700, 1525, 1350; sample 
identified as starting material (414): Fraction 3 (25 
mg); Vmax/cm4 3408, 1780, 1748, 1700, 1685, 1522, 1350; 
TLC analysis indicated two close spots,a further 
chromatography of this fraction resulted in 6.3 mg of a 
P-lactam containing component. 	Rf = 0.46 (A) (c.f 
starting material (414) Rf = 0.67 (A)); Vmax/cnrl 3410, 
1780, 1745,'1700, 1685 (sh), 1523, 1350; 'H n.m.r. (200 
MHz) 	ö/ppm 1.58 (d, J = 7.5 Hz, 3H), 2.2 (s, 3H), 4.6 
(m, 2H), 5.2 (m, 1H), 5.5 (m, 1H), 5.6-5.8 (m, 1H), 
6.9-8.2 (m,10H); M.S. (FAB, Thioglycerol) m/e 500 (m), 
426. 	The structure of sample was assigned as (505). 
1.2.7 Reactions of 4-nitrobenzyl 2-((3R)-phenoxyacet- 
amido-(4R)- acetylthio azetidin-2-on-1-yl )-
propenoate (414) 
a) 	With ethanethiol 
The acrylate derivative (414) (30 mg, 6.0 x 10-5 
mol) was dissolved in dichioromethane (5 ml) to which was 
added an excess of ethanethiol (11 mg, 1.8 x 	mol) in 
dichioromethane under nitrogen. 	The reaction was 
monitored by TLC analysis (A). After 1.5h at room 
temperature,no reaction was detectable. 	The reaction 
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mixture was then refluxed for 2h and no change was 
detected. 	The reaction mixture was cooled and excess 
pyridine (0.2 ml) was added and then refluxed for 10 
minutes. 	No reaction was detected by TLC analysis. 
Flash chromatography of the reaction mixture using a 
gradient eluent of ethyl acetate and petroleum ether 
(40-60) resulted in isolation of the starting material 
(414) (18mg, 60%) as a white foam. 	Vmax/cml 3410, 
1783, 1734, 1700, 1525, 1350; 'H n.m.r. (80 MHz) a/ppm 
2.2 (5, 3H), 4.6 (S, 2H), 5.3 (5, 2H), 5.6 (dd, J = 5, 
9Hz, lH), 6.6-6.1 (d, J = 5Hz, 3H), 6.8-8.3 (m, 10H). 
With Hydrogen Sulphide 
The acrylate derivative (414) (18 mg, 3.6 x 10 
mol) was dissolved in dichioromethane (10 ml) at room 
temperature under nitrogen. Hydrogen sulphide was 
bubbled through the reaction mixture for 5 minutes. 	The 
reaction mixture was flushed with nitrogen for 15 
minutes. 	TLC analysis indicated only the presence of 
the starting material (414), suggesting that no reaction 
had taken place. 	Flash chromatography using 50% ethyl 
acetate and 50% dichloromethane as eluent resulted in 15 
mg (70%) of the starting material (414). 	Vmax/cml 
3410, 1780, 1730, 1700, 1525, 1350. 
Reaction with Bromine 
The acrylate derivative (414) (20 mg, 4.0 x 10-5 
mol) was dissolved in dichloromethane (10 ml) and cooled 
to 0°C. 	A solution of aqueous bromine (10 ml, 1% w/v) 
was added and the solution stirred for 10 minutes. 
After the aqueous layer had decolourised, the organic 
layer was separated and washed with distilled water and 
then dried over anhydrous sodium sulphate. 	The dried 
organic layer was filtered and the solvent removed in 
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vacuo. 	Infra-red analysis of the crude product 
indicated the following peaks:. Vmax 1785, 1750, 1700, 
1520 and 1350 cm-1 . 	The sample was purified by 
preparative TLC (A) resulting in 12 mg of a solid. 
Infra red analysis indicated that the $-lactam carbonyl 
stretching frequency was absent. 	'max/cm' 1733, 1700 
(br), 1520, 1350. 
1.2.8 Synthesis of Methyl 2-((3R)-Phenoxyacetamido--(4R)-
Silver thiolatoazetidin-2--on-l-yl) 3-methyl-
but-2-enoate (465) 
The -lactam (407) (0.52 g, 1.27 mmol) was 
dissolved in methanol (10 ml) and cooled to 0°C under 
nitrogen. 	Silver nitrate (0.22g, 1.27 mmol) and 
pyridine (0.1g, 1.27 mmol) were added to the reaction 
mixture. 	The reaction vessel was covered by aluminium 
foil and stirred for 18h. 	The white precipitate was 
filtered under nitrogen, washed with cold methanol (2 x 
10 ml), diethyl ether (20 ml), and dried under vacuum. 
The pale yellow solid was stored at 0°C in the dark. 	Rf 
0.36 (C), Mpt 130°C(decomposed); Vmax/cm' 3405, 1765, 
1720, 1700, 1650; 'H n.m.r. (80 MHz) 5/ppm 2.1- 2.15 (s, 
6H), 3.75 (s, 3H), 4.5 (m, 2H), 5.3 (m, 2H), 6.8-7.3 (m, 
5H), 8.15 (d, J = 9Hz, 1H). 
1.2.9 Reactions of (465) 
a) 	With acetyl chloride 
The silver thiolate (465) (10mg, 2.1 x 	mol) 
was dissolved in acetonitrile (10 ml) under nitrogen. 
The reaction vessel was covered with aluminium foil and 
cooled to 0°C. 	A solution of acetyl chloride (1.6 mg, 
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2.1 x 10-5 mol) in acetonitrile (2 ml) was added dropwise 
to the reaction mixture and stirred for 5 minutes. 	The 
white precipitate was filtered under nitrogen (this 
darkened on exposure to light for 10 minutes). 	The 
filtrate was concentrated in vacuo. 	The residue was 
purified by flash chromatography using a gradient elution 
with ethyl acetate and petroleum ether (40-60), resulting 
in a foam (3 mg). 	Rf 0.55 (C); Vmax/cml 3400, 1780, 
1725, 1700, 1690, 1635; Comparison with the 
literature 218 confirmed the p_lactam (407) had been 
obtained in 35% yield. 
b) 	With bromine water 
The silver thiolate (465) (50 mg, 8.4 x 	mol) 
was dissolved -in dichioromethane (10 ml),with stirring. 
The solution was cooled to 0°C and then a solution of 
aqueous bromine (20 ml, 1% w/v) was added dropwise. 
After stirring for 5 minutes, the solution was diluted 
with a solution of saturated sodium bicarbonate (10 ml) 
and the organic layer was removed and washed with 
distilled water (2 x 5 ml) and brine (5 ml),and dried 
over anhydrous sodium sulphate. 	The filtrate was 
concentrated in vacuo. 	Infra-red analysis of the crude 
product indicated the following: umax/cm' 1785, 1725 
and 1700, suggesting that the p_lactam bond was intact. 
n.m.r. (80 MHz) of the crude product indicated an 
AA BB' proton resonance patterp typical of a paradi-
substituted aromatic ring ( 5= 8.2 - 7.7 ppm). TLC 
analysis indicated that the sample was unstable to 
silica. 	Work was stopped at this stage with this 
sample. 
c) 	With phenylselenenyl chloride 
The silver thiolate (465) (145 mg, 3.1 x 	mol) 
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was dissolved in dichioromethane (10 ml) under nitrogen. 
The reaction vessel was covered with aluminium foil. 	A 
solution of phenylselenenyl chloride (62 mg, V.I. x 10-4 
mol) in dichioromethane (10 cm 3 ) was added dropwise and 	-= 
the reaction mixture stirred at room temperature for 10 
minutes. 	The white suspension was filtered through 
celite. The solids were washed with dichioromethane and 
the solvent evaporated in vacuo. 	The residue was 
purified by flash chromatography on silica, using a dual 
eluent system consisting of a) petroleum ether (40-60) 
and b) 50% ethyl acetate/50% dichioromethane. 	This 
resulted in isolation of a yellow solid (L.)i*j (124 mg). 
Rf 0.64 (C), Vmax/cml 3415, 1775, 1725, 1695; 1 H n.m.r. 
(80 MHz) 5/ppm 1.9 (S, 3H), 2.1 (S, 3H), 3.69 (s, 3H), 
4.45 (s, 2H), 5.4 (m, 2H), 7.28 (m, 11H); M.S 
(Thioglycerol, FAB) m/e 519 (M+); accurate mass found 
519.071676 C23H24N205S Se requires 519.0717. The 
structure was assigned as (474b). 
Reaction of sulphur-seleno derivative (474b) with meta-
chloroperbenzoic acid (II1CPBA) 
The sulphur-seleno derivative (474b) (77mg, 1.5 x 
lO 	mol) was dissolved in dichloromethane (5 ml) and 
cooled to 0°C under nitrogen. 	To the stirred solution,a 
solution of mCPBA (26 mg, 1.5 x mol) in 
dichioromethane (1 ml) was added dropwise. 	The reaction 
mixture was stirred at 0°C and monitored by TLC (C). 
After 18h, some starting material (474b) was still present 
(TLC) but a new spot had developed at Rf = 0.76. 	The 
solvent was evaporated in vacuo. 	Infra-red analysis of 
the crude product indicated the following peaks, 
Vmax/cml 3600-2700 (br), 1830, 1720 (br). 	The residue 
was chromatographed on silica, using a gradient elution 
consisting of ethyl acetate and petroleum ether 
(40-60). 	Three components were isolated. Component 1 
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(4.9 mg), Rf 0.74 (B); Vmax/cml 3040, 2980, 1570, 
1475; structure unidentified. 	Component 2 (9.6 mg), Rf 
= 0.46 (B); Vmax/cnr4 3410, 1830, 1733, 1690,; 'H 
n.m.r. 1200 MHz) 5/ppm 2.10 (s, 3H), 2.30 (s, 3H), 3.80 
(S, 3H), 4.53 (s, 2H), 5.1 (d, j = 7.6 HZ, 1H), 6.9 - 7.7 
(complex, 6H); Structure identified as the thione 
derivative (477b). 	Component 3 (56mg), Rf = 0.26 (B); 
"max/cm 1 3415, 1775, 1725, 1695; structure was 
identified as the starting material (474b) by comparison 
of infra-red and TLC analysis. 	Attempts to improve the 
yield of the thione derivative (477b), by use of excess 
metachloroperbenzoic acid, resulted in no $-lactam 
containing component (IR) being isolated. 
d) 	With trimethyltin chloride 
Trimethyltin chloride (88.6 mg, 4.5 x 10 	mol) in 
dichiorornethane (2 ml) was added to a solution of the 
silver thiolate (465) (214 mg, 3.8 x 10 	mol) in 
dichloromethane (4 ml). 	The reaction vessel was covered 
with aluminium foil and stirred under nitrogen at room 
temperature and monitored by TLC analysis. 	After 10 
minutes,no starting material remained 	. Infra red 
analysis of the crude reaction indicated the following 
peaks: Vmax/cml 3400 (br), 1760 (br), 1720, 1650. 	The 
residue was purified by flash chromatography using two 
isocratic eluent systems, ethyl acetate/dichloromethane 
(1:1) and 100% ethyl acetate. 	A white solid was 
isolated (116 mg) from the first eluent system, Rf = 
0.45 , 	(ethyl acetate); Vmax/cml 3410, 3290, 1765, 
1720, 1700, 1665; 'H n.m.r. (200 MHz) S/ppm 0.63 (S, 
0.25H), 2.02 (s, 3H), 2.14 (5, 3H), 3.71 (s, 3H), 4.2-4.7 
(m, 2H), 5.01-5.44 (m, 2H), 6.8- 7.3 (m, 5H), 8.4 (s, 
lH): structure was tentatively suggested as (513). 
Work was stopped at this stage with this sample. 
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e) 	With chiorotrimethylsilane 
The silver thiolate (465) (126 mg, 2.68 x 10 -
mol) was dissolved in dichiormethane (5 ml) and stirred 
under nitrogen. 	The reaction mixture was then cooled to 
0°C, excess chlorotrimethylsilane (0.3 ml, 2.4 x 10 
mol) was added and the reaction mixture was stirred for 
24h. 	The reaction mixture was filtered through 
kieselguhr and the residue washed with dichloromethane. 
The solvent was evaporated in vacuo. 	Infra-red analysis 
of the crude product indicated the following peaks:-
Vmax/cml 3410, 3300 (brd), 176, 1720, 1685, 1670. 
Attempts to obtain a reasonable 'H n.m.r. spectrum were 
unsuccessful. 	The peaks were found to be too broad. 
Work was stopped at this stage with this sample. 
1.3.0. Novel route for the Conversion of Penicillin V to 
- 
a cephalosporin nucleus 
1.3.1. Atempted reaction of 4-Nitrobenzyl (C3R)-
phenoxyacetamido-(4R )-acetylthio-zetidin-2-one-
1-yl) triphenyiphosphoranylidenacetate (413) with 
5-oxo-2-phenyl-1 ,3-diozane (529) 
METHOD A 
The ketone (529) (324 mg, 1.2 x 	mol), 
obtained by vacuum distillation of the hydrated form 
(534)256 was dissolved in dichioromethane (5 ml) under 
nitrogen. 	To the reaction mixture was added a solution 
of the phosphorane (413) (150 mg, 2 x 10 4 mol) in 
dichloromethane (10 ml). 	The reaction mixture was 
stirred at room temperature and monitored by TLC and I.R. 
analysis. 	After 23h,no reaction was detectable (TLC 
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(A)). 	The reaction mixture was heated at 45°C for 
24h. Analysis indicated only the presence of starting 
materials (413) and (529). 	These were isolated by flash 
chromatogrphy using a gradient elution of ethyl acetate 
and petroleum ether (40-60). 	The first sample was a 
white solid (207 mg); Vrnax/cml 1745; 'H n.m.r. (60 
MHz) 5/ppm 4.6 (S, 4H), 5.9 (S, 1H), 7.5 (S, 5H); 	This 
was identified as the ketone (529). 	Further proof of 
its identity was obtained by reacting with ethyltri-
phenylphosphoranylidenacetate in dichloromethane to 
result in the condensation product. 	chromatography 
resulted in a clear oil (350 mg). Vmax/cml 2820, 1710, 
1665; 1 H n.m.r. (80 MHz) 5/ppm 1.2 (t, 7Hz, 3H), 4.2 (q, 
7Hz, 2H), 4.5 (S, 2H), 4.7 (S, 1H), 5.6 (S, 2H), 5.8 (m, 
lH), 7.3 (in, 5H). 
The second sample was a yellow foam (140 mg, 93% 
recovery) Vmax/cml 3410, 1770, 1700, 1630, 1520, 1350; 
Rf 0.38 (ethyl acetate). 	This was identified as the 
phosphorane (413). 	Further proof of its identity was 
obtained by reaction with formaldehyde to afford the 
condensation product, the acrylate derivative (414) 	Rf 
0.51 (A), Vmax/cm 	3410, 1780, 1730, 1700, 1520, 1350; 
'H n.m.r. (60 MHz) 5/ppm 2.3 (S, 3H), 4.7 (S, 2H), 5.00 
(d, J - 10Hz, 1H), 5.4 (S, 2H), 5.7 (dd, J = 10, 4Hz, 
1H), 6.1 (m, 3H), 6.9 - 8.4 (in, 9H). 
M11U(T fl 
The ketone (529) (320 mg, 1.79 x 	mol) was 
dissolved in dry toluene (30 ml) and flushed with 
nitrogen. 	A solution of the phosphorane (413) (1.34g, 
1.8 mmol) in dry toluene (10 ml) was added to the stirred 
reaction mixture at room temperature. 	The solution was 
refluxed for 24 hrs. 	The reaction solvent was removed 
in vacuo and the residue chromatographed on silica using 
eluent system B. 	Three components were isolated. 
Component 1 was a clear gum (360 mg), Rf 0.63 (B); 
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Vmax/cml 1745, 1130; 'H n.m.r. (60 MHz) a/ppm 4.5 (S, 
4H), 5.9 (s, 1H), 7.55 (5, 5H). 	This component was 
identified as ketone (529). 	Component 2 was a beige 
solid (360 mg). 	Rf 0.41 (B), Mpt 134-135°C, Vmax/cm 
1720, 1525, 1350; -H n.m.r. (80 MHz) 6/ppm 2.8 (s, 3H), 
5.5 (5, 2H), 8.0 (AB, 4H), 8.7 (5, 1H); 	M.S. (FAB, 
ThioglycerOl) m/e 278 (M), C12H10N204S (M.W 278.0361); 
Found c,51.2; H, 3.6; 	N, 9.8 requires c,51.7; H,3.6; 
N,10.1%. 	This component was identified as 
2-methyl-3-(4-nitro benzyloxy carbonyl )-thiazole (535) 
(93% yield). 	Component 3 was a yellow foam (300 mg), Rf 
0.21 (A), Vmax/cm 1 3410, 1765, 1695, 1630, 1525, 1350; 
1 H n.m.r. (60 MHz) 	6/ppm 2.3 (s, 3H), 4.7 (s, 2H), 5.4 
(S, 4H), 7.0 - 8.5 (m, 25H); this was identified as the 
phosphorane (413) (22% recovery). 	Work was stopped at 
this stage with this synthetic approach. 
1.4.0 	-Lactam Derivatives on Solid Supports 
1.4.1 Synthesis of (±) 3-(4-chloromethylphenyl)-3- 
trimethylsilyipropanoyl chloride (570)252 
Thionyl chloride (7.14g, 0.06 moles) was added to 
the hydroxy-acid derivative (549) (3g, 0.012 mol) 264 and 
stirred for 1.5 h. in DMF (10 ml). 	The solvent and 
excess SOC12 were removed in vacuo to afford the crude 
acyl chloride (570) (3.1g, 90%) of sufficient purity for 
use in the subsequent step. Vmax/cml 2960, 1800, 825; 
'H n.m.r. (80 MHz) 	6/ppm 0.0(s, 9H), 2.7 (dd, J = 5.1, 
10.5 Hz, lH), 3.2 (complex, 2H), 4.6 (s, 2H), 7.0 - 7.3 
(ABq, 4H). 
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1.4.2 Synthesis of (+) N,N-Diethyl 3-(4-chloromethyl-
phenyl )-3-trimethylsilylpropanoamide (565) 
The acid chloride (570) (0.5g, 0.002 mol) was 
dissolved in dichloromethane (5 ml). - diethylamine 
(0.15g, 0.002 mol) , saturated sodium 
bicarbonate (5 ml) and brine (5 ml) 	added,and the 
mixture stirred until reaction was complete (TLC). 	The 
organic layer was then separated, washed with sat, sodium 
bicarbonate (3 x 10 ml), citric acid (3 x 10 ml), brine 
(2 x 10 ml) and water (2 x 10 ml). 	The organic layer 
was dried over magnesium sulphate, filtered and the 
solvent removed in vacuo. 	The residue was 
chromatographed on silica using a gradient eluent system 
with ethyl acetate and petroleum ether (40-60). 	The 
required product (565) was obtained as a yellow viscous 
oil (0.36g) in 62% yield. Vmax/cml 2970, 1633, 964, 
840; 1 H n.m.r. (80 MHz) s/ppm 0.0 (S, 9H), 1.0 (t, j - 
9.9 Hz, 3H), 1.1 (t, J = 9.9 Hz, 3H), 2.7 (complex, 3H), 
3.2 (q, J = 9.9 Hz, 4H), 4.5 (S, 2H), 7.1 - 7.3 (ABq, 
4H); Found C, 62, 4; H, 8.5; N; 4.2; C17H28NOC1Si 
Requires C, 62. 7; H, 8.6; N, 4.3%. 
1.4.3 Reaction of N,N-diethyl (3)-(4-chromomethyl-
phenyl)-(3)-Trimethylsilylpropanoamide (565) with 
potassium salt of penicillin-V (564a) 
To a stirred suspension of potassium penicillin V 
(564a) (290 mg, 7.47 x 	mol) in 	'Y1eecorriae(6 
ml) was added a solution of the chloro-amide derivative 
(565) (240 mg, 7.5 x 10 	mol) in th1eLkcorrcrk(5 
ml). 	Potassium iodide (23 mg, 1.4 	mol) was added, 
and the reaction mixture was stirred under nitrogen for 
24h. 	The reaction was monitored by TLC analysis (C). 
The suspension was filtered through kieselguhr and washed 
with dichioromethane (4 x 20 ml). 	The solvent was 
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evaporated in vacuo and the residue was--- romatographed 
on silica, using a gradient eluent system with 
dichioromethane and ethyl acetate. 	The product (566a) 
was isolated as a gum (101 mg) in 30% yield 
(unoptimised). Rf = 0.65 (C); Vmax/cnrl 3405, 1790, 
1745, 1695, 1635; 'H n.m.r. (80 MHz) 5/ppm 0.0 (s, 9H), 
1.1 (M, J = 6Hz, 6H), 1.3 (S, 3H), 1.6 (s, 3H), 2.8 (m, 
3H), 3.3 (q, J = 6Hz, 4H), 4.5 (s, lH), 4.6 (s, 2H), 5.2 
(5, 2H), 5.6 (m, J = 4,12 Hz, 2H), 6.9 - 7.4 (m, 10H). 
1.4.4 Reaction of N,N-diethyl 3-(4-chloromethyl phenyl)-
3-Trimethyl silyl propanoamide (565) with sodium 
2-thienyl acetamido cephalosporinate (564b). 
To a stirred suspension of (564b) (305 mg, 7.6 x 
10 - ) mol) in dimethylformamide (7 ml) was added a 
solution of the chioro-amide (565) (243 mg, 7.6 x 10 -
mol) in dimethylformamide (5 ml) and potassium iodide 
(24mg). 	The reaction mixture was stirred under nitrogen 
for 8h, the reaction being monitored by TLC analysis 
(C). 	Thereaction solvent was evaporated in vacuo. 	The 
residue was dissolved in dichioromethane and the 
suspension filtered through kieselguhr. 	The kieselguhr 
was washed several times with dichloromethane (4 x 20 
ml), the solvent 	removed in vacuo, and the residue 
chromatographed on silica using a gradient eluent system 
with dichloromethane and ethyl acetate. 	The product 
(566b) was isolated as a gum (3005 mg) in 60% yield 
(unoptimised). 	Rf 0.49 (C); Vmax/cml 3410, 1785, 
1735, 1670, 1630, 1223; 'H n.m.r. (80MHz) O/ppm 0.0 (s, 
9H), 1.1 (m, j = 7Hz, 6H), 2.1 (s, 3H), 2.8 (m, 3H), 3.4 
(m, j = 7Hz, 5H), 3.8 (s, 2H), 4.5 - 5.2 (complex, 5H), 
5.8 (dd, j = 5, 9Hz, 1H), 6.4 (d, J = 9Hz, 1H), 6.9-7.3 
(complex, 8H). 
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1.4.5 cleavage of the (R) phenyoxyacetamido-penicillin-
anic acid (569a) from the "handle" derivative 
(566a) with tetra-n-butylaminonium fluoride (TBAF) 
The "handle" derivative (566a) (40 mg, 6.3 x 10-5 
mol) was dissolved in dry acetonitrile (5 ml) and flushed 
with nitrogen. 	The reaction mixture was stirred and 
cooled to 0°C,and a solution of TBAF in acetonitrile 
(0.022 M, 3 ml) was added dropwise. 	The reaction 
mixture was stirred for 5 min at 0°C and the solvent 
removed in vacuo. 	The residue was triturated with 
diethyl ether (3 x 10 ml), and then dissolved in distilled 
water (10 ml). 	The solution was washed with ethyl 
acetate (3 x 5 ml), and then cooled to 0°C. 	Ethyl 
acetate (10 ml) was added and the vigorously stirred 
solution was acidified carefully to pH 2.5 with 2N 
hydrochloric acid. 	The organic layer was removed and 
that 
dried with sodium sulphate. 	TLC analysis indicated/,no 
starting material was present (Rf = 0.65 (C)) and the 
solvent was removed in vacuo. 	A gum resulted (21 mg); 
Vmax/cml 3405, 1788, 1730, 1690. 	Comparison with an 
authentic sample of (6R), 5R-Phenoxy- acetamido 
penicillanic acid (569a) resulted in excellent agreement 
Vmax/cml 3405, 1786, 1728, 1690. 	The sample from 
diethyl ether washing had the following data:- Vmax/cml 
1650; 1 H n.m.r. (80 MHz) 5/ppm 1.1 (t, J = 9Hz, 6H), 
2.3 (5, 3H), 3.5 (q, J = 9Hz, 4H), 6.7 - 7.8 (complex, 
6H); these data suggested that the structure was a 
cinnamide derivative (567). 
Cleavage of (7R,6R) 2-thienylacetamidocephalosporanic 
acid (569b) from the "handle" derivative (566b) with 
tetra-n-butyl ammonium fluoride (TBAF) 
The "handle" derivative (566b) (60 mg, 9.21 x 10 5 
mol) was dissolved in acetonitrile (10 ml) and flushed 
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with nitrogen. 	The solution was cooled to 0°C and 
triethylamine in acetonitrile (0.2M, 0.5m1) was added. 
To the stirred reaction mixturesolution of TBAF (0.28 
mM, 3.30m1) was added dropwise. 
After 20 min. all volatile materials were removed 
in vacuo. 	To the residue,distilled water (30 ml) was 
added and a diethyl ether (3 x 20m1) extraction carried 
out. 	The aqueous layer was cooled to 0°c and ethyl 
acetate (20 ml) was added. 	The two phase system was 
vigorously stirred and adjusted to pH 8 with 5% w/v 
sodium carbonate. 	The organic layer was separated. The 
aqueous layer was diluted with ethyl acetate, cooled to 
0°C and acidified to pH 2.5 with 2N hydrochloric acid. 
The organic layer was separated, washed with brine, dried 
over sodium sulphate and filtered. 	The filtrate was 
concentrated in vacuo. 	A yellow gum resulted (20 mg) 
which wa 1not crystallisable. Vmax/cml 3405 (br), 1783, 
1740, 1685, 1604; This proved to be similar to an 
authentic sample of keflin acid (569b): Vmax cm-1 3405 
(br), 1785, 1742, 1685, 1605. 	The ethyacetate 
extraction of the basified solution resulted in a mixture 
of the cinnamide derivative (567) and the 
tetra-n-butylammonium keflin sal.t (568b). 	The diethyl 
ether extraction resulted in the cinnamide derivative 
(567); Vmax/cml 1650. 
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